N-benzhydryl indole compounds

ABSTRACT

Compounds of the formula  
                 
 
     in which R, R′, R 7 -R 11 , X, n 1  and n 3  are as defined herein. These compounds are useful as intermediates for preparing pharmaceutical compounds having pharmacological activity as chemical inhibitors of the activity of various phospholipase enzymes, particularly phospholipase A 2  enzymes.

[0001] This invention relates to novel N-Benzhydryl indole compoundsuseful as intermediates in the synthesis of compounds havingpharmacological activity as chemical inhibitors of the activity ofvarious phospholipase enzymes, particularly phospholipase A₂ enzymes,and more specifically cytosolic phospholipase A₂α.

BACKGROUND OF THE INVENTION

[0002] Leukotrienes and prostaglandins are important mediators ofinflammation, each of which classes contributes to the development of aninflammatory response in a different way. Leukotrienes recruitinflammatory cells such as neutrophils to an inflamed site, promote theextravasation of these cells and stimulate release of superoxide andproteases which damage the tissue. Leukotrienes also play apathophysiological role in the hypersensitivity experienced byasthmatics [See, e.g. B. Samuelson et al., Science, 237:1171-76 (1987)].Prostaglandins enhance inflammation by increasing blood flow andtherefore infiltration of leukocytes to inflamed sites. Prostaglandinsalso potentiate the pain response induced by stimuli.

[0003] Prostaglandins and leukotrienes are unstable and are not storedin cells, but are instead synthesized [W. L. Smith, Biochem. J.,259:315-324 (1989)] from arachidonic acid in response to stimuli.Prostaglandins are produced from arachidonic acid by the action of COX-1and COX-2 enzymes. Arachidonic acid is also the substrate for thedistinct enzyme pathway leading to the production of leukotrienes.

[0004] Arachidonic acid which is fed into these two distinctinflammatory pathways is released from the sn-2 position of membranephospholipids by phospholipase A₂ enzymes (hereinafter PLA₂). Thereaction catalyzed by PLA₂ is believed to represent the rate-limitingstep in the process of lipid mediated biosynthesis and the production ofinflammatory prostaglandins and leukotrienes. When the phospholipidsubstrate of PLA₂ is of the phosphotidyl choline class with an etherlinkage in the sn-1 position, the lysophospholipid produced is theimmediate precursor of platelet activating factor (hereafter calledPAF), another potent mediator of inflammation [S. I. Wasserman, HospitalPractice, 15:49-58 (1988)].

[0005] Most anti-inflammatory therapies have focussed on preventingproduction of either prostglandins or leukotrienes from these distinctpathways, but not on all of them. For example, ibuprofen, aspirin, andindomethacin are all NSAIDs which inhibit the production ofprostaglandins by COX-1/COX-2, but have no effect on the inflammatoryproduction of leukotrienes from arachidonic acid in the other pathways.Conversely, zileuton inhibits only the pathway of conversion ofarachidonic acid to leukotriense, without affecting the production ofprostaglandins. None of these widely-used anti-inflammatory agentsaffects the production of PAF.

[0006] Consequently the direct inhibition of the activity of PLA₂ hasbeen suggested as a useful mechanism for a therapeutic agent, i.e., tointerfere with the inflammatory response. [See, e.g., J. Chang et al,Biochem. Pharmacol., 36:2429-2436 (1987)].

[0007] A family of PLA₂ enzymes characterized by the presence of asecretion signal sequenced and ultimately secreted from the cell havebeen sequenced and structurally defined. These secreted PLA₂s have anapproximately 14 kD molecular weight and contain seven disulfide bondswhich are necessary for activity. These PLA₂s are found in largequantities in mammalian pancreas, bee venom, and various snake venom.[See, e.g., references 13-15 in Chang et al, cited above; and E. A.Dennis, Drug Devel. Res., 10:205-220 (1987).] However, the pancreaticenzyme is believed to serve a digestive function and, as such, shouldnot be important in the production of the inflammatory mediators whoseproduction must be tightly regulated.

[0008] The primary structure of the first human non-pancreatic PLA₂ hasbeen determined. This non-pancreatic PLA₂ is found in platelets,synovial fluid, and spleen and is also a secreted enzyme. This enzyme isa member of the aforementioned family. [See, J. J. Seilhamer et al, J.Biol. Chem., 264:5335-5338 (1989); R. M. Kramer et al, J. Biol. Chem.,264:5768-5775 (1989); and A. Kando et al, Biochem. Biophys. Res. Comm.,163:42-48 (1989)]. However, it is doubtful that this enzyme is importantin the synthesis of prostaglandins, leukotrienes and PAF, since thenon-pancreatic PLA₂ is an extracellular protein which would be difficultto regulate, and the next enzymes in the biosynthetic pathways for thesecompounds are intracellular proteins. Moreover, there is evidence thatPLA₂ is regulated by protein kinase C and G proteins [R. Burch and J.Axelrod, Proc. Natl. Acad. Sci. U.S.A., 84:6374-6378 (1989)] which arecytosolic proteins which must act on intracellular proteins. It would beimpossible for the non-pancreatic PLA₂ to function in the cytosol, sincethe high reduction potential would reduce the disulfide bonds andinactivate the enzyme.

[0009] A murine PLA₂ has been identified in the murine macrophage cellline, designated RAW 264.7. A specific activity of 2 mols/min/mg,resistant to reducing conditions, was reported to be associated with theapproximately 60 kD molecule. However, this protein was not purified tohomogeneity. [See, C. C. Leslie et al, Biochem. Biophys. Acta.,963:476-492 (1988)]. The references cited above are incorporated byreference herein for information pertaining to the function of thephospholipase enzymes, particularly PLA₂.

[0010] A cytosolic phospholipase A₂ (hereinafter “cPLA₂”) has also beenidentified and cloned. See, U.S. Pat. Nos. 5,322,776 and 5,354,677,which are incorporated herein by reference as if fully set forth. Theenzyme of these patents is an intracellular PLA₂ enzyme, purified fromits natural source or otherwise produced in purified form, whichfunctions intracellularly to produce arachidonic acid in response toinflammatory stimuli.

[0011] Now that several phospholipase enzymes have been identified, itwould be desirable to identify chemical inhibitors of the action ofenzymes, which inhibitors could be used to treat inflammatoryconditions, particularly where inhibition of production ofprostaglandins, leukotrienes and PAF are all desired results. Thereremains a need in the art for an identification of suchanti-inflammatory agents for therapeutic use in a variety of diseasestates. There also remains a need to identify novel intermediates andmethods of synthesizing such therapeutic agents.

SUMMARY OF THE INVENTION

[0012] This invention comprises intermediate compounds of formula I:

[0013] wherein

[0014] R is —(CH₂)_(n)—A, —(CH₂)_(n)—S—A, or —(CH₂)_(n)—O—A, where Arepresents:

[0015] D represents C₁-C₆ alkyl, C₁-C₆ alkoxy, —CF₃or —C₁₋₃alkyl-CF₃, Band C are each independently selected from the group consisting ofphenyl, pyridinyl, pyrimidinyl, furanyl, thiophenyl or pyrrolyl groups,each optionally substituted by from 1 to 3, preferably 1 to 2,substituents selected independently from the group consisting of H,halogen, —CN, —CHO, —CF₃, —OCF₃, —OH, —C₁-C₆ alkyl, C₁-C₆ alkoxy, —NH₂,—N(C₁-C₆)₂, —NH(C₁-C₆), —N—C(O)—(C₁-C₆), —NO₂, or by a 5- or 6-memberedheterocyclic or heteroaromatic ring containing 1 or 2 heteroatomsselected from O, N or S;

[0016] R′ is selected from the group consisting of —CH₂—OH,—CH₂—NH—S(O)₂—(CH₂)_(n2)-halo, —CH₂—NH—S(O)₂—CH═CH, —CH₂—NH₂, or aprotected form of —CH₂—NH₂;

[0017] R₇ and R₈ are independently selected from H, halogen, —CN, —CHO,—CF₃, —OCF₃, —OH, —C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ thioalkyl, —NH₂,—N(C₁-C₆)₂, —NH(C₁-C₆), —N—C(O)—(C₁-C₆), or —NO₂;

[0018] R₉ represents —(CH₂)_(n4)—CO₂H, an ester form of—(CH₂)_(n4)—CO₂H, or a pharmaceutically acceptable acid mimic ormimetic;

[0019] R₁₀ is selected from H, halogen, —CN, —CHO, —CF₃, —OCF₃, —OH,—C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ thioalkyl, —NH₂, —N(C₁-C₆)₂,—NH(C₁-C₆), —N—C(O)—(C₁-C₆), or —NO₂;

[0020] R₁₁ is selected from H, halogen, —CN, —CHO, —CF₃, —OCF₃, —OH,—C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ thioalkyl, —NH₂, —N(C₁-C₆)₂,—NH(C₁-C₆), —N—C(O)—(C₁-C₆), —NO₂, —N—C(O)—N(C₁-C₃ alkyl)₂,—N—C(O)—NH(C₁-C₃ alkyl), —N—C(O)—O—(C₁-C₃ alkyl), —SO₂—C₁-C₆ alkyl,—S—C₃-C₆ cycloalkyl, —S—CH₂—C₃-C₆ cycloalkyl, —SO₂—C₃-C₆ cycloalkyl,—SO₂—CH₂—C₃-C₆ cycloalkyl, C₃-C₆ cycloalkyl, —CH₂—C₃-C₆ cycloalkyl,—O—C₃-C₆ cycloalkyl, , —O—CH₂-C₃-C₆ cycloalkyl, phenyl, benzyl,benzyloxy, morpholino or other heterocycles such as pyrrolidino,piperidine, piperizine, furan, thiophene, imidazole, tetrazole,pyrazine, pyrazolone, pyrazole, imidazole, oxazole or isoxazole, therings of each of these groups each being optionally substituted by from1 to 3 substituents selected from the group of H, halogen, —CN, —CHO,—CF₃, —OH, —C₁-C₆ alkyl, C₁-C₆ alkoxy, —NH₂, —N(C₁-C₆)₂, —NH(C₁-C₆),—N—C(O)—(C₁-C₆), —NO₂, —SO₂(C₁-C₃ alkyl), —SO₂NH(C₁-C₃ alkyl),—SO₂N(C₁-C₃ alkyl)₂, or OCF₃;

[0021] n is an integer from 0 to 3;

[0022] n₁ is an integer from 0 to 3;

[0023] n₂ is an integer from 0 to 3

[0024] n₃ is an integer from 0 to 3;

[0025] n₄ is an integer from 0 to 2; and,

[0026] X is a linking group selected from the group consisting of —O—,—CH₂—, —SO₂—, —NH—, and —N(C₁-C₆-alkyl)—.

DETAILED DESCRIPTION OF THE INVENTION

[0027] A preferred embodiment of the invention comprises benzhydrylindole compounds of formula II:

[0028] wherein:

[0029] R′, R₇₋₁₁, X, n₁, n₂ and n₄ are as defined above; and,

[0030] R₁, R₂, R₃, R₄, R₅ and R₆ are each independently selected from H,halogen, —CN, —CHO, —CF₃, —OCF₃, —OH, —C₁-C₆ alkyl, C₁-C₆ alkoxy, —NH₂,—N(C₁-C₆)₂, —NH(C₁-C₆), —N—C(O)—(C₁-C₆), —NO₂, or a 5- or 6-memberedheterocyclic or heteroaromatic ring containing 1 or 2 heteroatomsselected from O, N or S.

[0031] The term halogen or halo is used in this specification to referto F, Cl, Br and I. Preferred halogen atoms in the R′ group—CH₂—NH—S(O)₂—(CH₂)_(n2)-halo include bromine and chlorine.

[0032] Preferred ester forms of the compounds of formula II wherein R₉is —(CH₂)n₄—CO₂H, are the C₁-C₈ alkyl esters, including straight,branched and cyclic alkyl groups, and benzyl esters.

[0033] Commercially available and art recognized amine protecting groupsare useful to form the protected forms of the —(CH₂)_(n1)—CH₂—NH₂ groupsdescribed above. These include those represented by the formulae below,wherein the number of carbon atoms in the chain are merely presented forillustration and do not limit the number of carbon atoms in thecorresponding carbon chains of this invention.

[0034] Other non-limiting examples of amine protecting groups usefulWith the compounds of this invention include, but are not limited to,the following:

[0035] 1) amide types such as formyl, acetyl, chloroacetyl,trichloroacetyl, o-nitrophenylacetyl, o-nitrophenoxyacetyl,trifluoroacetyl, acetoacetyl, -phthalyl, and p-toluenesulfonyl;

[0036] 2) aromatic carbamate types such as benzyloxycarbonyl (CBZ), andbenzyl substituted one or more time with with alkyl, cyano, nitro,chloro, fluoro, bromo, and methoxy; diphenylmethyl,1-(p-biphenyl)-1-methylethyl, 9-fluorenylmethyl (Fmoc), 2-phenylethyl,and cinnamyl groups;

[0037] 3) aliphatic carbamate types such as tert-butyloxycarbonyl (Boc),ethyl, diisopropylmethyl, allyl, vinyl, t-amyl, diisopropylmethyl, andisobutyl ; 4) cyclic alkyl carbamate types such as cyclopentyl,cyclohexyl, cyclopropylmethyl, and adamantyl;

[0038] 5) alkyl type amine protecting groups such as triphenylmethyl(trityl) and benzyl;

[0039] 6) trialkylsilane groups such as trimethylsilane, triethylsilane,triisopropylsilane, tri-t-butylsilane, triphenylsilane, tritolylsilane,trimesitylsilane, methyldiphenylsilane, dinaphthylmethylsilane,bis(diphenyl)methylsilane, etc.; and

[0040] 7) thiol containing types of protecting groups, such asphenylthiocarbonyl and dithiasuccinoyl protecting groups.

[0041] Other preferred amine protecting groups for use with thisinvention are ethoxycarbonyl groups, acyl groups, including4-chlorobutyryl isobutyryl, o-nitrocinnamoyl, picolinoyl,acylisothiocyanate, aminocaproyl, benzoyl and the like, and acyloxygroups including methoxycarbonyl, 9-fluorenylmethoxycarbonyl,2,2,2-trifluoroethoxycarbonyl, 2-trimethylsilylethxoy carbonyl,vinyloxycarbonyl, allyloxycarbonyl, 1,1-dimethylpropynyloxycarbonyl,p-nitrobenzyloxycarbony, 2,4-dichlorobenzyloxycarbonyl, and the like.

[0042] Pharmaceutically acceptable acid mimics or mimetics which mayappear at R₉ include those selected from the formulae:

[0043] wherein R_(a) is selected from —CF₃, —CH₃, phenyl, or benzyl,with the phenyl or benzyl groups being optionally substituted by from 1to 3 groups selected from C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ thioalkyl,—CF₃, halogen, —OH, or —COOH; R_(b) is selected from

[0044] —CF₃, —CH₃, —NH₂, phenyl, or benzyl, with the phenyl or benzylgroups being optionally substituted by from 1 to 3 groups selected fromC₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ thioalkyl, —CF₃, halogen, —OH, or—COOH; and R_(c) is selected from —CF₃ or C₁-C₆ alkyl.

[0045] Another preferred embodiment of the compounds of this inventionis represented by formula III:

[0046] wherein each of the variables R₁ through R₁₁, X and n4 are asdefined above. A particularly preferred embodiment are compounds offormula III in which R₁ through R₆ are each hydrogen.

[0047] Another preferred embodiment of the compounds of this inventionare those of formula IV:

[0048] wherein each of the variables R₁ through R₁₁, and X are asdefined above.

[0049] A particularly preferred embodiment of the of this invention arecompounds of formula IV in which R₁ through R₆ are each hydrogen.

[0050] Among the most preferred compounds of the present invention arethe compounds below which are designated Intermediates No. 1, 2 and 3.An illustrative method for making these intermediates is also shown.These examples of highly preferred compounds and methods should not beconstrued as limiting the scope of the invention.

[0051] Intermediate No. 1

[0052]4-{2-[2-(2-Amino-ethyl)-1-benzyhydryl-5-chloro-1H-indol-3-yl]-ethanesulfonyl}-benzoicacid methyl ester

[0053] Step 1: 2-Bromo-4-chloroaniline(1.0 eq) was dissolved in CH₂Cl₂(0.25M), then triethylamine and triflouroacetyl anhydride(1.1 eq each)were added. The resulting mixture was stirred at room temperature for 1hour. Solvent was then stripped-off from the reaction mixture, and theresidue was purified by flash chromatography with dichloromethane aseluent to give the described product in 97% yield. m/z(M-H)⁻300.0.

[0054] Step 2: N-(2-Bromo-4-chlorophenyl)-2,2,2-trifluoroacetamide (step1, 1.0 eq) was mixed with 3-butyn-1-ol(2.0 eq),dichlorobis(triphenylphosphine)palladium(II) (2.5% eq),triethylamine(3.0 eq), Cul(5% eq) in DMF(0.2M) in a sealed vessel underN₂ and heated to 120° C. for 4 hours. The reaction mixture was thendiluted with ethyl acetate, washed with brine and dried over Na₂SO₄.Furthermore, evaporate the solvent and the residue was purified by flashcolumn chromatography with 2% MeOH/CH₂Cl₂ to give the described2-(5-Chloro-1H-indol-2-yl)ethanol in 67% yield. m/z(M-H)⁻194.09

[0055] Step 3: 2-(5-chloro-1H-indol-2-yl)ethanol (1 eq) was added to asolution (under N₂) containing tert-Butyldiphenylchlorosilane (1.2 eq),imidazole (2.5 eq), and DMF (1.8M). The reaction was stirred overnight.Quenched with NaHCO_(3 (aq)) and extracted with a Et₂O/EtOAc mixture.The organic layer was washed with water and brine and dried over sodiumsulfate. Purified with silica gel column and 1:4 Hexane/CH₂Cl₂ aseluent. Obtained2-({[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indole (yellowoil) in 98% yield.

[0056] Step 4: Methyl 4-[(2-oxoethyl)sulfanyl]benzoate (3.7 eq) wasadded to a solution containing2-({[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indole (1 eq), TFA(3 eq), and 1,2-dichloroethane (0.1M) at 0° C. under N₂. Then Et₃SiH (12eq) was added and the reaction was allowed to return to room temperatureand stirred overnight. Quenched reaction with NaHCO_(3(aq)) andextracted with EtOAc and washed with brine and dried over sodiumsulfate. Purified with silica gel column and 1:5 EtOAc/Hexane as eluent.Obtained methyl4-({2-[2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)benzoate(yellow solid) in 79% yield.

[0057] Step 5: Methyl4-({2-[2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)benzoate(1 eq) was added to a suspension of NaH (1.1 eq) in DMF (0.37M) at 0° C.under N₂. After 30 minutes Ph₂CHBr (1.8 eq) was added and the reactionwas warmed to room temperature. After 3 hours the reaction was quenchedwith NH₄Cl_((aq)) and extracted with EtOAc/Et₂O mix and washed withwater and brine and dried over sodium sulfate. Purified with silica gelcolumn and 1:5 EtOAc/Hexane. Obtained methyl3-[4-({2-[1-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)phenyl]benzoate(yellow gum) in 65% yield.

[0058] Step 6: NMO (4 eq) was added to a solution/suspension containingmethyl3-[4-({2-[1-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)phenyl]benzoate(1 eq), ACN (0.1M), and molecular sieves (1 g/mmole of benzoate) underN₂. After 10 minutes TPAP (0.12 eq) was added and the mixture was heatedto 40° C. After 1.5 hours the reaction was cooled and filtered and thefiltrate was collected. Purified with silica gel column and 1:5EtOAc/Hexane. Obtained methyl3-[4-({2-[1-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(white solid) in 71% yield.

[0059] Step 7: Tetrabutylammonium fluoride (1M in THF) (1.2 eq) wasadded to a solution of methyl3-[4-({2-[1-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(1 eq) and THF (0.1M) at 0° C. under N₂. Warmed reaction to roomtemperature and after 1 hour quenched with NH₄Cl_((aq)). Extracted withEtOAc and washed with brine and dried over sodium sulfate. Purified withsilica gel column and 1:9 EtOAc/CH₂Cl₂. Obtained methyl3-[4-({2-[1-benzhydryl-5-chloro-2-(2-hydroxyethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(white solid) in 86% yield.

[0060] Step 8: CH₃SO₂Cl (2 eq) and Et₃N (2.5 eq) were added to asolution of methyl3-[4-({2-[1-benzhydryl-5-chloro-2-(2-hydroxyethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate (1 eq) in CH₂Cl₂ (0.02M) at 0° C. under N₂. After 1 hour thereaction was warmed to room temperature. After an additional hour waterwas added and extracted with CH₂Cl₂ and washed with brine and dried oversodium sulfate. Removed solvent to obtain methyl3-(4-{[2-(1-benzhydryl-5-chloro-2-{2-[(methylsulfonyl)oxy]ethyl}-1H-indol-3-yl)ethyl]sulfonyl}phenyl)benzoate(light-yellow solid) in 99% yield.

[0061] Step 9: Methyl3-(4-{[2-(1-benzhydryl-5-chloro-2-{2-[(methylsulfonyl)oxy]ethyl}-1H-indol-3-yl)ethyl]sulfonyl}phenyl)benzoate(1 eq), sodium azide (5 eq), and DMF (0.05M) were placed together underN₂ and heated to 60° C. After 1 hour the reaction was cooled and waterwas added. Extracted with EtOAc/Et₂O mix and washed with water and brineand dried over sodium sulfate. Removed solvent to obtain methyl3-[4-({2-[2-(2-azidoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(light-yellow solid) in 99% yield.

[0062] Step 10: Methyl3-[4-({2-[2-(2-azidoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(1 eq), PPh₃ (2 eq), and THF (0.1M) were placed together under N₂ andstirred overnight. Water (1 mL/1 mmole benzoate) was added and reactionwas again stirred overnight. The solution was concentrated and purifiedwith silica gel column and 3:1 EtOAc/Hexane followed by 5% MeOH inCH₂Cl₂. Obtained methyl3-[4-({2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(light-yellow solid) in 99% yield.

[0063] Synthesis of Intermediate No. 1 is also described below inExample 135, Steps 1-8. This intermediate could also be synthesized bymethod K or method M, which are set forth below.

[0064] Intermediate No. 2

[0065]4-{2-[2-(2-Amino-ethyl)-1-benzyhydryl-5-chloro-1H-indol-3-yl]-ethoxy}-benzoicacid methyl ester.

[0066] Step 1: To 4-hydroxy-benzoic acid methyl ester (1.0 eq) in DMF(0.83 M) was added K₂CO₃ (2.0 eq) followed by2-bromo-1,1-diethoxy-ethane and the reaction mixture was stirred at 110°C. for 2 days. TLC showed a new spot. The reaction mixture was dilutedwith ethyl acetate, washed with 1N NaOH, water, and brine, dried oversodium sulfate, and solvent was removed to afford desired product in 84%yield. This material was used in the next step without furtherpurification.

[0067] Step 2: To the above product (1.0 eq) and 5-chloro-2-methylindole (1.0 eq) in CH₂Cl₂ (0.12 M) was added triethylsilane (3.0 eq)followed by trifluoroacetic acid (3.0 eq). After being stirred overnightat room temperature, added water and trifluroacetic acid (1.0 eq) to thereaction mixture, stirred at room temperature for two days, diluted withCH₂Cl₂, washed with 1N NaOH, water, brine, dried over sodium sulfate.Trituration of the material with CH₂Cl₂ and hexanes afforded the C3alkylated indole in 92% yield

[0068] Step 3: To the indole from above (1.0 eq) in DMF (0.36 M) at 25°C. was added NaH (1.2 eq, 60% dispersion in oil), and the brown solutionwas stirred at 0 to −5° C. for 1 h and then compoundbromodiphenylmethane was added (1.1 eq), and then the reaction mixturewas stirred overnight. It was then quenched with water, diluted withethyl acetate, washed with water and brine, dried over sodium sulfateand purified by column chromatography to yield 72% of the desiredproduct.

[0069] Step 4: To the N-alkylated indole from above (1.0 eq) in CCl₄(0.2 M) was added N-bromosuccinimide (2.0 eq) and a catalytic amount ofbenzoyl peroxide. The solution was heated to reflux for 3h, cooled to25° C., filtered, and the solid was washed with CCl₄. The filtrate wasconcentrated to a foam, which was dried. The foam was dissolved inacetone, and Ag₂CO₃ (1.1 eq.) was added followed by water and thereaction mixture was stirred overnight at room temperature. It wasfiltered and washed with acetone. The filtrate was concentrated to aresidue, to which was added water. This mixture was extracted with ethylacetate, washed with brine, dried over sodium sulfate and thenchromatographic purification on the residue gave the desired product in85% yield. Alternatively the dibromide from the reaction with NBS couldbe poured into DMSO (10-20% concentration by weight) stirred for 30minutes at room temperature. When the reaction was deemed complete itwas poured into water and the resulting precipitate was isolated byfiltration, the cake was washed with water and dried to yield anessentially quantitative yield.

[0070] Step 5: To the above aldehyde (1.0 equiv) in CH₃NO₂ (0.2 M) wasadded ammonium acetate (4 equiv) and the resulting mixture was heated toreflux for 4 h. The reaction mixture was then diluted with EtOAc andwashed with brine. The aqueous phase was extracted with EtOAc. Thecombined organic extracts were washed with brine, dried over sodiumsulfate, and concentrated until an orange crystalline solidprecipitated. The mixture was refrigerated overnight and the nitroolefin(76% yield) was collected by filtration. Evaporation of the solutionphase and purification of the residue by column chromatography (gradientelution 100% toluene→11% EtOAc-toluene) afforded an additional amount ofthe nitroolefin (23% yield).

[0071] Step 6: Zinc dust (20 equiv) was suspended in 5% aqueous HClsolution (8 M Zn/5% HCl). To this mixture was added HgCl₂ (0.28 equiv).The mixture was shaken for 10 min, the aqueous phase was decanted andreplaced with fresh 5% HCl, and again the mixture was shaken for 5 minand the aqueous phase was removed. The zinc-mercury amalgam thusgenerated was then added to a mixture of the nitroolefin (1.0 equiv) andconc. HCl (80 equiv) in THF (0.04 M nitroolefin/THF). The mixture wasmaintained at a gentle reflux for 1 h. The formation of product wasfollowed by TLC analysis. The mixture was cooled to room temperature andthe solids were removed by filtration through Celite. Conc. NH₄OH wasadded to the solution phase and the mixture was concentrated on therotary evaporator. The residue was dissolved in CH₂Cl₂ and conc. NH₄OH.The aqueous phase was extracted with CH₂Cl₂, and the organic phase waswashed with brine, dried over sodium sulfate, and concentrated.Purification by column chromatography afforded the desired product (65%yield).

[0072] Synthesis of Intermediate No. 2 is also described in Example 1,Steps 1-6. This intermediate could also be synthesized using methods K,L, or M, as set forth below.

[0073] Intermediate No. 3

[0074]4-{3-[2-(2-Amino-ethyl)-1-benzyhydryl-5-chloro-1H-indol-3-yl]-propyl}-benzoicacid methyl ester

[0075] Step 1: A mixture of methyl-4-iodobenzoate (5.3 g, 20.2 mmol),allyl alcohol (1.78 g, 30.3 mmol), NaHCO₃ (4.24 g, 50.5 mmol), Pd(OAc)₂(0.14 g, 0.60 mmol), (n-Bu)₄NBr (6.55 g, 20.2 mmol) and 4-A molecularSieves (4.1 g) in anhydrous DMF (69 mL) was stirred at room temperaturefor 4 days. The reaction mixture was filtered through celite and thefiltrate poured onto water and extracted with EtOAc. Organic layer waswashed with brine, dried (Na₂SO₄), and concentrated under vaccum. Flashchromatography (silica gel, 10-20% EtOAc-hexanes) gave 2.11 g (85% basedon the recovered starting material) of the desired4-(3-Oxo-propyl)-benzoic acid methyl ester as a clear oil.

[0076] Step 2: To a solution of 5-chloro-2-methylindole (0.86 g, 5.2mmol) and 4-(3-Oxo-propyl)-benzoic acid methyl ester (1.0 g, 5.2 mmol)in methylene chloride (50 mL), was added TFA (1.78 g, 15.6 mmol),followed by triethylsilane (1.81 g, 15.6 mmol). The reaction mixture wasstirred overnight, quenched with sat. NaHCO₃ solution (50 mL), and theorganic layer was washed with sat. NaHCO₃ solution, water, brine, anddried (Na₂SO₄). Solvent was removed under reduced pressure, and theresidue was purified by flash column chromatography with 10-20%EtOAc/hexanes to yield the desired product in 94% (1.67 g) yield.

[0077] Step 3: To a solution of the product from step 2 (1.66 g, 4.86mmol) in DMF (20 mL) was added NaH (60% in mineral oil, 0.24 g, 5.83mmol) under N₂ atmosphere. The mixture was stirred for 1 h at roomtemperature, followed by the dropwise addition of benzhydryl bromide(1.8 g, 7.29 mmol) in DMF (5 mL). This reaction mixture was stirredovernight at room temperature. Water (500 mL) was added to reactionmixture, it was extracted with EtOAc, washed with brine, dried (Na₂SO₄),and concentrated under reduced pressure to a brown syrup, which waspurified by silica-gel chromatography using 10% EtOAc/hexanes as eluentto isolate 4 as a white solid in 59% (1.47 g) yield.

[0078] Step 4: The product from above (1.46 g, 2.87 mmol) was dissolvedin CCl₄ (14.5 mL), followed by the addition of NBS (1.02 g, 5.73 mmol)and benzoyl peroxide (2 mg). The reaction mixture was heated to refluxfor 1 h (until all the starting material disappeared). This mixture wascooled to room temperature, filtered and the solid was washed with CCl₄.The filtrate was evaporated to a brown residue, which was dissolved inacetone (40 mL) and water (4 mL), Ag₂CO₃ (1.75 g, 3.16 mmol) was thenadded to this solution and after being stirred overnight at roomtemperature, it was filtered through celite, the solvent was evaporatedunder reduced pressure, and water was added to the residue. It wasextracted with EtOAc, washed with brine, dried (Na₂SO₄), and evaporatedto a syrup, which was purified by 10% EtOAc/hexanes to isolate the2-formyl indole (1.13 g) in 75% yield. Alternatively the dibromide fromthe reaction with NBS could be poured into DMSO (10-20% concentration byweight) and stirred for 30 minutes at room temperature. When thereaction was deemed complete it was poured into water and the resultingprecipitate was isolated by filtration, the cake was washed with waterand dried to yield an essentially quantitative yield.

[0079] Step 5: To a solution of the 2 formyl indole from above (0.52 g,1 mmol) in CH₃NO₂ (6.2 mL) was added NH₄OAC (0.077 g, 1 mmol), themixture was heated to reflux for 1 h, NH₄OAc (0.077 g, 1 mmol) was thenadded, heating at reflux was continued for an additional 1 h, NH₄Oac(0.077 g, 1 mmol) was added again and the heating continued for further1 h. The reaction mixture was allowed to attain room temperature, EtOAc(50 mL) was added, followed by the addition of 100 mL water. The aqueouslayer was extracted with EtOAc, and the combined organic layers werewashed with brine, dried (Na₂SO₄), and evaporated to a yellow foam,which was subjected to chromatographic purification using 10%EtOAc/hexanes as an eluent to yield 6 as a yellow foam in 68% yield(0.38 g).

[0080] Step 6: Zn(Hg) was made by adding HgCl₂ ( 3.4 g, 7.2 mmol) to amixture of Zn-dust (34.68 g, 530.35 mmol) and 5% HCl (38 mL) in a 100 mLbeaker, this mixture was stirred vigorously for 10 min. Aqueous phasewas decanted and added 38 mL of 5% HCl again and the mixture was stirredfor 10 min. Aqueous phase was decanted. This solid was added to thevinyl nitro compound 6 (15 g, 26.57 mmol) in THF (660 mL) and conc. HCl(64.5 mL). This mixture was stirred at room temperature for 1 h, then atreflux for 15 min. The reaction mixture was cooled to room temperatureand filtered through celite. Aq. NH₄OH solution (200 mL) was added tothe filtrate, stirred for 15 min and THF was removed under reducedpressure. The aqueous layer was extracted with CH₂Cl₂, combined organiclayer was washed with brine, dried (Na₂SO₄) and concentrated to a brownfoam, which was purified by column chromatography by eluting the columnwith CHCl₃ in the beginning to remove non-polar impurities then with 2%MeOH/CHCl₃ to isolate the desired amine in 46% yield (6.1 g).

[0081] Synthesis of Intermediate No. 3 is also described below inExample 42, Steps 1-6. This intermediate could also be formed usingMethods J, K, or M, as set forth below.

[0082] Intermediate No. 4

[0083]4-{2-[2-(2-Amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethylamino}-benzoicacid methyl ester

[0084] Step 1: To a solution of 4-chloro-2-iodoaniline (16.5 g, 65.1mmol) in DMF (250 mL) at rt were added α-bromodiphenylmethane (21.5 g,84.6 mmol) and ^(i)Pr₂NEt (23 mL, 130 mmol) and the reaction mixture washeated at 45° C. overnight. After the volatile was removed under reducedpressure, the residue was dissolved in EtOAc, washed with water (3×) andbrine and dried over MgSO₄. Purification on SiO₂ column chromoatography(hexanes to 5% EtOAc/hexanes) gave the desiredBenzhydryl-(4-chloro-2-iodo-phenyl)-amine (26.1 g, 97% yield) as ayellowish solid.

[0085] Step 2: A mixture of benzhydryl-(4-chloro-2-iodo-phenyl)-amine(26.1 g, 62.2 mmol), PdCl₂(PPh₃)₂ (1.90 g, 2.67 mmol), Cul (1.2 g, 6.2mmol), 3-butyn-1-ol, and Et₃N (120 mL) was stirred at 45° C. for 20hours. The reaction mixture was filtered through celite and rinsed withEtOAc. The filtrate was concentrated, redissolved in EtOAc, washed withwater (3×) and brine, and dried over MgSO₄. The crude4-[2-(Benzhydryl-amino)-5-chloro-phenyl]-but-3-yn-1-ol (25.5 g) was usedin the next step directly without further purification.

[0086] Step 3: A solution of the crude4-[2-(benzhydryl-amino)-5-chloro-phenyl]-but-3-yn-1-ol (25.5 g) and Cul(2.7 g, 14.1 mmol) in DMF (200 mL) was heated at 125° C. for 24 hours.The reaction mixture was filtered through celite and rinsed with EtOAc.The filtrate was concentrated, redissolved in EtOAc, washed with water(3×) and brine, and dried over MgSO₄. Silica gel column chromatography(30% EtOAc/hexanes) yielded the desired2-(1-Benzhydryl-5-chloro-1H-indol-2-yl)-ethanol as a yellow solid (14.5g, 73% over 2 steps).

[0087] Step 4: To a solution of2-(1-benzhydryl-5-chloro-1H-indol-2-yl)-ethanol (15.3 g, 42.3 mmol) inCH₂Cl₂ (190 mL) at 0° C. were added imidazole (3.72 g, 55.0 mmol) andTBDPSCI (13.2 mL, 50.8 mmol). After stirring at the same temperature for1.5 hours, the reaction mixture was washed with cold water (3×) andbrine, and dried over MgSO₄. The crude silyl ether was used in the nextstep directly without further purification.

[0088] Step 5: To a solution of the crude silyl ether in Et₂O (200 mL)at 0° C. was added oxalyl chloride (4.84 mL, 55.5 mmol) dropwise. Thereaction mixture was allowed to warm to rt and stirring continued for 4hours before Et₃N (35 mL) and MeOH (10 mL) were added. The mixture waswashed with water, brine, and dried over MgSO₄. The crude keto ester wasused directly in the next step.

[0089] Step 6: To the keto ester in THF (300 mL) was added BH₃.Me₂S (10M, 36 mL) dropwise at rt and the reaction mixture was refluxedovernight. The mixture was cooled at 0° C. before NaOH (30%, 150 mL) wasadded and stirring continued for 30 min. THF was removed under reducedpressure and the reaction mixture was extracted with EtOAc, washed withwater, brine, and dried over MgSO₄. Purification on columnchromatography (15 to 20% EtOAc/hexanes) yielded the desired product asa white solid (15.9 g, 24.7 mmol, 58% over 3 steps).

[0090] Step 7: To a solution of oxalyl chloride (0.372 mL, 4.27 mmol) inCH₂Cl₂ (10 mL) at 78° C. was added DMSO (0.661 mL, 9.31 mmol) dropwise.The reaction mixture was stirred at the same temperature for 5 minbefore a solution of2-{1-benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl}-ethanol(2.50 g, 3.88 mmol) in CH₂Cl₂ (8 mL) was introduced. After additional 40min stirring, ^(i)Pr₂NEt (3.38 mL, 19.4 mmol) was added and the reactionwas quenched with cold water (5 mL) and extracted with CH₂Cl₂. Theorganic layer was dried over MgSO₄ and evaporated. The crude{1-Benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl)-acetaldehydewas used directly in the next step.

[0091] Step 8: To a solution of the crude aldehyde (3.88 mmol) in1,2-dichloroethane (39 mL) at 0° C. were added methyl 4-aminobenzoate(645 mg, 4.27 mmol), acetic acid (1.33 mL), and NaBH(OAc)₃. The reactionmixture was allowed to warm to rt overnight and quenched with coldNaHCO₃. An extractive workup furnished the desired4-(2-{1-Benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl}-ethylamino)-benzoicacid methyl ester which was used directly in the next step withoutfurther purification.

[0092] Step 9: To4-(2-{1-benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl}-ethylamino)-benzoicacid methyl ester (3.88 mmol) in THF (25 mL) at 0° C. was added amixture of HOAc:1M TBAF (in THF) (2.3 mL:5.8 mL) and the reactionmixture was allowed to stir at rt for 18 h. Extractive workup followedby trituration with 5%EtOAc/hex gave the desired4-{2-[1-Benzhydryl-5-chloro-2-(2-hydroxy-ethyl)-1H-indol-3-yl]-ethylamino}-benzoicacid methyl ester with slight impurity as an off-white solid (92%, over3 steps).

[0093] Step 10: To a solution of4-{2-[1-benzhydryl-5-chloro-2-(2-hydroxy-ethyl)-1H-indol-3-yl]-ethylamino}-benzoicacid methyl ester (1.64 g, 3.04 mmol) in CH₂Cl₂ at 0° C. were added Et₃N(0.636 mL, 4.56 mmol) and MsCl (0.282 mL, 3.64 mmol). After stirring atthe same temperature for 35 min, the reaction mixture was quenched withcold water. An extractive workup revealed the crude mesylate as anoff-white solid (1.70 g, 90%).

[0094] Step 11: A solution of the crude mesylate (1.70 g, 2.75 mmol) andNaN₃ (89 mg, 13.8 mmol) in DMF (14 mL) was stirred at 80° C. for 6 h.The reaction mixture was diluted with EtOAc and subjected to an aqueousworkup followed by flash column chromatography to yield the desired4-{2-[2-(2-Azido-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethylamino}-benzoicacid methyl ester (813 mg, 52% yield).

[0095] Step 12: To4-{2-[2-(2-azido-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethylamino}-benzoicacid methyl ester (400 mg, 0.709 mmol) in THF (4 mL) at 0 C was addedPh₃P (223 mg, 0.851 mmol) in portions. The reaction mixture was stirredat rt for 11 h and 35° C. for 4 h before water (50 uL) was added andstirring continued overnight. The reaction mixture was diluted withEtOAc, dried with MgSO₄ and purified by flash column chromatography(EtOAc to 20%MeOH/EtOAc with 1% Et₃N) to give the desired4-{2-[2-(2-Amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethylamino}-benzoicacid methyl ester (201 mg, 53%) as a solid.

[0096] Synthesis of Intermediate No. 4 is also described below inExample 142, Steps 1-12.

[0097] Intermediate No. 5

[0098]4-({2-[2-(2-Amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethyl}-methyl-amino)-benzoicacid methyl ester

[0099] Step 1: Crude{1-Benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl}-acetaldehydefrom Intermediate No. 4 synthesis Step 7 was treated with4-Methylamino-benzoic acid methyl ester according to the procedure inIntermediate No. 4 step 8 to yield the desired4-[(2-{1-Benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl}-ethyl)-methyl-amino]-benzoicacid methyl ester in 73% yield.

[0100] Step 2: The title compound was prepared according to theprocedure described for Intermediate No 4 step 9. The crude4-({2-[1-Benzhydryl-5-chloro-2-(2-hydroxy-ethyl)-1H-indol-3-yl]-ethyl}-methyl-amino)-benzoicacid methyl ester was used in the next step directly without furtherpurification.

[0101] Step 3-6:4-({2-[2-(2-Azido-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethyl}-methyl-amino)-benzoicacid methyl ester was prepared according to the procedure described forIntermediate No. 4 steps 10-12 in 61% (3 steps).

[0102] Step 7: A solution of4-({2-[2-(2-azido-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethyl}-methyl-amino)-benzoicacid methyl ester (410 mg, 0.709 mmol) and 10% Pd/C (155 mg) inMeOH:CH₂Cl₂ (=7 mL:1 mL) was stirred under H₂ atmosphere (1 atm) for 2 h15 min. The reaction mixture was filtered through celite and rinsed withMeOH and CH₂Cl₂. Flash column chromatography (CH₂Cl₂to 8% MeOH/CH₂Cl₂)of the residue gave the desired4-({2-[2-(2-Amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethyl}-methyl-amino)-benzoicacid methyl ester in 78% yield (305 mg).

[0103] Synthesis of Intermediate No. 5 is also described below inExample 146, Steps 1-7.

[0104] The compounds of this invention may be used as intermediates inthe synthesis of pharmaceutically useful compounds of formula V:

[0105] wherein:

[0106] X is a linking group selected from of —O—, —CH₂—, —SO₂—, —NH—,and —N(C₁-C₆—alkyl)—;

[0107] R₁, R₂, R₃, R₄, R₅ and R₆ are each independently selected from H,halogen, —CN, —CHO, —CF₃, —OCF₃, —OH, —C₁-C₆ alkyl, C₁-C₆ alkoxy, —NH₂,—N(C₁-C₆)₂, —NH(C₁-C₆), —N—C(O)—(C₁-C₆), —NO₂, or a 5- or 6-memberedheterocyclic or heteroaromatic ring containing 1 or 2 heteroatomsselected from O, N or S;

[0108] R₇ and R₈ are independently selected from H, halogen, —CN, —CHO,—CF₃, —OCF₃, —OH, —C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ thioalkyl, —NH₂,—N(C₁-C₆)₂, —NH(C₁-C₆), —N—C(O)—(C₁-C₆), or —NO₂;

[0109] R₉ is the formula —(CH₂)_(n4)—CO₂H or a pharmaceuticallyacceptable acid mimic or mimetic, as defined above;

[0110] R₁₀ is selected from H, halogen, —CN, —CHO, —CF₃, —OCF₃, —OH,—C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ thioalkyl, —NH₂, —N(C₁-C₆)₂,—NH(C₁-C₆), —N—C(O)—(C₁-C₆), or —NO₂;

[0111] R₁₁ is selected from H, halogen, —CN, —CHO, —CF₃, —OCF₃, —OH,—C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ thioalkyl, —NH₂, —N(C₁-C₆)₂,—NH(C₁-C₆), —N—C(O)—(C₁-C₆), —NO₂, —N—C(O)—N(C₁-C₃ alkyl)₂,—N—C(O)—NH(C₁-C₃ alkyl), —N—C(O)—O—(C₁-C₃ alkyl), —SO₂—C₁-C₆ alkyl,—S—C₃-C₆ cycloalkyl, —S—CH₂—C₃-C₆ cycloalkyl, —SO₂—C₃-C₆ cycloalkyl,—SO₂—CH₂—C₃-C₆ cycloalkyl, C₃-C₆ cycloalkyl, —CH₂—C₃-C₆ cycloalkyl,—O—C₃-C₆ cycloalkyl, —O—CH₂—C₃-C₆ cycloalkyl, phenyl, benzyl, benzyloxy,morpholino or other heterocycles such as pyrrolidino, piperidine,piperizine furan, thiophene, imidazole, tetrazole, pyrazine, pyrazolone,pyrazole, imidazole, oxazole or isoxazole, the rings of each of these R₄groups each being optionally substituted by from 1 to 3 substituentsselected from the group of H, halogen, —CN, —CHO, —CF₃, —OH, —C₁-C₆alkyl, C₁-C₆ alkoxy, —NH₂, —N(C₁-C₆)₂, —NH(C₁-C₆), —N—C(O)—(C₁-C₆),—NO₂, —SO₂(C₁-C₃ alkyl), —SO₂NH(C₁-C₃ alkyl), —SO₂N(C₁-C₃ alkyl)₂, orOCF₃;

[0112] n₁ is an integer from 1 to 3;

[0113] n₂ is an integer from 0 to 4;

[0114] X, is selected from a chemical bond, —S—, —O—, —S(O)—, —S(O)₂—,—NH—, —NHC(O)—, —C═C—

[0115] R₁₂ is a ring moiety selected from C₁-C₆ alkyl, C₁-C₆ fluorinatedalkyl, C₃-C₆ cycloalkyl, tetrahydropyranyl, camphoryl, adamantyl, CN,—N(C₁-C₆ alkyl)₂, phenyl, pyridinyl, pyrimidinyl, furyl, thienyl,napthyl, morpholinyl, triazolyl, pyrazolyl, piperidinyl, pyrrolidinyl,imidazolyl, piperizinyl, thiazolidinyl, thiomorpholinyl, tetrazole,indole, benzoxazole, benzofuran, imidazolidine-2-thione,7,7-dimethyl-bicyclo[2.2.1]heptan-2-one or pyrrolyl groups, eachoptionally substituted by from 1 to 3, preferably 1 to 2, substituentsindependently selected from H, halogen, —CN, —CHO, —CF₃, —OH, —C₁-C₆alkyl, C₁-C₆ alkoxy, —NH₂, —N(C₁-C₆)₂, —NH(C₁-C₆), —N—C(O)—(C₁-C₆),—NO₂, —SO₂(C₁-C₃ alkyl), —SO₂NH₂, —SO₂NH(C₁-C₃ alkyl), SO₂N(C₁-C₃alkyl)₂, OCF₃, —COOH, —CH₂—COOH, —CH₂—N(C₁-C₆ alkyl), —CH₂—N(C₁-C₆alkyl)₂, —CH₂—NH₂, pyridine or

[0116] or a pharmaceutically acceptable salt or ester form thereof.

[0117] Among the more preferred ester forms of the compounds of formulaV wherein R₉ is the formula —(CH₂)_(n4)—CO₂H, are the C₁-C₈ alkylesters, including straight, branched or cyclic alkyl groups, or benzylesters.

[0118] The final pharmaceutically useful compounds of formula V, whichmay be prepared using the intermediate compounds of this invention,inhibit cPLA₂ activity which is required for supplying arachidonic acidsubstrate to cyclooxygenase-1 or -2 and 5-lipoxygenase which in turninitiate the production of prostaglandins and leukotrienes respectively.In addition, cPLA₂ activity is essential for producing thelyso-phospholipid that is the precursor to PAF. Thus the final compoundsare useful in the treatment and prevention of disease states in whichleukotrienes, prostaglandins or PAF are involved. Moreover, in diseaseswhere more than one of these agents plays a role, a cPLA₂ inhibitorwould be expected to be more efficacious than leukotriene, prostaglandinor PAF receptor antagonists and also more effective than cyclooxygenaseor 5-lipoxygenase inhibitors.

[0119] Therefore, the compounds of formula V, pharmaceuticalcompositions containing these compounds and methods of using suchcompounds described herein are useful in treating and preventing thedisorders treated by cyclooxygenase-2, cycloxygenase-1, and5-lipoxygenase inhibitors and also antagonists of the receptors for PAF,leukotrienes or prostaglandins. Diseases which may be treated includebut are not limited to: pulmonary disorders including diseases such asasthma, chronic bronchitis, and related obstructive airway diseases;allergies and allergic reactions such as allergic rhinitis, contactdermatitis, allergic conjunctivitis, and the like; inflammation such asarthritis or inflammatory bowel diseases, skin disorders such aspsoriasis, atopic eczema, acne, UV damage, burns and dermatittis;cardiovascular disorders such as atherosclerosis, angina, myocardialischaemia, hypertension, platelet aggregation, and the like; and renalinsufficiency induced by immunological or chemical. The compounds offormula V may also be cytoprotective, preventing damage to thegastrointestinal mucosa by noxious agents. These compounds will also beuseful in the treatment of adult respiratory distress syndrome,endotoxin shock and ischeamia induced injury including myocardial orbrain injury.

[0120] These compounds, compositions and methods will be especiallyuseful in the treatment of arthritic disorders, including but notlimited to rheumatoid arthritis, spondyloarthropathies, gouty arthritis,osteoarthritis, systemic lupus erythematosus and juvenile arthritis, andalso in the treatment of post-operative inflammation including thatfollowing ophthalmic surgery such as cataract surgery or refractivesurgery.

[0121] The pharmaceutical agents described above can be used asantipyretic agents. They may be utilized in methods of treating pain,particularly the pain associated with inflammation.

[0122] Compounds of formula V and pharmaceutically acceptablecompositions thereof are useful in the treatment of menstrual cramps,pre-term labor, tendonitis, bursitis, allergic neuritis, cytomegalovirusinfection, apoptosis, including HIV-induced apoptosis, lumbago, liverdisease including hepatitis. They are also useful in treatinggastrointestinal conditions such as inflammatory bowel disease, Crohn'sdisease, gastritis, irritable bowel syndrome and ulcerative colitis andfor the prevention of treatment of cancer such as colorectal cancer. Thepharmaceutical compounds and compositions described herein are alsouseful for the prevention or treatment of benign and malignanttumors/neoplasia including cancers such as colorectal cancer, braincancer, bone cancer, epithelial cell-derived neoplasia (epithelialcarcinoma) such as basal cell carcinoma, adenocarcinoma,gastrointestinal cancer, including lip cancer, mouth cancer, esophogealcancer, small bowel cancer and stomach cancer, colon cancer, livercancer, bladder cancer, pancreatic cancer, ovarian cancer, cervicalcancer, lung cancer, breast cancer, and skin cancers, such as squamouscell and basal cell cancers, prostate cancer, renal cell carcinoma, andother known cancers that effect epithelial cells throughout the body.Neoplasias for which these compositions are contemplated to beparticularly useful are gastrointestinal cancer, Barrett's esophagus,liver cancer, bladder cancer, pancreas cancer, ovarian cancer, prostaticcancer, cervical cancer, lung cancer, breast cancer, and skin cancer,such as squamous cell and basal cell cancers. The compounds and methodscan also be used to treat the fibrosis occurring with radiation therapy.Such compositions can be used to treat subjects having adenomatouspolyps, including those with familial adenomatous polyposis (FAP).Additionally, such compositions can be used to prevent polyps fromforming in patients at risk of FAP. Compounds of this invention areuseful in the treatment of cancers because of their anti-angiogeniceffects.

[0123] The novel intermediate compounds of formula I and the finalpharmaceutically useful compounds of formula V may be prepared byvarious methods which are set forth generally and illustratedspecifically in the following synthetic methods and specific examples.The following examples are presented to illustrate certain embodimentsof the present invention, but should not be construed as limiting thescope of this invention.

[0124] Method A

[0125] The initial indole of Method A may be alkylated at the C3position with aldehydes or the corresponding acetals in the presence ofa Lewis or Bronsted acid, such as boron triflouride etherate ortriflouroacetic acid. In the synthetic scheme, above, X is as definedherein and Ph refers to the corresponding phenyl ring optionallysubstituted by R₇, R₈ and R₉. The indole nitrogen may then be alkylatedby treatment with a strong base such as sodium bis(trimethylsilyl)amide, n-BuLi, sodium hydride or potassium hydride in a solvent such asDMF, DMSO or THF followed by exposure to the appropriate alkyl halide.The resulting product can be treated with carbon tetrabromide in carbontetrachloride and a catalytic amount of benzoyl peroxide to effectdibromination of the C2 methyl group. The dibromide can then either bestirred with silver carbonate in acetone water or poured into DMSO andstirred. Both of these procedures generate the aldehyde which is thensubjected to the nitro aldol reaction with nitromethane and a catalyticamount of ammonium acetate at reflux. The resulting vinyl nitrointermediate is reduced to the amine upon treatment with zinc mercuryamalgam in a mixture of THF and conc. HCL at reflux. This amine can thenbe treated with the requisite sulfonyl chloride under biphasicconditions, aqueous sodium bicarbonate/dichloromethane, or in organicsolvent with the addition of a hindered organic amine base. The finalhydrolysis was accomplished under basic conditions with sodium hydroxidein water and methanol and THF at room temperature or at elevatedtemperature. Alternatively it may be cleaved by treatment with sodiumthiomethoxide in a solvent such as THF or DMF at elevated temperatures(50° C.-100° C.). This method was used in the synthesis of Examples1-887, 108-112, and 126-128.

[0126] Method B

[0127] The initial halide of Method B is refluxed in aqueous sodiumsulfite and a suitable cosolvent if necessary, such as alcohol, dioxaneetc, for the required amount of time to form the desired sodiumsulfonate. This intermediate was treated with thionyl chloride,phosphorous pentachloride or oxalyl chloride, in dichloromethane with asmall amount of DMF and stirred for several hours at room temperatureuntil the sulfonyl chloride is formed. The thus formed sulfonyl chlorideis then used crude in Method A. This method was used in the synthesis ofExamples 1-887,108-112 and 126-128 when the sulfonyl chloride was notcommercially available.

EXAMPLE 14-[2-(1-Benzhydryl-2-{2-[(benzylsulfonyl)amino]ethyl}-5-chloro-1H-indol-3-yl)ethoxylbenzoicAcid

[0128] This synthesis is depicted in Method A

[0129] Step 1: To 4-hydroxy-benzoic acid methyl ester (1.0 eq) in DMF(0.83 M) was added K₂CO₃ (2.0 eq) followed by2-bromo-1,1-diethoxy-ethane and the reaction mixture was stirred at 110°C. for 2 days. TLC showed a new spot. The reaction mixture was dilutedwith ethyl acetate, washed with 1N NaOH, water, and brine, dried oversodium sulfate, and solvent was removed to afford desired product in 84%yield. This material was used in the next step without furtherpurification.

[0130] Step 2: To the above product (1.0 eq) and 5-chloro-2-methylindole (1.0 eq) in CH₂Cl₂ (0.12 M) was added triethylsilane (3.0 eq)followed by trifluoroacetic acid (3.0 eq). After being stirred overnightat room temperature, added water and trifluroacetic acid (1.0 eq) to thereaction mixture, stirred at room temperature for two days, diluted withCH₂Cl₂, washed with 1N NaOH, water, brine, dried over sodium sulfate.Trituration of the material with CH₂Cl₂ and hexanes afforded the C3alkylated indole in 92% yield

[0131] Step 3: To the indole from above (1.0 eq) in DMF (0.36 M) at 25°C. was added NaH (1.2 eq, 60% dispersion in oil), and the brown solutionwas stirred at 0 to −5° C. for 1 h and then compoundbromodiphenylmethane was added (1.1 eq), and then the reaction mixturewas stirred overnight. It was then quenched with water, diluted withethyl acetate, washed with water and brine, dried over sodium sulfateand purified by column chromatography to yield 72% of the desiredproduct.

[0132] Step 4: To the N-alkylated indole from above (1.0 eq) in CCl₄(0.2 M) was added N-bromosuccinimide (2.0 eq) and a catalytic amount ofbenzoyl peroxide. The solution was heated to reflux for 3 h, cooled to25° C., filtered, and the solid was washed with CCl₄. The filtrate wasconcentrated to a foam, which was dried. The foam was dissolved inacetone, and Ag₂CO₃ (1.1 eq.) was added followed by water and thereaction mixture was stirred overnight at room temperature. It wasfiltered and washed with acetone. The filtrate was concentrated to aresidue, to which was added water. This mixture was extracted with ethylacetate, washed with brine, dried over sodium sulfate and thenchromatographic purification on the residue gave the desired product in85% yield. Alternatively the dibromide from the reaction with NBS couldbe poured into DMSO (10-20% concentration by weight) stirred for 30minutes at room temperature. When the reaction was deemed complete itwas poured into water and the resulting precipitate was isolated byfiltration, the cake was washed with water and dried to yield anessentially quantitative yield.

[0133] Step 5: To the above aldehyde (1.0 equiv) in CH₃NO₂ (0.2 M) wasadded ammonium acetate (4 equiv) and the resulting mixture was heated toreflux for 4 h. The reaction mixture was then diluted with EtOAc andwashed with brine. The aqueous phase was extracted with EtOAc. Thecombined organic extracts were washed with brine, dried over sodiumsulfate, and concentrated until an orange crystalline solidprecipitated. The mixture was refrigerated overnight and the nitroolefin(76% yield) was collected by filtration. Evaporation of the solutionphase and purification of the residue by column chromatography (gradientelution 100% toluene→1% EtOAc-toluene) afforded an additional amount ofthe nitroolefin (23% yield).

[0134] Step 6: Zinc dust (20 equiv) was suspended in 5% aqueous HClsolution (8 M Zn/5% HCl). To this mixture was added HgCl₂ (0.28 equiv).The mixture was shaken for 10 min, the aqueous phase was decanted andreplaced with fresh 5% HCl, and again the mixture was shaken for 5 minand the aqueous phase was removed. The zinc-mercury amalgam thusgenerated was then added to a mixture of the nitroolefin (1.0 equiv) andconc. HCl (80 equiv) in THF (0.04 M nitroolefin/THF). The mixture wasmaintained at a gentle reflux for 1 h. The formation of product wasfollowed by TLC analysis. The mixture was cooled to room temperature andthe solids were removed by filtration through Celite. Conc. NH₄OH wasadded to the solution phase and the mixture was concentrated on therotary evaporator. The residue was dissolved in CH₂Cl₂ and conc. NH₄OH.The aqueous phase was extracted with CH₂Cl₂, and the organic phase waswashed with brine, dried over sodium sulfate, and concentrated.Purification by column chromatography afforded the desired product (65%yield).

[0135] Step 7: To methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(1.0 equiv) and sat. NaHCO₃ (0.14 M) in CH₂Cl₂ (0.07 M) was added□-toluenesulfonyl chloride (1.0 equiv). After 1 h the mixture was pouredinto saturated sodium bicarbonate and extracted with CH₂Cl₂. Thecombined organic phase was washed with brine, dried over sodium sulfateand purified by column chromatography (gradient elution using 20%EtOAc-hexanes→50% EtOAc-hexanes) to afford 86% of the desired product.

[0136] Step 8: The resulting ester was hydrolyzed by stirring with 1NNaOH (5 equiv) in THF (0.07 M) and enough MeOH to produce a clearsolution. The reaction was monitored by TLC (10% MeOH-CH₂Cl₂) for thedisappearance of starting material. The mixture was heated in a 60degrees C. oil bath for 2 hour. The mixture was concentrated, dilutedwith H₂O, and acidified to pH 2-4 using 1 M HCl. The aqueous phase wasextracted with EtOAc and the organic phase was washed with brine, driedover sodium sulfate, and concentrated to afford the desired product in92% yield. HRMS calc for [C₃₉H.₃₅ClN₂O₅.S+H] 679.2028 found 679.2031.

[0137] EXAMPLE 2

4-[2-(1-Benzhydryl-5-chloro-2-{2-[(isopropylsulfonyl)amino]ethyl}-1H-indol-3-yl)ethoxy]benzoicAcid

[0138] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and isopropylsulfonyl chloride according to theprocedure in Example 1 Step 7 in 55% yield.

[0139] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 81% yield. HRMS calc for[C₃₅H.₃₅ClN₂O₅.S+H] 631.2028 found 631.2029.

[0140] EXAMPLE 3

4-[2-(1-Benzhydryl-2-{2-[(butylsulfonyl)amino]ethyl}-5-chloro-1H-indol-3-yl)ethoxy]benzoicAcid

[0141] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and 1-butanesulfonyl chloride according to theprocedure in Example 1 Step 7 in 61% yield.

[0142] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 90% yield. HRMS calc for[C₃₆H.₃₇ClN₂O₅.S+H] 645.2185 found 645.2185.

EXAMPLE 44-{2-[1-Benzhydryl-5-chloro-2-(2-{[(1-methyl-1-H-imidazol-4-yl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0143] Step 1: To methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) (1.0 equiv) and Et₃N (3.0 equiv) or pyridine (3.0equiv) in CH₂Cl₂ (0.05 M) was added 1-methylimidazole-4-sulfonylchloride (1.2 equiv). The reaction was monitored by TLC (10%MeOH—CH₂Cl₂) and was heated if necessary. After 30 min the mixture waspoured into saturated sodium bicarbonate and extracted with CH₂Cl₂. Thecombined organic phase was washed with brine, dried over sodium sulfateand purified by column chromatography to afford 92% of the desiredproduct.

[0144] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 89% yield. HRMS calc for[C₃₆H.₃₃ClN₄O₅.S+H] 669.1933 found 669.1932.

EXAMPLE 54-{2-[1-Benzhydryl-2-(2-{[(5-bromo-6-chloro-3-pyridinyl)sulfonyl]amino}ethyl)-5-chloro-1H-indol-3-yl]ethoxy}benzoicAcid

[0145] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and 3-bromo-2-chloropyridine-5-sulfonyl chlorideaccording to the procedure in Example 1 Step 7 in 74% yield.

[0146] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 98% yield. HRMS calc for[C₃₇H.₃₀BrCl₂N₃O₅.S+H] 778.0539 found 778.0544.

EXAMPLE 64-[2-(1-Benzhydryl-5-chloro-2-{2-[({[(1R)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methyl}sulfonyl)amino]ethyl}-1H-indol-3-yl)ethoxy]benzoicAcid

[0147] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and (1R)-(−)-10-camphorsulfonyl chloride accordingto the procedure in Example 1 Step 7 in 77% yield.

[0148] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 94% yield. HRMS calc for[C₄₂H₄₃ClN₂O₆.S+H] 739.2603 found 739.26.

EXAMPLE 74-(2-{1-Benzhydryl-5-chloro-2-[2-({[(methylsulfonyl)methyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0149] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and (methanesulfonyl)methanesulfonyl chlorideaccording to the procedure in Example 4 Step 1 in 43% yield.

[0150] Step 2: The ester intermediate was hydrolyzed according toExample 117 Step 2 to afford the title acid in 95% yield. HRMS calc for[C₃₄H₃₃ClN₂O₇.S₂+H] 681.1491 found 681.1489.

EXAMPLE 84-(2-{1-Benzhydryl-5-chloro-2-[2-({[(2-(1-naphthyl)ethyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0151] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step5, Example 1) and 2-(1-naphthyl) ethanesulfonyl chloride accordingto the procedure Example 1 Step 7 in 60% yield.

[0152] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. HRMS calc for[C₄₄H₃₉ClN₂O₅.S+H] 743.2341 found 743.2338.

EXAMPLE 94-{2-[1-Benzhydryl-5-chloro-2-{2-[({2-nitrobenzyl}-sulfonyl)amino]ethyl}-1H-indol-3-yl)ethoxy]benzoicAcid

[0153] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and 2-nitro-□-toluenesulfonyl chloride according tothe procedure in Example 1 Step 7 in 82% yield.

[0154] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 85% yield. HRMS calc for[C₃₉H₃₄ClN₃O₇.S+H] 724.1879 found 724.1877.

EXAMPLE 104-{2-[1-Benzhydryl-5-chloro-2-(2{[(3,4-dichlorobenzyl)sulfonyl]amino}-ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0155] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and [(3,4-dichlorophenyl)-methyl]sulfonyl chlorideaccording to the procedure in Example 1 Step 7 in 82% yield.

[0156] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 86% yield. HRMS calc for[C₃₉H₃₃Cl₃N₂O₅.S+H] 747.1249 found 747.1249.

EXAMPLE 114-{2-[1-Benzhydryl-5-chloro-2-(2-{[(3,5-dichlorobenzyl)sulfonyl]amino}-ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0157] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and [(3,5-dichlorophenyl)-methyl]sulfonyl chlorideaccording to the procedure in Example 1 Step 7 in 100% yield.

[0158] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 98% yield. HRMS calc for[C₃₉H₃₃Cl₃N₂O₅.S+H] 747.1249 found 747.1249.

EXAMPLE 124-(2-{1-Benzhydryl-5-chloro-2-(2-({[(3-(trifluoromethyl)benzyl]sulfonyl}-amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0159] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and [[3-(trifluoromethyl)-phenyl]methyl]sulfonylchloride according to the procedure in Example 1 Step 7 in 74% yield.

[0160] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 86% yield. HRMS calc for[C₄₀H₃₄ClF₃N₂O₅S+H] 747.1902 found 747.1904.

EXAMPLE 134-(2-{1-Benzhydryl-5-chloro-2-(2-({[(4-(trifluoromethyl)benzyl]sulfonyl}-amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0161] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and [[4-(trifluoromethyl)phenyl]methyl]sulfonylchloride according to the procedure in Example 1 Step 7 in 77% yield.

[0162] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 83% yield. HRMS calc for[C₄₀H₃₄ClF₃N₂O₅S+H] 747.1902 found 747.1901.

EXAMPLE 144-{2-[1-Benzhydryl-5-chloro-2-(2-{[(4-fluorobenzyl)sulfonyl]amino}-ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0163] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and [(4-fluorophenyl)methyl]sulfonyl chlorideaccording to the procedure in Example 1 Step 7 Step 1 in 86% yield.

[0164] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 94% yield. HRMS calc for[C₃₉H₃₄ClFN₂O₅S+H] 697.1934 found 697.1938.

EXAMPLE 154-{2-[1-Benzhydryl-5-chloro-2-(2-{[(4-chlorobenzyl)sulfonyl]amino}-ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0165] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and [(4-chlorophenyl-)methyl]sulfonyl chlorideaccording to the procedure in Example 1 Step 7 in 73% yield.

[0166] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 99% yield. HRMS calc for[C₃₉H₃₄Cl₂N₂O₅S+H] 713.1638 found 713.1643.

EXAMPLE 162-(2-{[(2-Aminobenzyl)sulfonyl]amino}ethyl)-4-{2-[1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoicAcid

[0167] Step 1: To methyl4-{2-[1-benzhydryl-5-chloro-2-{2-[2-nitrobenzyl]benzyl}-sulfonyl)amino]ethyl}-1H-indol-3-yl)ethoxy]benzoate,Example 9, step 1, (1.0 equiv) in CH₂Cl₂ (0.014 M) was added a mixtureof tin(II) chloride dihydrate (3.0 equiv) dissolved in concentrated HCl.After 16 h the mixture was basified (pH 10) with 3 N NaOH and extractedwith CH₂Cl₂. The combined organic phase was washed with brine, driedover sodium sulfate and purified by column chromatography (gradientelution using 20% EtOAc-hexanes→50% EtOAc-hexanes) to afford 83% of thedesired product.

[0168] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 83% yield. HRMS calc for[C₃₉H₃₆ClN₃O₅S+H] 694.2137 found 694.2136.

[0169] EXAMPLE 17

4-{2-[1-Benzhydryl-5-chloro-2-(2-{[(dimethylamino)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0170] Step 1: This compound was prepared from methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) and dimethylsulfamoyl chloride according to theprocedure in Example 1 Step 7 in 49% yield.

[0171] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1to afford the title acid in 95% yield. HRMS calc for[C₃₄H₃₄ClN₃O₅S+H] 632.1981 found 632.1984.

EXAMPLE 184-{2-[1-Benzhydryl-5-chloro-2-(2-{[(3,4-difluorobenzyl)sulfonyl]amino}-ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0172] Step 1: To 3,4-difluorobenzyl bromide (1.0 equiv) in H₂O(0.74 M)was added sodium sulfite (1.1 equiv). The mixture was heated to refluxfor 16 hours then cooled to room temperature. The white precipitate wasfiltered and dried to afford 95% of the sodium sulfonate intermediate.

[0173] Step 2: To 3,4-difluorobenzyl sodium sulfonate (7.6 equiv) inCH₂Cl₂ (0.76 M) was added DMF (5.6 equiv) and SOCl₂ (30 equiv). After 1h the mixture was concentrated and azeotroped with toluene. The residuewas suspended in CH₂Cl₂ (0.38 M) and methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) (1.0 equiv) and sat. NaHCO₃ (0.76 M) were added.After 1 h the mixture was poured into H₂O and extracted with CH₂Cl₂. Thecombined organic phase was washed with brine, dried over sodium sulfateand purified by column chromatography (gradient elution using 20%EtOAc-hexanes→40% EtOAc-hexanes) to afford 94% of the methyl esterintermediate.

[0174] Step 3: The methyl ester was hydrolyzed according to Step 8Example 1 to afford the title acid in 93% yield. HRMS calc for[C₃₉H₃₃ClF₂N₂O₅S+H] 715.184 found 715.1843.

EXAMPLE 194-{2-[1-benzhydryl-5-chloro-2-(2-{[(2-naphthylmethyl)sulfonyl]amino{ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0175] Step 1: The sulfonyl chloride intermediate was prepared from2-(bromomethyl)naphthalene according to the procedure in Example 18 Step1-2 in 34% yield.

[0176] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in58% yield.

[0177] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 74% yield. HRMS calc for[C₄₃H₃₇ClN₂O₅S+H] 729.2185 found 729.2189.

EXAMPLE 203-({[(2-{1-benzhydryl-3-[2-(4-carboxyphenoxy)ethyl]-5-chloro-1H-indol-2-yl}ethyl)amino]sulfonyl}methyl)benzoicAcid

[0178] Step 1: The sulfonyl chloride intermediate was prepared frommethyl 3-(bromomethyl)benzoate according to the procedure in Example 18Step 1-2.

[0179] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in23% yield.

[0180] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title diacid in 93% yield. HRMS calc for[C₄₀H₃₅ClN₂O₇S+H] 723.1926 found 723.1932

EXAMPLE 214-(2-{1-benzhydryl-5-chloro-2-[2-({[(E)-2-phenylethenyl]sulfonyl}amino)ethyl′-1H-indol-3-yl}ethoxy)benzoicAcid

[0181] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) was added trans-□-styrenesulfonyl chloride accordingto the procedure in Example 1 Step 7 to generate the product in 66%yield.

[0182] Step2—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 98% yield. HRMS calc for[C₄₀H₃₅ClN₂ O₅S+H] 691.2028 found 691.2034.

EXAMPLE 224-{2-[1-benzhydryl-5-chloro-2-(2-{[(trifluoromethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0183] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1 )was added trifluoromethylsulfonyl chloride accordingto the procedure in Example 1 Step 7 to generate the product in 49%yield.

[0184] Step2—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. HRMS calc for[C₃₃H₂₈ClF₃N₂O₅S+H] 657.1432 found 657.1435.

EXAMPLE 234-[2-(1-benzhydryl-5-chloro-2-{2-[(cyclopropylsulfonyl)amino]ethyl}-1H-indol-3-yl)ethoxy]benzoicAcid

[0185] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added cyclopropanesulfonyl chloride according tothe procedure in Example 1 Step 7 to generate the product in 75% yield.

[0186] Step2—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 84% yield. HRMS calc for[C₃₅H₃₃ClN₂O₅S+H] 629.1872 found 629.1874.

EXAMPLE 244-(2-{1-benzhydryl-2-[2-({[3,5-bis(trifluoromethyl)benzyl]sulfonyl}amino)ethyl]-5-chloro-1H-indol-3-yl}ethoxy)benzoicAcid

[0187] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added 3,5-bis(trifluoromethyl)benzylsulfonylaccording to the procedure in Example 1 Step 7 to generate the productin 79% yield.

[0188] Step2—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 81% yield. HRMS calc for[C₄₁H₃₃ClF₆N₂O₅S+H] 815.1776 found 815.1776.

EXAMPLE 252-{[(2-{1-benzhydryl-3-[2-(4-carboxyphenoxy)ethyl]-5-chloro-1H-indol-2-yl}ethyl)amino]sulfonyl}benzoicAcid

[0189] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1 )was added methyl (2-chlorosulfonyl)benzoateaccording to the procedure in Example 1 Step 7 to generate the productin 100% yield.

[0190] Step2—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 61% yield. HRMS calc for[C₃₉H₃₃ClN₂O₇S +H] 709.177 found 709.1772.

EXAMPLE 264-[2-(1-benzhydryl-5-chloro-2-{2-[(2-naphthylsulfonyl)amino]ethyl}-1H-indol-3-yl)ethoxy]benzoicAcid

[0191] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1 )was added 2-naphthalenesulfonyl chloride accordingto the procedure in Example 1 Step 7 to generate the product in 53%yield.

[0192] Step2—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. HRMS calc for[C₄₂H₃₅ClN₂O₅S +H] 715.2028 found 715.2034.

EXAMPLE 274-{2-[1-benzhydryl-5-chloro-2-(2{[(3,5-dichlorophenyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0193] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added 3,5-dichlorobenzenesulfonyl chlorideaccording to the procedure in Example 1 Step 7 to generate the productin 60% yield.

[0194] Step2—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 88% yield. HRMS calc for[C₃₈H₃₁Cl₃N₂O₅S+H] 733.1092 found 733.1096.

EXAMPLE 284-{2-[1-benzhydryl-5-chloro-2-(2{[(3,4-dichlorophenyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0195] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added 3,4-dichlorobenzenesulfonyl chlorideaccording to the procedure in Example 1 Step 7 to generate the productin 60% yield.

[0196] Step2—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 80% yield. HRMS calc for[C₃₈H₃₁Cl₃N₂O₅S+H] 733.1092 found 733.1094.

EXAMPLE 294-{2-[1-benzhydryl-5-chloro-2-(2-{[(2,3-dichlorobenzyl)sulfonyl]amino}ethyl)-1Hindol-3-yl]ethoxy}benzoic Acid

[0197] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added (2,3-dichlorophenyl)-methyl]sulfonylchloride according to the procedure in Example 1 Step 7 to generate theproduct in 50% yield.

[0198] Step2-The resulting ester was hydrolyzed by stirring with KOH (67mg, 5 equiv.) in THF (5 mL) MeOH (5 mL) and H₂O (2 mL). The reaction wasmonitored by TLC (10% MeOH-CH₂Cl₂) for the disappearance of startingmaterial. The mixture was stirred overnight at room temperature and thenconcentrated, diluted with H₂O, and acidified to pH 2-4 using 1 M HCl.The aqueous phase was extracted with EtOAc and the organic phase waswashed with brine, dried over sodium sulfate, and concentrated to affordthe desired product in 98% yield. HRMS calc for [C₃₉H₃₃Cl₃N₂ O₅S+H]747.1249 found 747.1254.

EXAMPLE 304-{2-[1-benzhydryl-5-chloro-2-(2-{[(2,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0199] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added (2,4-dichlorophenyl)-methyl]sulfonylchloride according to the procedure in Example 1 Step 7 to generate theproduct in 98% yield.

[0200] Step2—The ester intermediate was hydrolyzed according to Step 2Example 29 to afford the title acid in 90% yield. HRMS calc for[C₃₉H₃₃Cl₃N₂O₅S+H] 747.1249 found 747.1255.

EXAMPLE 314-{2-[1-benzhydryl-5-chloro-2-(2{[(2,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1Hindol-3-yl]ethoxy}benzoic Acid

[0201] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added (2-chlorophenyl)-methyl]sulfonyl chlorideaccording to the procedure in Example 1 Step 7 to generate the productin 86% yield.

[0202] Step2—The ester intermediate was hydrolyzed according to Step 2Example 29 to afford the title acid in 90% yield. HRMS calc for[C₃₉H₃₄Cl₂N₂O₅S+H] 713.1638 found 713.1644.

[0203] EXAMPLE 32

4-{2-[1-benzhydryl-5-chloro-2-(2-{[(4-chloro-2-nitrobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0204] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added [(4-chloro-2-nitro)-methyl]sulfonylchloride according to the procedure in Example 1 Step 7 to generate theproduct in 74% yield.

[0205] Step2—The ester intermediate was hydrolyzed according to Step 2Example 29 to afford the title acid in 90% yield. HRMS calc for[C₃₉H₃₃Cl₂N₃O₇S+H] 758.1489 found 758.1494.

[0206] The acid resulting from Method A, or any subsequent method couldbe used as a subtrate for palladium catalyzed amination reaction using abase, an amine, a phosphine ligand and palidium reagent.

[0207] EXAMPLE 33

4-[2-(1-benzhydryl-2-{2-[(benzylsulfonyl)amino]ethyl}-5-morpholin-4-yl-1H-indol-'3-yl)ethoxy]benzoicAcid

[0208] Step 1—A flask was charged withtris(dibenzylideneacetone)dipalladium(0) (0.01 eq.),2-(di-t-butylphosphino)biphenyl (0.04 eq.), sodium t-butoxide (2.4 eq.)and the acid from step 8 (1.0 eq.). 1.5 ml toluene (1.0 M) was added tothe flask followed by morpholine (1.2 eq.) The reaction was heated toreflux for five hours. The reaction mixture was partitioned between 5%hydrochloric acid and dietheyl ether. The organic layer was washed withdistilled water, followed by brine, dried over sodium sulfate andconcentrated. The product was purified by preparatory LC—MS to afford7.8% of the desired product. HRMS calc for [C₄₃H₄₃N₃O₆S+H] 730.2945found 730.2945.

EXAMPLE 344-{2-[1-Benzhydryl-5-chloro-2-(2-{[(2-cyanobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0209] Step 1: (2-Cyano-phenyl)-methanesulfonyl chloride was preparedaccording to Example 18 Step 1-2 (crude yield 100%).

[0210] Step 2: The title compound was prepared from4-{2-[2-(2-amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethoxy}-benzoicacid methyl ester and (2-cyano-phenyl)-methanesulfonyl chlorideaccording to Example 1 Step 7 as a white solid in 72% yield.

[0211] Step3—The ester intermediate was hydrolyzed according to Step 8Example to afford the title acid in 74% yield. MS (ES) m/z (M−1) 702.0;HRMS Calcd. for C₄₀H₃₅ClN₃O₅S(M+1):704.1980. Found: 704.1984. Anal.Calcd. for C₄₀H₃₄ClN₃O₅S: C, 68.22; H, 4.87; N, 5.97. Found: C, 67.92;H, 5.11; N, 5.54.

EXAMPLE 354-{2-[1-Benzhydryl-5-chloro-2-(2{[(2-cyanobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0212] Step 1: The sulfonyl chloride intermediate was prepared from3,5-difluorobenzyl bromide according to the procedure in Example 18 Step1-2 in 95% yield.

[0213] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in78% yield.

[0214] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title diacid in 83% yield. HRMS calc for[C₃₉H₃₃ClF₂N₂O₅S+H] 715.184 found 715.1842.

EXAMPLE 364-{2-[1-Benzhydryl-5-chloro-2-(2-{[(3-cyanobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0215] Step 1: (3-Cyano-phenyl)-methanesulfonyl chloride was preparedaccording to Example 18 Step 1-2 (crude yield 100%).

[0216] Step 2: The title compound was prepared from4-{2-[2-(2-amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethoxy}-benzoicacid methyl ester and (2-cyano-phenyl)-methanesulfonyl chlorideaccording to Example 1 Step 7.

[0217] Step3—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 81% yield. MS (ES) m/z (M−1)702.1; HRMS Calcd. for C₄₀H₃₃ClN₃O₅S(M−1):702.1834. Found: 702.1833.Anal. Calcd. for C₄₀H₃₄ClN₃O₅S·0.8H₂O: C, 67.00; H, 5.00; N, 5.86.Found: C, 67.22; H, 5.19; N, 5.44.

EXAMPLE 374-{2-[1-Benzhydryl-5-chloro-2-(2-{[(4-cyanobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0218] Step 1(4-Cyano-phenyl)-methanesulfonyl chloride was preparedaccording to Example 18 Step 1-2 (crude yield 100%).

[0219] Step 2: The title compound was prepared from4-{2-[2-(2-amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethoxy}-benzoicacid methyl ester and (2-cyano-phenyl)-methanesulfonyl chlorideaccording to Example 1 Step 7.

[0220] Step3—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 77% yield. MS (ES) m/z (M−1)702.1; HRMS Calcd. for C₄₀H₃₅ClN₃O₅S(M+1): 704.1980. Found: 704.1981.Anal. Calcd. for C₄₀H₃₄ClN₃O₅S: C, 68.22; H, 4.87; N, 5.97. Found: C,68.09; H, 4.97; N, 5.73.

EXAMPLE 38 4-(2-{1-Benzhydryl-5-chloro-2-[2-({[4-(1piperidinylsulfonyl)benzyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0221] Step 1:[4-(Piperidine-1-sulfonyl)-phenyl]-methanesulfonylchloride was prepared according to Example 18 Step 1-2 (crude yield100%).

[0222] Step 2: The title compound was prepared from4-{2-[2-(2-amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethoxy}-benzoicacid methyl ester and (2-cyano-phenyl)-methanesulfonyl chlorideaccording to Example 1 Step 7.

[0223] Step3—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 73% yield. MS (ES) m/z (M−1)824.2; HRMS Calcd. for C₄₄H₄₃ClN₃O₇S₂(M−1):824.2236. Found: 824.2246.Anal. Calcd. for C₄₄H₄₄ClN₃O₇S₂·0.5H₂O: C, 63.25; H, 5.43; N, 5.03.Found: C, 62.85; H, 5.64; N, 4.64.

EXAMPLE 394-(2-{2-[2-({[4-(Aminosulfonyl)benzyl]sulfonyl}amino)ethyl]-1-benzhydryl-5-chloro-1H-indol-3-yl}ethoxy)benzoicAcid

[0224] Step 1: (4-Sulfamoyl-phenyl)-methanesulfonyl chloride wasprepared according to Example 18 Step 1-2 (crude yield 100%).

[0225] Step 2: The title compound was prepared from4-{2-[2-(2-amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethoxy}-benzoicacid methyl ester and (2-cyano-phenyl)-methanesulfonyl chlorideaccording to Example 1 Step 7.

[0226] Step3—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 69% yield. MS (ES) m/z (M−1)755.9; HRMS Calcd. for C₃₉H₃₅ClN₃O₇S₂ (M−1): 756.1613. Found: 756.1612.Anal. Calcd. for C₃₉H₃₆ClN₃O₇S₂: C, 61.77; H, 4.79; N, 5.54. Found: C,61.93; H, 5.12; N, 5.19.

EXAMPLE 404-(2-{1-Benzhydryl-5-chloro-2-[2-(4-methanesulfonyl-phenylmethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoic Acid

[0227] Step 1: ((4-Methanesulfonyl-phenyl)-methanesulfonyl chloride wasprepared according to Example 18 Step 1-2 (crude yield 100%).

[0228] Step 2: The title compound was prepared from4-{2-[2-(2-amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethoxy}-benzoicacid methyl ester and (2-cyano-phenyl)-methanesulfonyl chlorideaccording to Example 1 Step 7.

[0229] Step3—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 75% yield. MS (ES) m/z (M−1)755.0; HRMS Calcd. for C₄₀H₃₈ClN₂O₇S₂(M+1): 757.1804. Found: 757.1804.Anal. Calcd. for C₄₀H₃₇ClN₂O₇S₂·H₂O: C, 61.96; H, 5.07; N, 3.61. Found:C, 61.82; H, 5.10; N, 3.48.

EXAMPLE 414-(2-{1-Benzhydryl-5-chloro-2-[2-(4-diethylsulfamoyl-phenylmethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoic Acid

[0230] Step 1: (4-Diethylsulfamoyl-phenyl)-methanesulfonyl chloride wasprepared according to Example 18 Step 1-2 (crude yield 100%).

[0231] Step 2: The title compound was prepared from4-{2-[2-(2-amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethoxy}-benzoicacid methyl ester and (2-cyano-phenyl)-methanesulfonyl chlorideaccording to Example 1 Step 7.

[0232] Step3—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 66% yield. MS (ES) m/z (M−1)812.1; HRMS Calcd. for C₄₃H₄₅ClN₃O₇S₂(M+1): 814.2382. Found: 814.2385.Anal. Calcd. for C₄₃H₄₄ClN₃O₇S₂·0.3H₂O: C, 62.99; H, 5.48; N, 5.14.Found: C, 62.91; H, 5.67; N, 4.79.

EXAMPLE 424-{3-[1-Benzhydryl-5-chloro-2-(2-phenylmethanesulfonylamino-ethyl)-1H-indol-3-yl]-propyl}-benzoicAcid

[0233] Step 1: A mixture of methyl-4-iodobenzoate (5.3 g, 20.2 mmol),allyl alcohol (1.78 g, 30.3 mmol), NaHCO₃ (4.24 g, 50.5 mmol), Pd(OAc)₂(0.14 g, 0.60 mmol), (n-Bu)₄NBr (6.55 g, 20.2 mmol) and 4-A molecularSieves (4.1 g) in anhydrous DMF (69 mL) was stirred at room temperaturefor 4 days. The reaction mixture was filtered through celite and thefiltrate poured onto water and extracted with EtOAc. Organic layer waswashed with brine, dried (Na₂SO₄), and concentrated under vaccum. Flashchromatography (silica gel, 10-20% EtOAc-hexanes) gave 2.11 g (85% basedon the recovered starting material) of the desired4-(3-Oxo-propyl)-benzoic acid methyl ester as a clear oil.

[0234] Step 2: To a solution of 5-chloro-2-methylindole (0.86 g, 5.2mmol) and 4-(3-Oxo-propyl)-benzoic acid methyl ester (1.0 g, 5.2 mmol)in methylene chloride (50 mL), was added TFA (1.78 g, 15.6 mmol),followed by triethylsilane (1.81 g, 15.6 mmol). The reaction mixture wasstirred overnight, quenched with sat. NaHCO₃ solution (50 mL), and theorganic layer was washed with sat. NaHCO₃ solution, water, brine, anddried (Na₂SO₄). Solvent was removed under reduced pressure, and theresidue was purified by flash column chromatography with 10-20%EtOAc/hexanes to yield the desired product in 94% (1.67 g) yield.

[0235] Step 3: To a solution of the product from step 2 (1.66 g, 4.86mmol) in DMF (20 mL) was added NaH (60% in mineral oil, 0.24 g, 5.83mmol) under N₂ atmosphere. The mixture was stirred for 1 h at roomtemperature, followed by the dropwise addition of benzhydryl bromide(1.8 g, 7.29 mmol) in DMF (5 mL). This reaction mixture was stirredovernight at room temperature. Water (500 mL) was added to reactionmixture, it was extracted with EtOAc, washed with brine, dried (Na₂SO₄),and concentrated under reduced pressure to a brown syrup, which waspurified by silica-gel chromatography using 10% EtOAc/hexanes as eluentto isolate 4 as a white solid in 59% (1.47 g) yield.

[0236] Step 4: The product from above (1.46 g, 2.87 mmol) was dissolvedin CCl₄ (14.5 mL), followed by the addition of NBS (1.02 g, 5.73 mmol)and benzoyl peroxide (2 mg). The reaction mixture was heated to refluxfor 1 h (until all the starting material disappeared). This mixture wascooled to room temperature, filtered and the solid was washed with CCl₄.The filtrate was evaporated to a brown residue, which was dissolved inacetone (40 mL) and water (4 mL), Ag₂CO₃ (1.75 g, 3.16 mmol) was thenadded to this solution and after being stirred overnight at roomtemperature, it was filtered through celite, the solvent was evaporatedunder reduced pressure, and water was added to the residue. It wasextracted with EtOAc, washed with brine, dried (Na₂SO₄), and evaporatedto a syrup, which was purified by 10% EtOAc/hexanes to isolate the2-formyl indole (1.13 g) in 75% yield. Alternatively the dibromide fromthe reaction with NBS could be poured into DMSO (10-20% concentration byweight) and stirred for 30 minutes at room temperature. When thereaction was deemed complete it was poured into water and the resultingprecipitate was isolated by filtration, the cake was washed with waterand dried to yield an essentially quantitative yield.

[0237] Step 5: To a solution of the 2 formyl indolw from above (0.52 g,1 mmol) in CH₃NO₂ (6.2 mL) was added NH₄OAC (0.077 g, 1 mmol), themixture was heated to reflux for 1 h, NH₄OAc (0.077 g, 1 mmol) was thenadded, heating at reflux was continued for an additional 1 h, NH₄Oac(0.077 g, 1 mmol) was added again and the heating continued for further1 h. The reaction mixture was allowed to attain room temperature, EtOAc(50 mL) was added, followed by the addition of 100 mL water. The aqueouslayer was extracted with EtOAc, and the combined organic layers werewashed with brine, dried (Na₂SO₄), and evaporated to a yellow foam,which was subjected to chromatographic purification using 10%EtOAc/hexanes as an eluent to yield 6 as a yellow foam in 68% yield(0.38 g).

[0238] Step 6: Zn(Hg) was made by adding HgCl₂ ( 3.4 g, 7.2 mmol) to amixture of Zn-dust (34.68 g, 530.35 mmol) and 5% HCl (38 mL) in a 100 mLbeaker, this mixture was stirred vigorously for 10 min. Aqueous phasewas decanted and added 38 mL of 5% HCl again and the mixture was stirredfor 10 min. Aqueous phase was decanted. This solid was added to thevinyl nitro compound 6 (15 g, 26.57 mmol) in THF (660 mL) and conc. HCl(64.5 mL). This mixture was stirred at room temperature for 1 h, then atreflux for 15 min. The reaction mixture was cooled to room temperatureand filtered through celite. Aq. NH₄OH solution (200 mL) was added tothe filtrate, stirred for 15 min and THF was removed under reducedpressure. The aqueous layer was extracted with CH₂Cl₂, combined organiclayer was washed with brine, dried (Na2SO4) and concentrated to a brownfoam, which was purified by column chromatography by eluting the columnwith CHCl₃ in the beginning to remove non-polar impurities then with 2%MeOH/CHCl₃ to isolate the desired amine in 46% yield (6.1 g)

[0239] Step 7: To the amine(1.0 equiv.) and sat. NaHCO₃ (0.14 M) inCH₂Cl₂ (0.07 M) was added □-toluenesulfonyl chloride (1.0 equiv.). After1 h the mixture was poured into saturated sodium bicarbonate andextracted with CH₂Cl₂. The combined organic phase was washed with brine,dried over sodium sulfate and purified by column chromatography toafford 84% of the desired product.

[0240] Step 8: The resulting ester was hydrolyzed by stirring with 1NNaOH (5 equiv.) in THF (0.07 M) and enough MeOH to produce a clearsolution. The reaction was monitored by TLC (10% MeOH—CH₂Cl₂) for thedisappearance of starting material. The mixture was stirred overnight atroom temperature and then. concentrated, diluted with H₂O, and acidifiedto pH 2-4 using 1 M HCl. The aqueous phase was extracted with EtOAc andthe organic phase was washed with brine, dried over sodium sulfate, andconcentrated to afford the desired product in 100% yield. HRMS calc for[C₄₀H₃₇ClN₂O₄S+H] 677.2235 found 677.224.

EXAMPLE 434-{3-[1-benzhydryl-5-chloro-2-(2-{[(3,5-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0241] Step 1: This compound was prepared from the intermediate inExample 42 step 6 and (3,5-dichlorophenyl)-methyl]sulfonyl chlorideaccording to the procedure in Example 43 Step 7 which yielded 98% of thedesired product.

[0242] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 100% yield. HRMS calc for[C₄₀H₃₅Cl₃N₂O₄S+H] 745.1456 found 745.1458.

EXAMPLE 444-{3-[1-benzhydryl-5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0243] Step 1: This compound was prepared from the intermediate inExample 42 step 6 and (3,4-dichlorophenyl)-methyl]sulfonyl chlorideaccording to the procedure in Example 43 Step 7 which yielded 96% of thedesired product.

[0244] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 98% yield. HRMS calc for[C₄₀H₃₅Cl₃N₂O₄S+H] 745.1456 found 745.1458.

EXAMPLE 454-[2-(1-benzhydryl-5-chloro-2-(2-[(methylsulfonyl)amino]ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0245] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added methanesulfonyl chloride according to theprocedure in Example 4 Step 1 to generate the product in 92% yield.

[0246] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. HRMS calc for[C₃₃H₃₁ClN₂O₅S+H] 603.1715 found 603.1717.

EXAMPLE 464-[2-(1-benzhydryl-5-chloro-2-{2-[(phenylsulfonyl)amino]ethyl}-1H-indol-3-yl]ethoxy}benzoicAcid

[0247] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added benzenesulfonyl chloride according to theprocedure in Example 4 Step 1 to generate the product in 90% yield.

[0248] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 90% yield. HRMS calc for[C₃₈H₃₃ClN₂O₅S+H] 665.1872 found 665.1869

EXAMPLE 474-(2-{1-benzhydryl-5-chloro-2-[2-({[3-(trifluoromethyl)benzyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0249] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy)benzoate(Step 5, Example 1)was added {[3-(trifluoromethyl)phenyl]methyl}sulfonylchloride according to the procedure in Example 1 Step 7 to generate theproduct in 74% yield.

[0250] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 86% yield. HRMS calc for[C₄₀H₃₄ClF₃N₂O₅S+H] 747.1902 found 747.1904

EXAMPLE 482-{[(2-{[(2-{1-benzhydryl-3-[2-(4-carboxyphenoxy)ethyl]-5-chloro-1H-indol-2-yl}ethyl)amino]sulfonyl}ethyl)amino]carbonyl}benzoicAcid

[0251] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added 2-phthalimidoethanesulfonyl chlorideaccording to the procedure in Example 1 Step 7 to generate the productin 78% yield.

[0252] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 99% yield. HRMS calc for[C₄₂H₃₈ClN₃O₈S+H] 780.2141 found 780.2148

EXAMPLE 494-{2-[{1-benzhydryl-5-chloro-2-(2-}[(3-(pyridinylmethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0253] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added (3-pyridylmethyl)sulfonyl chlorideaccording to the procedure in Example 1 Step 7 to generate the productin 52% yield.

[0254] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 94% yield. HRMS calc for[C₃₈H₃₄ClN₃O₅S—H] 678.18349 found 678.18277.

EXAMPLE 504-{2-[{1-benzhydryl-5-chloro-2-(2-{[(4-(pyridinylmethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0255] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added (4-pyridylmethyl)sulfonyl chlorideaccording to the procedure in Example 1 Step 7 to generate the productin 57% yield.

[0256] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. m/z (M−1) HRMS calcfor [C₃₈H₃₄ClN₃O₅S—H] 678.18349 found 678.18249

EXAMPLE 514-{2-[{1-benzhydryl-5-chloro-2-(2-{[(2-(pyridinylmethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0257] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1)was added (2-pyridylmethyl)sulfonyl chlorideaccording to the procedure in Example 1 Step 7 to generate the productin 42% yield.

[0258] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 56% yield. HRMS calc for[C₃₈H₃₄ClN₃O₅S—H] 678.18349 found 678.18312

EXAMPLE 514-{3-[1-benzhydryl-5-chloro-2-(2-{[(2,6-dimethylbenzyl)sulfonyl]amino}ethyl)-1H-indoly-3-yl]propyl}benzoicAcid

[0259] Step 1: The sulfonyl chloride intermediate was prepared from2,6-dimethylbenzyl chloride according to the procedure in Example 18Step 1-2 in 100% yield.

[0260] Step 2: The methyl ester was prepared from the sulfonyl chlorideand the intermediate in Example 42 step 6 according to the procedure inExample 42 Step 7 in 30% yield.

[0261] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 100% yield. HRMS calc for[C₄₂H₄₁ClN₂O₄S—H] 703.24028 found 703.23973

EXAMPLE 534-{2-[1-benzhydryl-5-chloro-2-(2-{[(cyclohexylmethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0262] Step 1: The sulfonyl chloride intermediate was prepared from(bromomethyl)cyclohexane according to the procedure in Example 18 Step1-2 in 100% yield.

[0263] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in20% yield.

[0264] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 73% yield. HRMS calc for[C₃₉H₄₁ClN₂O₅S—H] 683.23519 found 683.23474

EXAMPLE 544-{2-[1-benzhydryl-5-chloro-2-(2-{[(4-nitrobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0265] Step 1: The sulfonyl chloride intermediate was prepared from4-nitrobenzyl bromide according to the procedure in Example 18 Step 1-2in 95% yield.

[0266] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in80% yield.

[0267] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title compound in 90% yield. HRMS calc for[C₃₉H₃₄ClN₃O₇S+H] 724.1879 found 724.1884.

EXAMPLE 554-{2-[1-benzhydryl-5-chloro-2-(2-{[(3-nitrobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0268] Step 1: The sulfonyl chloride intermediate was prepared from3-nitrobenzyl bromide according to the procedure in Example 18 Step 1-2in 95% yield.

[0269] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in85% yield.

[0270] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title compound in 85% yield. HRMS calc for[C₃₉H₃₄ClN₃O₇S+H] 724.1879 found 724.1885.

EXAMPLE 564-{2-[1-Benzhydryl-5-chloro-2-{2-[({2-nitrobenzyl}-sulfonyl)amino]ethyl}-1H-indol-3-yl)propyl]benzoic Acid

[0271] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) was added and 2-nitro-□-toluenesulfonyl chlorideaccording to the procedure in Example 1 Step 7 to generate the productin 65% yield.

[0272] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. HRMS calc for[C₄₀H₃₆ClN₃O₆S+H] 722.2086 found 722.2088.

EXAMPLE 574-{3-[1-benzhydryl-5-chloro-2-(2-{[(4-fluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0273] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) was added and (4-Fluoro-phenyl)-methanesulfonylchloride according to the procedure in Example 1 Step 7 to generate theproduct in 77% yield.

[0274] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 68% yield. HRMS calc for[C₄₀H₃₆ClFN₂O₄S+H] 695.2141 found 695.2145.

EXAMPLE 584-(3-{1-benzhydryl-5-chloro-2-[2-({[4-(trifluoromethyl)benzyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}propyl)benzoicAcid

[0275] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) was added and(4-Trifluoromethyl-phenyl)-methanesulfonyl chloride according to theprocedure in Example 1 Step 7 to generate the product in 50% yield.

[0276] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. HRMS calc for[C₄₁,H₃₆ClF₃N₂O₄S+H] 745.2109 found 745.2114.

EXAMPLE 594-(3-{1-benzhydryl-5-chloro-2-[2-({[3-(trifluoromethyl)benzyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}propyl)benzoicAcid

[0277] Step 1: To methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) was added and(3-Trifluoromethyl-phenyl)-methanesulfonyl chloride according to theprocedure in Example 1 Step 7 to generate the product in 56% yield.

[0278] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 82% yield. HRMS calc for[C₄₁H₃₆ClF₃N₂O₄S+H] 745.2109 found 745.211.

EXAMPLE 604-{3-[1-benzhydryl-5-chloro-2-(2-{[(4-chlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0279] Step 1: To the methyl methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) was added and (4-chlorophenyl)-methanesulfonylchloride according to the procedure in Example 1 Step 7 to generate theproduct in 74% yield.

[0280] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 79% yield. HRMS calc for[C₄₀H₃₆Cl₂N₂O₄S+H] 711.1846 found 711.1847.

EXAMPLE 614-{3-[1-benzhydryl-5-chloro-2-(2-{[(2-pyridinylmethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0281] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) was added pyridin-2-yl-methanesulfonyl chloridechloride according to the procedure in Example 4 Step 1 to generate theproduct in 75% yield.

[0282] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 96% yield. HRMS calc for[C₃₉H₃₆ClN₃O₄S+H] 678.2188 found 678.2187.

EXAMPLE 624-{3-[1-benzhydryl-5-chloro-2-(2-{[(3-pyridinylmethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0283] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) was added pyridin-3-yl-methanesulfonyl chloridechloride according to the procedure in Example 4 Step I to generate theproduct in 75% yield.

[0284] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 88% yield.

EXAMPLE 634-{3-[1-benzhydryl-5-chloro-2-(2-{[(4-pyridinylmethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0285] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) was added pyridin-4-yl-methanesulfonyl chloridechloride according to the procedure in Example 4 Step 1 to generate theproduct in 75% yield.

[0286] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 77% yield. HRMS calc for[C₃₉H₃₆ClN₃O₄S—H] 676.20423 found 676.20405

[0287] EXAMPLE 64

4-{3-[1-benzhydryl-5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0288] Step 1: The sulfonyl chloride intermediate was prepared from3-chlorobenzyl bromide according to the procedure in Example 18 Step1-2.

[0289] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) according to the procedure in Example 1 Step 7 in10% yield.

[0290] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title compound in 100% yield. HRMS calc for[C₄₀H₃₆Cl₂N₂O₄S—H] 709.17000 found 709.16961

EXAMPLE 654-{3-[1-benzhydryl-5-chloro-2-(2-{[(3-nitrobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0291] Step 1: The sulfonyl chloride intermediate was prepared from3-nitrobenzyl bromide according to the procedure in Example 18 Step 1-2.

[0292] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) according to the procedure in Example 1 Step 7 in43% yield.

[0293] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title compound in 88% yield. HRMS calc for[C₄₀H₃₆ClN₃O₆S—H] 720.19405 found 720.19398

EXAMPLE 664-{3-[1-benzhydryl-5-chloro-2-(2{[(3-chlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0294] Step 1: The sulfonyl chloride intermediate was prepared from3-chlorobenzyl bromide according to the procedure in Example 18 Step1-2.

[0295] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) according to the procedure in Example 1 Step 7 in27% yield.

[0296] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title compound in 93% yield. HRMS calc for[C₄₀H₃₆Cl₂N₂O₄S—H] 709.17000 found 709.16963

EXAMPLE 674-{3-[1-benzhydryl-5-chloro-2-(2-{([(2,5-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0297] Step 1: The sulfonyl chloride intermediate was prepared from2,5-dichlorobenzyl bromide according to the procedure in Example 18 Step1-2.

[0298] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) according to the procedure in Example 1 Step 7 in59% yield.

[0299] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title compound in 100% yield. HRMS calc for[C₄₀H₃₅Cl₃N₂O₄S—H] 743.13103 found 743.13079

EXAMPLE 684-{3-[1-benzhydryl-5-chloro-2-(2-{[(3-methoxybenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0300] Step 1: The sulfonyl chloride intermediate was prepared from3-methoxybenzyl bromide according to the procedure in Example 18 Step1-2.

[0301] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 6, Example 42) according to the procedure in Example 1 Step 7 in20% yield.

[0302] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title compound in 100% yield. HRMS calc for[C₄₁H₃₉ClN₂O₅S—H] 705.21954 found 705.21909

EXAMPLE 694-{3-[2-(2-{[(2-aminobenzyl)sulfonyl]amino}ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoicAcid

[0303] Step 1: The intermediate from Step 1 Example 56 was treated withSnCl₂ according to the procedure in Step 1 Example 16 to yield the aminoester in 99% yield.

[0304] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. HRMS calc for[C₄₀H₃₈ClN₃O₄S—H] 690.21988 found 690.21941

EXAMPLE 704-{3-[1-Benzhydryl-5-chloro-2-(2-{[(2-methylbenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0305] Step 1: The sulfonyl chloride intermediate was prepared from2-Methylbenzyl bromide according to the procedure in Example 18 Step 1-2in quantitative yield.

[0306] Step 2: The methyl ester was prepared from the sulfonyl chlorideand the intermediate in Example 42 step 6 according to the procedure inExample 42 Step 7 in 50% yield.

[0307] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 93% yield. HRMS calc for[C₄₁H₃₉ClN₂O₄S—H] 689.22463 found 689.22421

EXAMPLE 714-{2-[1-Benzhydryl-5-chloro-2-(2-{([(4-trifluorometoxybenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0308] Step 1: The sulfonyl chloride intermediate was prepared from4-Trifluorometoxybenzyl bromide according to the procedure in Example 18Step 1-2 in quantitative yield.

[0309] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in48% yield.

[0310] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 85% yield. HRMS calc for[C₄₀H₃₄ClF₃N₂O₆S—H] 761.17054 found 761.17031

EXAMPLE 724-{2-[1-Benzhydryl-5-chloro-2-(2-{([(2-fluoro-6-nitrobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0311] Step 1: The sulfonyl chloride intermediate was prepared from2-Fluoro, 6-nitrobenzyl bromide according to the procedure in Example 18Step 1-2 in quantitative yield.

[0312] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in91% yield.

[0313] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. m/z (M−1) 740.05

EXAMPLE 734-{2-[1-Benzhydryl-5-chloro-2-(2-{[(2-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0314] Step 1: The c chloride intermediate was prepared from3,5-dichlorobenzyl bromide according to the procedure in Example 18 Step1-2 in theoritical yield.

[0315] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in100% yield.

[0316] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 81% yield. m/z (M−1) 747.2. HRMScalc for [C₃₉H₃₃Cl₃N₂O₅S—H] 745.11030 found 745.10954.

EXAMPLE 744-{2-[1-Benzhydryl-5-chloro-2-(2-{[(2,6-difluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0317] Step 1: The sulfonyl chloride intermediate was prepared from2,6-difluorobenzyl bromide according to the procedure in Example 18 Step1-2 in 95% yield.

[0318] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in86% yield.

[0319] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 71% yield. m/z (M−1)714. HRMS calcfor [C₃₉H₃₃ClF₂N₂O₅S—H] 713.16940 found 713.16906

EXAMPLE 754-(2-{1-benzhydryl-5-chloro-2-[2-({[(6-chloro-3-pyridinyl)methyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0320] Step 1: (6-chloro-3-pyridinyl)-methanol (1.0 eq.) was taken up indichloromethane and stirred overnight with carbon tetrabromide (1.5 eq.)and 1,3-bis(diphenylphosphino)propane (0.75 eq.) Ether was added to thesolution and filtration followed by concetration of the filtrateafforded (6-chloro-3-bromomethyl) pyridine in 62% yield.

[0321] Step 2: The sulfonyl chloride intermediate was prepared from theproduct of Step 1 according to the procedure in Example 18 steps 1-2.

[0322] Step 3: The methyl ester was prepared from the sulfonyl chlorideand methy4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in78% yield

[0323] Step 4: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 89% yield. HRMS calc for[C₃₈H₃₃Cl₂N₃O₅S—H] 712.14452 found 712.14420.

EXAMPLE 764-(2-{1-benzhydryl-5-chloro-2-[2-({[(5,6-dichloro-2-[pyridinyl)methyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0324] Step 1: 5,6-dichloro-3-pyridinemethanol (1.0 eq.) was taken up indichloromethane and stirred overnight with carbon tetrabromide (1.5 eq.)and 1,3-bis(diphenylphosphino)propane (0.75 eq.) Ether was added to thesolution and filtration followed by concentration of the filtrateafforded the 5,6-dichloro-3-bromomethylpyridine in 130% yield.

[0325] Step 2: The sulfonyl chloride intermediate was prepared from theproduct of Step 1 according to the procedure in Example 18 steps 1-2 in81% yield

[0326] Step 3: The methyl ester was prepared from the sulfonyl chlorideand methy4-{2-[2-(2-aminoethl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in79% yield

[0327] Step 4: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 109% yield. HRMS calc for[C₃₈H₃₂Cl₃N₃O₅S—H] 746.10554 found 746.10549.

EXAMPLE 774-{2-[1-Benzhydryl-5-chloro-2-(2-{[(3-methoxybenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy)benzoicAcid

[0328] Step 1: The sulfonyl chloride intermediate was prepared from3-methoxybenzyl bromide according to the procedure in Example 18 Step1-2 in 68% yield.

[0329] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in68% yield.

[0330] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title diacid in 93% yield. m/z (M−1) 707.0

EXAMPLE 784-{2-[1-Benzhydryl-5-chloro-2-(2-{[(3,5-dimethylbenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0331] Step 1: The sulfonyl chloride intermediate was prepared from3,5-dimethylbenzyl bromide according to the procedure in Example 18 Step1-2 in 38% yield.

[0332] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in38% yield.

[0333] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title diacid in 88% yield. m/z (M−1)705.0 HRMScalc for [C₄₁H₃₉ClN₂O₅S—H] 705.21954 found 705.21916.

EXAMPLE 794-{2-[1-Benzhydryl-5-chloro-2-(2-{[(2-methylbenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0334] Step 1: The sulfonyl chloride intermediate was prepared from2-methylbenzyl bromide according to the procedure in Example 18 Step 1-2in 35% yield.

[0335] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in35% yield.

[0336] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title diacid in 90% yield. m/z (M−1)691.0. HRMScalc for [C₄₀₁H₃₇ClN₂O₅S—H] 691.20389 found 691.20350

EXAMPLE 804-{2-[1-Benzhydryl-5-chloro-2-(2-{[(2,6-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0337] Step 1: The sulfonyl chloride intermediate was prepared from2,6-dichlorobenzyl bromide according to the procedure in Example 18 Step1-2 in 3% yield.

[0338] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in 3%yield.

[0339] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title diacid in 92% yield. m/z (M−1)745.0

[0340] The intermediate amine, synthesized using method A, was treatedwith chloromethylsulfonyl chloride either under Schoft and Baummanconditions or under anhydrous conditions with an organic base yielded achloromethyl sulfonamide intermediate. This intermediate could betreated with a varuiety of nucleophiles in DMF with a suitable organicbase, Hunigs base, triethylamine etc, and heated until the reaction wascomplete. The resulting intermediates where then hydrolyzed to yield thefinal compound. R13, R14 and R15 in the scheme for Method C, above,represent the optional substitution defined above for R₁₂.

[0341] Examples 81-86 and 118-121 were synthesized using Method C.

EXAMPLE 81 4-(2-{1-benzhydryl-5-chloro2[2({[(phenylsulfanyl)methyl]sulfonyl}amino) ethyl]-1H-indol-3-yl}ethoxy)benzoic acid

[0342] The title compound was synthesized as depicted in Method C.

[0343] Step 1: To the methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) was added chloromethanesulfonyl chloride accordingto the procedure in Example 1 Step 7 to generate the product in 99%yield.

[0344] Step 2: To methyl4-{2-[1-benzhydryl-5-chloro-2-(2{[(chloromethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoate(0.080M, 1.0 equiv.) and iPr₂NEt (3.4 equiv.) in N,N-dimethylformamidewas added thiophenol (2.1-2.5 equiv.) and the mixture was stirred at120° C. for 3.5 days. The reaction mixture was diluted with EtOAc andwashed with water and brine. The combined organic phase was dried overmagnesium sulfate and purified by flash chromatography.

[0345] Step 3:The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 93% yield. m/z (M−1) 709.11. HRMScalc for [C₃₉H₃₅ClN₂O₅S₂—H] 709.16031 found 709.15999.

EXAMPLE 824-(2-{1-benzhydryl-5-chloro-2-[2-(2,6-dimethyl-phenylsulfanylmethanesulfonylamino)-ethyl]-]-1H-indol-3-yl}-ethoxy)-benzoic acid

[0346] Step1 :To methyl4-{2-[1-benzhydryl-5-chloro-2-(2-{[(chloromethyl)sulfonyl]amino}ethyl)-'1H-indol-3-yl]ethoxy}benzoate,Example 81 step 1, was added 2,6-dimethylthiophenol according to theprocedure in Example 81 step 2 and 3.. The product was purified by theflash chromatography with 25% EtOAc/hexane in 32% yield.

[0347] Step2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 80% yield. m/z (M<1)751.0. HRMScalc for [C₄₀H₃₉ClN₂O₅S₂—H] 737.19161 found 737.19128.

EXAMPLE 834-(2-(1-benzhydryl-5-chloro-2-[2-(2-methoxy-phenylsulfanylmethanesulfonylamino)-ethyl]-]-1H-indol-3-yl}-ethoxy)-benzoic Acid

[0348] Step 1 :To methyl4-{2-[1-benzhydryl-5-chloro-1-(2-{[(chloromethyl)sulfonyl]amino}ethyl)-'1H-indol-3-yl]ethoxy}benzoate,Example 81 step1, was added 2-methoxythiophenol according to theprocedure in Example 81 step 2 and 3.. The product was purified by theflash chromatography 30% EtOAc/hexane in 36% yield.

[0349] Step2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 94% yield. m/z (M-1) 753.3. HRMScalc for [C₄₀H₃₇ClN₂O₆S₂—H] 739.17088 found 739.17052.

EXAMPLE 844-(2-{1-benzhydryl-5-chloro-2-[2-(2-chloro-6-methyl-phenylsulfanylmethanesulfonylamino)-ethyl]-]-1-H-indol-3-yl}-ethoxy)-benzoic Acid

[0350] Step 1: To methyl4-{2-[l-benzhydryl-5-chloro-2-(2-{[(chloromethyl)sulfonyl]amino}ethyl)-'1H-indol-3-yl]ethoxy}benzoate,Example 81 step 1, was added 2-chloro-6-methylthiophenol according tothe procedure in Example 81 step 2 and 3.. The product was purified bythe flash chromatography 25% EtOAc/hexane in 46% yield..

[0351] Step2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 100% yield. m/z (M−1)771.2. HRMScalc for [C₄₀H₃₆Cl₂N₂O₅S₂—H] 757.13699 found 757.13730.

EXAMPLE 854-(2-{1-benzhydryl-5-chloro-2-[2-(3,5-dichloro-phenylsulfanylmethanesulfonylamino)-ethyl]-]-1H-indol-3-yl}-ethoxy)-benzoic acid

[0352] Step1: To methyl4-{2-[1-benzhydryl-5-chloro-2-(2-{[(chloromethyl)sulfonyl]amino}ethyl)-'1H-indol-3-yl]ethoxy)benzoate,Example 81 step1, was added 3,5-dichlorothiophenol according to theprocedure in Example 81 step 2 and 3.. The product was purified by theflash chromatography 25% EtOAc/hexane in 40% yield.

[0353] Step2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 98% yield. m/z (M−1)793.2. HRMScalc for [C₃₉H₃₃Cl₃N₂O₅S₂—H] 777.08237 found 777.08159.

EXAMPLE 864-(2-{1-benzhydryl-5-chloro-2-[2-(3,4-dimethoxy-phenylsulfanylmethanesulfonylamino)-ethyl]-]-1H-indol-3-yl}-ethoxy)-benzoic acid

[0354] Step1: To methyl4-{2-[1-benzhydryl-5-chloro-2-(2-{[(chloromethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoate,Example 81 step1, was added 3,4-dimethoxythiophenol according to theprocedure in Example 81 step 2 and 3.. The product was purified by theflash chromatography with 35% EtOAc/hexane in 40% yield..

[0355] Step2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 99% yield. m/z (M−1)783.3. HRMScalc for [C₄₁H₃₉ClN₂O₇S₂—H] 769.18144 found 769.18120.

[0356] The intermediate amine, synthesized using method A, was treatedwith chloroethanesulfonyl chloride under anhydrous conditions with anorganic base yielded a vinyl sulfonamide intermediate. This intermediatecould be treated with a variety of nucleophiles in DMF with a suitableorganic base, Hunigs base, triethylamine etc, and heated until thereaction was complete. The resulting intermediates where then hydrolyzedto yield the final compound.

[0357] Examples 87-99 and 100-105, 113-117, 122-125 and 139 weresynthesized with Method D.

EXAMPLE 874-(2-{1-Benzhydryl-5-chloro-2-[2-(2-morpholin4-ylethanesulfonylamino)-ethyl]-1H-indol-3-yl)-ethoxy)-benzoicacid

[0358] The title compound was synthesis as depicted in Method D

[0359] Step 1: To methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(0.16 M, 1.0 equiv.), Step 5, Example 1, and triethylamine (2.3 equiv.)in THF was added 2-chloroethanesulfonyl chloride (1.2 eq) dropwise.After 4 h the mixture was poured into brine and extracted with EtOAc.The combined organic phase was dried over magnesium sulfate and purifiedby column chromatography to afford 75% of the vinyl sulfonamide.

[0360] Step2: To the product from step 1 in 1-propanol was addedmorpholine. After 5 h the reaction mixture was evaporated to drynessbefore redissolving in EtOAc. The organic phase was washed with brine,dried over magnesium sulfate, and purified by column chromatography togive the desired methyl ester in 89% yield.

[0361] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 89% yield. m/z (M−1) 702.17. HRMScalc for [C₃₈H₄₀ClN₃O₆S —H] 700.2535 found 700.22500.

EXAMPLE 884-(2-{1-Benzhydryl-5-chloro-2-[2-(2-pyrazol-1-yl-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicAcid

[0362] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 1H-pyrazole according to the procedure in Example87 step 2 except that it was heated at 80° C. for 18 h, in 90% yield.

[0363] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 61% yield. m/z (M−1) 681.24. HRMScalc for [C₃₇H₃₅ClN₄O₅S —H] 681.19439 found 681.19407.

EXAMPLE 894-(2-(1-Benzhydryl-5-chloro-2-[2-(2-phenylamino-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicAcid

[0364] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and aniline according to the procedure in Example 87step 2 except that it was heated at 80° C. for 8 days, in 50% yield.

[0365] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 98% yield. m/z (M−1) 706.26. HRMScalc for [C₄₀H₃₈ClN₃O₅S —H] 706.21479 found 706.21452.

EXAMPLE 904-(2-{1-benzhydryl-5-chloro-2-[2-({[2-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)ethyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0366] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 1,4-dioxa-8-aza-spiro[4.5]decane according to theprocedure in Example 87 step 2 except that it was stirred overnight, in82% yield.

[0367] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. m/z (M−1) 756.2. HRMScalc for [C₄₁H₄₄ClN₃O₇S —H] 756.25157 found 756.25142.

EXAMPLE 914-[2-(1-benzhydryl-5-chloro-2-{2-[({2-[4-(2-pyridinyl)-1-piperazinyl]ethyl}sulfonyl)amino]ethyl}-1H-indol-3-yl)ethoxy]benzoicAcid

[0368] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 1-Pyridin-2-yl-piperazine according to theprocedure in Example 87 step 2 except that it was stirred overnight, in86% yield.

[0369] .Step2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. m/z (M−1) 776.2. HRMScalc for [C₄₃H₄₄ClN₅O₅S —H] 776.26789 found 776.26750.

EXAMPLE 924-(2-{1-benzhydryl-5-chloro-2-[2-({[2-(1H-1,2,4-triazol-1-yl)ethyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0370] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 1H-[1,2,4] triazole according to the procedure inExample 87 step 2 except that it was refluxed for 4 days, in 64% yield

[0371] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 100% yield. m/z (M−1) 682.1. HRMScalc for [C₃₆H₃₄ClN₅O₅S —H] 682.18964 found 682.18964.

EXAMPLE 934-(2-{1-benzhydryl-5-chloro-2-[2-({[2-(3,5-dimethyl-1H-pyrazol-1-yl)ethyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0372] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 3,5-dimethyl-1H-pyrazole according to theprocedure in Example 87 step 2 except that it was refluxed for refluxed24 hours, in 95% yield.

[0373] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 62% yield. m/z (M−1) 709.2. HRMScalc for [C₃₉H₃₉ClN₄O₅S—H] 709.22569 found 709.22532.

EXAMPLE 944-(2-{1-benzhydryl-5-chloro-2-[2-({[2-(3-methyl-1H-pyrazol-1-yl)ethyl]sulfonyl}amino)ethyl]-1H-indol-3-ylethoxy)benzoicAcid

[0374] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 3-methyl-1H-pyrazole according to the procedure inExample 87 step 2 except that it was stirred overnight, in 88% yield.

[0375] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 86% yield. m/z (M−1) 695.2. HRMS calc for [C₃₈H₃₇ClN₄O₅S —H]695.21004 found 695.20951.

EXAMPLE 954-(2-{1-benzhydryl-5-chloro-2-[2-({([2-(4-methyl-1H-pyrazol-1-yl)ethyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0376] Step 1: The compound was prepared from the intermediate fromExample 87 step land 4-methyl-1H-pyrazole according to the procedure inExample 87 step 2 except that it was refluxed for 2 days, in 81% yield.

[0377] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 93% yield. m/z (M−1) 695.2. HRMS calc for [C₃₈H₃₇ClN₄O₅S —H]695.21004 found 695.20954

EXAMPLE 964-[2-(1-benzhydryl-5-chloro-2-{2-[({2-[(2R,6S)-2,6-dimethyl-1-piperidinyl]ethyl}sulfonyl)amino]ethyl}-1H-indol-3-yl)ethoxy]benzoicAcid

[0378] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 2,6-dimethyl-piperidine according to the procedurein Example 87 step 2 except that it was heated at 70° C. overnight, in54% yield.

[0379] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 79% yield. m/z (M−1) 726.3. HRMS calc for [C₄₁H₄₆ClN₃O₅S —H]726.27739 found 726.27720.

EXAMPLE 974-(2-{1-benzhydryl-5-chloro-2-[2-({[2-(2-thioxo-1-imidazolidinyl)ethyl]sulfonyl}amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0380] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and imidazolidine-2-thione according to the procedurein Example 87 step 2 except that it was refluxed for 3 days, in 17%yield..

[0381] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 88% yield. m/z (M−1) 715.3. HRMS calc for [C₃₇H₃₇ClN₄O₅S —H]715.18211 found 715.18161.

EXAMPLE 984-(2{-1-benzhydryl-5-chloro-2-[2-({[2-(1,3-thiazolidin-3-yl)ethyl]sulfonyl)amino)ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0382] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and thiazolidine according to the procedure in Example87 step 2 except that it was refluxed overnight, in 33% yield.

[0383] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 93% yield. m/z (M−1) 702.3. HRMS calc for [C₃₇H₃₈ClN₃O₅S₂ —H]702.18686 found 702.18659.

EXAMPLE 994-(2-{1-benzhydryl-5-chloro-2-[2-(2-[1,2,3]triazol-1-yl-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}ethoxy)benzoicAcid

[0384] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 1H-[1,2,3] triazole according to the procedure inExample 87 step 2 except that it was refluxed for 5 days, in 23% yield.

[0385] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 100% yield. m/z (M−1) 682.0. HRMS calc for [C₃₆H₃₄ClN₅O₅S —H]682.18964 found 682.18933.

EXAMPLE 1004-(3-{1-Benzhydryl-5-chloro-2-[2-(2-morpholin4-yl-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}-propyl)-benzoicAcid

[0386] Step 1: To methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate, Step 6, Example 42, (0.16 M, 1.0 equiv.) and triethylamine (2.3equiv.) in THF was added 2-chloroethanesulfonyl chloride (1.2 eq)dropwise. After 4 h the mixture was poured into brine and extracted withEtOAc. The combined organic phase was dried over magnesium sulfate andpurified by column chromatography to afford the vinyl sulfonamide.

[0387] Step2: To the product from step 1 in 1-propanol was addedmorpholine. After 5 h the reaction mixture was evaporated to drynessbefore redissolving in EtOAc. The organic phase was washed with brine,dried over magnesium sulfate, and purified by column chromatography togive the desired methyl ester in 100% yield.

[0388] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 85% yield. m/z (M−1) 698.12. HRMScalc for [C₃₉H₄₂ClN₃O₅S —H] 698.24609 found 698.24581.

EXAMPLE 1014-[3-(1-Benzhydryl-5-chloro-2-{2-[2-(2,6-dimethyl-piperidin-1-yl)-ethanesulfonylamino]-ethyl}-1H-indol-3-yl)-propyl]-benzoicAcid

[0389] Step 1: The compound was prepared from the intermediate fromExample 100 step 1 and 2,6-dimethylpiperdine according to the procedurein Example 100 step 2 except that it was refluxed for heated at 80° C.for 1 d 17 h, in 59% yield.

[0390] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 86% yield. m/z (M−1) 724.20. HRMScalc for [C₄₂H₄₈ClN₃O₄S—H] 724.29813 found 724.29776.

EXAMPLE 1024-[3-(1-Benzhydryl-5-chloro-2-{2-[2-(3,5-dimethyl-pyrazol-1-yl)-ethanesulfonylamino]-ethyl}-1H-indol-3-yl)-propyl]-benzoicAcid

[0391] Step 1: The compound was prepared from the intermediate fromExample 100 step 1 and 3,5-dimethyl-1H-pyrazole according to theprocedure in Example 100 step 2 except that it was refluxed for heatedat 80° C. for 1 d, in quantitative yield.

[0392] Step2—The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 89% yield. m/z (M−1) 707.16. HRMScalc for [C₄₀H₄₁ClN₄O₄S—H] 707.24642 found 707.24597.

EXAMPLE 103 and 1044-(2-{1-benzhydryl-5-chloro-2-[2-(2-tetrazol-2-yl-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}ethoxy)benzoicacid and4-(2-{1-benzhydryl-5-chloro-2-[2-(2-tetrazol-1-yl-ethanesulfonylamino)-ethyl]-1-H-indol-3-yl}ethoxy)benzoicAcid

[0393] Step 1: The mixture of4-{2-[1-Benzhydryl-5-chloro-2-(2-ethenesulfonylamino-ethyl)-1H-indol-3-yl]-ethoxy}-benzoicacid methyl ester (0.2 M, 1.0 equiv.), 1H-tetrazole(4.0 equiv.) andiPr₂NEt(4.3 equiv.) in 1-propanol was refluxed overnight. It wasevaporated to dryness before redissolving in EtOAc. The organic phasewas washed with water and brine, dried over magnesium sulfate, purifiedby column chromatography to give two isomers in 41% and 52% yields,respectively.

[0394] Step2: The ester intermediates were hydrolyzed according to Step8 Example 1, except that the pH was adjusted to 4-5, to afford the titleacids4-(2-{1-benzhydryl-5-chloro-2-[2-(2-tetrazol-2-yl-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}ethoxy)benzoicacid in 92% yield. m/z (M−1) 683.3;4-(2-{1-benzhydryl-5-chloro-2-[2-(2-tetrazol-1-yl-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}ethoxy)benzoicacid in 83% yield. m/z (M−1) 683.3. HRMS calc for [C₃₅H₃₃ClN₆O₅S—H]683.18489 found 683.18458;4-(2-{1-benzhydryl-5-chloro-2-[2-(2-tetrazol-1-yl-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}ethoxy)benzoicacid in 83% yield. HRMS calc for [C₃₅H₃₃ClN₆O₅S—H] 683.18489 found683.18435.

[0395] The substituted nitro aromatic was treated with ethyl oxalate inthe presence of potassium or sodium in an alcoholic solvent. Theresulting oxalate ester was treated with a suitable reducing agent, suchas iron powder, and the resulting amine cyclized to the indole under thereaction conditions. The carboxylate was next reduced with any of avariety of reducing agents, lithium aluminum hydride, dibal etc and theresulting alcohol was oxidized using reagents such as manganese dioxide,Swern condition NMO/TPAP etc. This 2 formyl indole was next alkylated bytreatment with a strong base such as Na/KHMDS, NaH, etc and thenalkylated with a suitable halide. The aldehyde was next treated withnitromethane and a base such as ammonium acetate to yield a vinyl nitrointermediate that could be reduced by a variety of agents such asLithium Aluminum Hydride or Zn(Hg) amalgam in HCl. The resulting aminewas sulfonylated using a sulfonly chloride either under biphasic Schottand Baummen conditions or anhydrous conditions with an organic base.This intermediate could be reductively alkylated at C3 using an aldehydeor an acetal under the action of a Bronsted or Lewis acid such astriflouroacetic acid and a reducing agent such as triethylsilane. Thereulting intermediate was hydrolyzed using a base, NaOH, KOH, LiOH and amixture of solvents including an alcoholic solvent, water andtetrahydrofuran.

[0396] Examples 105-107 were synthesized with Method E.

EXAMPLE 105 4-{2-[1-Benzhydryl-6-chloro-2-(2-phenylmethanesulfonylamino-ethyl)-1H-indol-3-yl]-ethoxy}-benzoic acid

[0397] The title compound was synthesized as depicted in Method E.

[0398] Step 1: To potassium (6.24 g) in ether at rt were added ethanol(40 mL, in 100 mL ether), diethyl oxalate (27.85 g, in 60 mL ether), and4-chloro-2-nitrotoluene (in 40 mL ether). The reaction mixture wasstirred at rt for 15 h and followed by sonication for 7 h before pouringonto cold 1 N HCl. After neutralization, the aqueous layer was extractedwith EtOAc and the combined organic layers were washed with brine anddried. After evaporation, the crude3-(4-Chloro-2-nitro-phenyl)-2-oxo-propionic acid ethyl ester was useddirectly in the next step without further purification.

[0399] Step 2: To crude 3-(4-chloro-2-nitro-phenyl)-2-oxo-propionic acidethyl ester (151 mmol) in ethanol:glacial HOAc (1:1, v/v, 560 mL) at rtwas added iron powder (74.4 g) and the reaction mixture was stirred atreflux for 4 h. The mixture was filtered and evaporated to give aresidue which was redistributed in dichloromethane/l N HCl. The organiclayer was washed with 1 N HCl, NaHCO₃, and brine and dried. Evaporationfollowed by crystallization (DCM) gave 6-Chloro-1H-indole-2-carboxylicacid ethyl ester as a pale yellow solid (16.8 g, 50% over 2 steps).

[0400] Step 3: To 6-chloro-1H-indole-2-carboxylic acid ethyl ester (8.57g) in THF at 0 ° C. was added lithium aluminum hydride solution (1 M, inTHF) dropwise and the reaction mixture was stirred for 3.5 h. Themixture was quenched with H₂O, 15% NaOH, and H₂O before it was filteredand rinsed with THF. Evaporation of the solvent gave 7.77 g of the crude(6-Chloro-1H-indol-2-yl)-methanol which was used directly in the nextstep.

[0401] Step 4: To (6-chloro-1H-indol-2-yl)-methanol (37.7 mmol) in THFat 0° C. was added manganese (IV) oxide and the mixture was stirred atrt for 16 h. The mixture was filtered over celite and rinsed with THFand EtOAc and evaporated to near dryness. The solid was filtered andwashed with cold EtOAc/hex to give 6-Chloro-1H-indole-2-carbaldehyde(62%, 2 steps).

[0402] Step 5: To 6-chloro-1H-indole-2-carbaldehyde (1 equiv.) in DMF at0° C. was added NaH (1.25 equiv.) portionwise followed by benzhydrylbromide (1.46 equiv.) and Bu₄NI (0.05 equiv.). The mixture was stirredat rt for 42 h before quenching with cold 0.4 N HCl at 0° C. Afterneutralization, the aqueous layer was extracted with ether and theorganic layer was washed with cold H₂O and dried. Flash chromatographyon silica gel gave 1-benzhydryl-6-chloro-1H-indole-2-carbaldehyde in 40%yield.

[0403] Step 6: A solution of1-benzhydryl-6-chloro-1H-indole-2-carbaldehyde (0.5 M, 1 equiv.) andNH₄OAc (1 equiv.) in nitromethane was heated at 95° C. for 70 min. Themixture was diluted with EtOAc, washed with water, and dried.Evaporation of the volatiles, followed by trituration with ether/hexaneproduced 1-Benzhydryl-6-chloro-2-(2-nitro-vinyl)-1H-indole in 48% yield.

[0404] Step 7: To lithium aluminum hydride (1 M in THF, 4 equiv.) in THFat 0° C. was added 1-benzhydryl-6-chloro-2-(2-nitro-vinyl)-1H-indole(0.1 M, 1 equiv.) dropwise and the reaction mixture was stirred for 2 h.The mixture was quenched with H₂O, 15% NaOH, and H₂O, filtered throughcelite and rinsed with EtOAc. After evaporation, the residue waspurified by column chromatography to generate2-(1-Benzhydryl-6-chloro-1H-indol-2-yl)-ethylamine in 40% yield.

[0405] Step 8: To 2-(1-Benzhydryl-6-chloro-1H-indol-2-yl)-ethylamine wasadded phenylmethanesulfonyl chloride according to the procedure inExample 1 Step 7 to generateN-[2-(1-Benzhydryl-6-chloro-1H-indol-2-yl)-ethyl]-C-phenyl-methanesulfonamidein 90% yield.

[0406] Step 9: ToN-[2-(1-Benzhydryl-6-chloro-1H-indol-2-yl)-ethyl]-C-phenyl-methanesulfonamide(0.033 M, 1 equiv.) in DCM at 0° C. were added 4-(2-oxo-ethoxy)-benzoicacid methyl ester (3.3 equiv.), triethylsilane (6 equiv.), and TFA (5equiv.). The reaction mixture was stirred at rt for 2 d 20 h beforeaqueous workup. Purification by silica gel chromatography followed byreverse phase HPLC gave4-{2-[1-Benzhydryl-6-chloro-2-(2-phenylmethanesulfonylamino-ethyl)-1H-indol-3-yl]-ethoxy}-benzoicacid methyl ester in 35% yield.

[0407] Step 10: The ester intermediate from step 9 was hydrolyzedaccording to Step 8 Example 1 to afford the title acid in 64% yield.

EXAMPLE 1064-(2-{1-Benzhydryl-6-chloro-2-[2-(3,4-dichloro-phenylmethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicAcid

[0408] Step 1: To 2-(1-Benzhydryl-6-chloro-1H-indol-2-yl)-ethylamine,Example 105 step 7 was added (3,4-dichloro-phenyl)-methanesulfonylchloride according to the procedure in Example 105 Step 7 to generateN-[2-(1-benzhydryl-6-chloro-1H-indol-2-yl)-ethyl]-C-(3,4-dichloro-phenyl)-methanesulfonamidein quantitative yield.

[0409] Step 2:N-[2-(1-Benzhydryl-6-chloro-1H-indol-2-yl)-ethyl]-C-(3,4-dichloro-phenyl)-methanesulfonamidewas reductively alkylated as described in Example 105 step 9 to give4-(2-{1-benzhydryl-6-chloro-2-[2-(3,4-dichloro-phenylmethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicacid methyl ester in 38% yield.

[0410] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 96% yield. m/z (M−1) 747.27.

EXAMPLE 1074-(2-(1-Benzhydryl-6-chloro-2-[2-(3,5-dichloro-phenylmethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicAcid

[0411] Step 1: To 2-(1-Benzhydryl-6-chloro-1H-indol-2-yl)-ethylamine,Example 105 step 7 was added (3,5-dichloro-phenyl)-methanesulfonylchloride according to the procedure in Example 105 Step 7 to generateN-[2-(1-benzhydryl-6-chloro-1H-indol-2-yl)-ethyl]-C-(3,5-dichloro-phenyl)-methanesulfonamidein quantitative yield.

[0412] Step 2:N-[2-(1-Benzhydryl-6-chloro-1H-indol-2-yl)-ethyl]-C-(3,4-dichloro-phenyl)-methanesulfonamidewas reductively alkylated as described in Example 105 step 9 to give4-(2-{1-benzhydryl-6-chloro-2-[2-(3,5-dichloro-phenylmethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicacid methyl ester in 31% yield.

[0413] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 95% yield. m/z (M−1) 747.27.

EXAMPLE 1084-{2-[1-Benzhydryl-5-chloro-2-(2-{[(2-cyanobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0414] Step 1: The sulfonyl chloride intermediate was prepared from2-bromomethyl-benzonitrile according to the procedure in Example 18 Step1-2 in 100% yield.

[0415] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7.

[0416] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 72% overall yield. HRMS calcd. forC₄₀H₃₅ClN₃O₅S(M+1): 704.1980; found: 704.1984. HRMS calcd. forC₄₀H₃₅ClN₃O₅S(M+1): 704.1980; found: 704.1984.

EXAMPLE 1094-{2-[1-Benzhydryl-5-chloro-2-(2-{[(tetrahydro-2H-pyran-2-ylmethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0417] Step 1: The sulfonyl chloride intermediate was prepared from2-bromomethyl-tetrahydro-pyran according to the procedure in Example 18Step 1-2 in 100% yield.

[0418] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7.

[0419] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 20% overall yield HRMS calcd. forC₃₈H₃₈ClN₂O₆S(M−1): 685.2145; found: 685.2143.

EXAMPLE 1104-{2-[1-Benzhydryl-2-(2-{[(1,3-benzoxazol-2-ylmethyl)sulfonyl]amino}ethyl)-5-chloro-1H-indol-3-yl]ethoxy}benzoicAcid

[0420] Step 1: The sulfonyl chloride intermediate was prepared from2-bromomethyl-benzooxazole according to the procedure in Example 18 Step1-2 in 100% yield.

[0421] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7.

[0422] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 26% overall yield . HRMS calcd.for C₄₀H₃₅ClN₃O₆S(M+1): 720.1930; found: 720.1924.

EXAMPLE 1114-{2-[1-Benzhydryl-5-chloro-2-(2-{[(cyanomethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0423] Step 1: The sulfonyl chloride intermediate was prepared from3-bromomethyl-[1,2,4]oxadiazole according to the procedure in Example 18Step 1-2 in 100% yield.

[0424] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7.

[0425] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 59% overall yield. HRMS calcd. forC₃₄H₃₁ClN₃O₅S(M+1): 628.1668; found: 628.1662.

EXAMPLE 1124-{2-[1-Benzhydryl-5-chloro-2-(2-{[(3-thienylmethyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethoxy}benzoicAcid

[0426] Step 1: The sulfonyl chloride intermediate was prepared from3-bromomethyl 3-bromomethyl-thiophene according to the procedure inExample 18 Step 1-2 in 100% yield.

[0427] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethoxy}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7.

[0428] Step 3: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 25% overall yield. HRMS calcd. forC₃₂H₃₁ClN₂O₅S₂(M−1): 683.1447; found: 683.1445.

EXAMPLE 1134-[2-(1-Benzhydryl-5-chloro-2-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethanesulfonylamino]-ethyl}-1H-indol-3-yl)-ethoxy]-benzoicAcid

[0429] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 2-methyl-pyrrolidine according to the procedure inExample 87 step 2 in 91% yield.

[0430] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 99% yield. HRMS calc for [C₃₉H₄₂ClN₃O₅S—H] 698.24609 found698.24572.

EXAMPLE 1144-[2-(1-Benzhydryl-5-chloro-2-{2-[2-(2-methyl-piperidin-1-yl)-ethanesulfonylamino]-ethyl}-1H-indol-3-yl)-ethoxy]-benzoicAcid

[0431] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 2-methyl-piperidine according to the procedure inExample 87 step 2 in 91% yield.

[0432] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 96% yield. HRMS calc for [C₄₀H₄₄ClN₃O₅S—H] 712.26174 found712.26113.

EXAMPLE 1154-[2-(1-Benzhydryl-5-chloro-2-{2-[2-(2,5-dimethyl-pyrrolidin-1-yl)-ethanesulfonylamino]-ethyl}-1H-indol-3-yl)-ethoxy]-benzoicAcid

[0433] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 2,5-dimethyl-pyrrolidine according to theprocedure in Example 87 step 2 in 81% yield.

[0434] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 96% yield. HRMS calc for [C₄₀H₄₄ClN₃O₅S−H] 712.26174 found712.26114.

EXAMPLE 1164-(2-{1-Benzhydryl-5-chloro-2-[2-(2-thiomorpholin-4-yl-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicAcid

[0435] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and thiomorpholine according to the procedure inExample 87 step 2 in 93% yield.

[0436] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 90% yield. HRMS 10 calc for [C₃₈H₄₀ClN₃O₅S₂—H] 716.20251 found716.20217.

EXAMPLE 1174-(2-{1-Benzhydryl-5-chloro-2-[2-(2-piperidin-1-yl-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicAcid

[0437] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and piperidine according to the procedure in Example87 step 2 in 99% yield.

[0438] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 92% yield. HRMS calc for [C₃₉H₄₂ClN₃O₅S—H] 698.24609 found698.24570.

EXAMPLE 1184-{2-[1-benzhydryl-5-chloro-2-(2-o-tolylsulfanylmethanesulfonylamino-ethyl)-1H-indol-3-yl]-ethoxy}-benzoicacid

[0439] Step1: To methyl4-{2-[1-benzhydryl-5-chloro-2-(2-{[(chloromethyl)sulfonyl]amino}ethyl)-'1H-indol-3-yl]ethoxy}benzoate,Example 81 step1, was added o-thiocresol according to the procedure inExample 81 step 2 and 3. The product was purified by the preperativeHPLC in 45% yield.

[0440] Step2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 98% yield. m/z (M−1)723.07. HRMScalc for [C₄₀H₃₇ClN₂O₅S—H] 723.17596 found 723.17596.

EXAMPLE 1194-(2-{1-benzhydryl-5-chloro-2-[2-(2-chloro-phenylsulfanylmethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicacid

[0441] Step1: To methyl4-{2-[1-benzhydryl-5-chloro-2-(2-{[(chloromethyl)sulfonyl]amino}ethyl)-'¹H-indol-3-yl]ethoxy}benzoate,Example 81 step 1, was added 2-chlorothiophenol according to theprocedure in Example 81 step 2 and 3. The product was purified by thepreperative HPLC in 53% yield.

[0442] Step2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 100% yield. m/z (M−1)743.08. HRMScalc for [C₃₉H₃₄Cl₂N₂O₅S₂—H] 743.12134 found 743.12111.

EXAMPLE 1204-(2-(1-benzhydryl-5-chloro-2-[2-(2,6-dichloro-phenylsulfanylmethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicacid

[0443] Step1: To methyl4-{2-[1-benzhydryl-5-chloro-2-(2-{[(chloromethyl)sulfonyl]amino}ethyl)-'1H-indol-3-yl]ethoxy}benzoate,Example 81 step 1, was added 2,6-dichlorothiophenol according to theprocedure in Example 81 step 2 and 3. The product was purified by thepreperative HPLC in 15.7% yield and hydrolized acid in 37%.

[0444] Step2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 98% yield. m/z (M−1) 776.93. HRMScalc for [C₃₉H₃₃Cl₃N₂O₅S₂—H] 777.08237 found 777.08205.

EXAMPLE 1214-(2-{1-benzhydryl-5-chloro-2-[2-(2,5-dimethoxy-phenylsulfanylmethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicacid

[0445] Step1: To methyl4-{2-[1-benzhydryl-5-chloro-2-(2-{[(chloromethyl)sulfonyl]amino}ethyl)-'1H-indol-3-yl]ethoxy}benzoate,Example 81 step1, was added 2,5-dimethoxythiophenol according to theprocedure in Example 81 step 2 and 3.. The product was purified by theflash chromatography 35% EtOAc/hexane in 65% yield.

[0446] Step2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 99.5% yield. m/z (M−1)769.18.HRMS calc for [C₄₁H₃₉ClN₂O₇S₂—H] 769.18144 found 769.18121.

EXAMPLE 1224-[2-(1-benzhydryl-5-chloro-2-{2-[2-(3-hydroxy-pyrrolidine-1-yl)-ethanesulfonylamino]-ethyl}-1H-indol-3-yl)-ethoxy]-benzoicAcid

[0447] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 3-pyrrolidinol according to the procedure inExample 87 step 2 in 90% yield without the column purification.

[0448] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 84% yield. m/z (M−1)699.99. HRMS calc for [C₃₈H₄₀ClN₃O₆S—H]700.22535 found 700.22490.

EXAMPLE 1234-[2-(1-Benzhydryl-5-chloro-2-{2-[2-(4-hydroxy-piperidin-1-yl)-ethanesulfonylamino]-ethyl}-1H-indol-3-yl)-ethoxy]-benzoicAcid

[0449] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and 4-hydroxypiperidine according to the procedure inExample 87 step 2 in 95% yield without the column purification.

[0450] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 42% yield. m/z (M−1)714.03. HRMS calc for [C₃₉H₄₂ClN₃O₆S—H]714.24100 found 714.24085.

EXAMPLE 1244-[2-(1-Benzhydryl-5-chloro-2-{2-[2-(2-dimethylaminomethyl-piperidin-1-yl)-ethanesulfonylamino]-ethyl}-1H-indol-3-yl)-ethoxy]-benzoicAcid

[0451] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and N-(2-piperidylmethyl)-dimethylamine according tothe procedure in Example 87 step 2 in 90% yield without the columnpurification.

[0452] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 71% yield. m/z (M−1)754.94. HRMS calc for [C₄₂H₄₉ClN₄O₅S—H]755.30394 found 755.30344

EXAMPLE 1254-(2-{1-Benzhydryl-5-chloro-2-[2-(2-imidazol-1-yl-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoicAcid

[0453] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and imidazole according to the procedure in Example 87step 2 except that it was heated at 120° C. for 4.5 days, in 87% yield.

[0454] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 60% yield. m/z (M−1)681.17. HRMS calc for [C₃₇H₃₅ClN₄O₅S—H]681.19439 found 681.19409.

EXAMPLE 1264-{3-[1-benzhydryl-5-chloro-2-(2-{[(2,6-difluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0455] Step 1: The sulfonyl chloride intermediate was prepared from2,6-difluorobenzyl bromide according to the procedure in Example 18 Step1-2 in quantitative yield.

[0456] Step 2: The methyl ester was prepared from the sulfonyl chlorideand methyl4-{2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]propyl}benzoate(Step 5, Example 1) according to the procedure in Example 1 Step 7 in53% yield.

[0457] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1 to afford the title acid in 92% yield. m/z (M−1)711.2. HRMScalc for [C₄₀H₃₅ClF₂N₂O₄S—H] 711.19013 found 711.18965.

EXAMPLE 1274-(3-[1-benzhydryl-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoicAcid

[0458] Step 1: 2-methylindole was treated with the intermediate fromExample 42 step 1 and the procedure from Example 42 step 2 to yield thedesired product in 88%.

[0459] Step 2: The product from above was alkylated with benzhydrylbromide according to the proceure in Example 42 step 3 to yield theproduct in 65%.

[0460] Step 3: The product from above was oxidized using the conditionsoutlined in Example 42 step 4 to yield the desired 2-formyl indole in85% yield.

[0461] Step 4: The indole from above was subjected to the nitro aldolconditions outlined in Example 42 step 5.

[0462] Step 5: The vinyl nitro compound from above was reduced under theconditions outlined in Example 42 step 6 to yield the desired aminoindole in 39% yield.

[0463] Step 6: The amine from step 5 was treated with(3,4-dichlorophenyl)-methyl]sulfonyl chloride according to the procedurein Example 43 Step 7 which yielded 100% of the desired product.

[0464] Step 7: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 24% yield. HRMS calc for[C₄₀H₃₆ClN₂O₄S—H] 709.1700 found 709.16951.

EXAMPLE 1284-[3-(1-benzhydryl-2-{2-[(benzylsulfonyl)amino]ethyl}-1H-indol-3-yl)propyl]benzoicAcid

[0465] Step 1: This compound was prepared from the intermediate inExample 127 step 5 [1-toluenesulfonyl chloride according to theprocedure in Example 43 Step 7 which yielded 83% of the desired product.

[0466] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 43 to afford the title acid in 95% yield. HRMS calc for[C₄₀H₃₈N₂O₄S—H] 641.24795 found 641.24761.

[0467] The appropriately substituted halo amine is reacted withtriflouroacetic anhydride to yield an intermediate that could be treatedwith a Pd^(ii) catalyst in the presence of a base such as triethlyamineand Cul and a suitable alkyne under heat yielded the desired indoleintermediate. The primary alcohol was protected as a silyl ether using asilyl chloride such as t-Butldiphenylsilyl chloride and a base such asimidazole. The protected indole is then treated with oxallyl chloridefollowed by methanol which produced the desired oxalate ester whichcould be alkylated using a suitable base such as cesium carbonate inrefluxing acetonitrile and a halide. The oxallate could then be reducedvia the action of a suitable reducing agent such as borane. Theresulting primary alcohol was converted to a halide, using for ExampleCBr₄ and a phosphine, which could then be a nucleophile such as athiophenol. The resulting thioether could be oxidized by a variety ofoxidizing agents including oxone and TPAP/NMO. The resulting sulfone canbe deprotected via the action of a flouride source such as TBAF, CsF orHF. The resulting alcohol could be converted to a halide or mesylate,for Example using methane sulfonyl chlroide and an organic base, whichcould then be displaced by sodium azide in DMF.The resulting alkyl azidecould be reduced under the action of triphneyl phosphine and wet THF.The amine could be sulfonylated by the action of a sulfonyl chlorideunder either biphasic Shcott and Baumman conditions, Aq. Bicarbonate anddichloromethane, or under anhydrous conditions consisting ofdichloromethane and an organic base such as Hunigs base. The reultingintermediate was hydrolyzed using a base, NaOH, KOH, LiOH and a mixtureof solvents including an alcoholic solvent, water and tetrahydrofuran.

[0468] The following Examples 129-132 were synthesized with Method F.

EXAMPLE 129 3-[4-({2-[1-Benzhydryl-5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoic Acid

[0469] Step 1: 2-Bromo-4-chloroaniline(1.0 eq) was dissolved in CH₂Cl₂(0.25 M), then triethylamine and triflouroacetyl anhydride(1.1 eq each)were added. The resulting mixture was stirred at room temperature for 1hour. Solvent was then stripped-off from the reaction mixture, and theresidue was purified by flash chromatography with dichloromethane aseluent to give the described product in 97% yield. m/z(M—H)⁻300.0.

[0470] Step 2: N-(2-Bromo-4-chlorophenyl)-2,2,2-trifluoroacetamide(step1, 1.0 eq) was mixed with 3-butyn-1-ol(2.0 eq),dichlorobis(triphenylphosphine)palladium(II) (2.5% eq),triethylamine(3.0 eq), Cul(5% eq) in DMF(0.2 M) in a sealed vessel underN₂ and heated to 120° C. for 4 hours. The reaction mixture was thendiluted with ethyl acetate, washed with brine and dried over Na₂SO₄.Furthermore, evaporate the solvent and the residue was purified by flashcolumn chromatography with 2% MeOH/CH₂Cl₂ to give the describedproduct(A) in 67% yield. m/z(M—H)⁻194.09

[0471] Step 3: 2-(5-Chloro-1H-indol-2-yl)ethanol(step 2,1.0 eq) andimidazole(2.0 eq) were dissolved in DMF(0.3 M) at room temperature withstirring before tert-butylchlorodiphenylsilane (1.2 eq) was added. Theresulting mixture was kept stirred overnight at room temperature beforeit was quenched with a saturated sodium bicarbonate aqueous solution andextracted with ethyl acetate. Organic phase was washed with water andbrine and dried over Na₂SO₄. Solvent was removed and residue waspurified with column with CH₂Cl₂ as eluent to give the desired productas brown gum in over 90% yield. m/z(M—H)⁻433.0

[0472] Step 4:2-({[tert-Butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indole(step 3, 1.0eq) was dissolved in ether (0.4 M) and the solution was cooled to 0° C.Oxalyl chloride (1.2 eq) was added to the above cold solution withvigorous stirring. The reaction mixture was kept stirred at 0° C. for 1hour before EtOH was added, followed by NEt₃. The resulting mixture wasthen diluted with more EtOH before it was poured into water. Extractwith EtOAc. Organic phase washed with brine, dried over Na₂SO₄,concentrated to give the desired product as yellowish solid in 70%yield. m/z(M−H)⁻533.0

[0473] Step 5: Ethyl[2-({[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl](oxo)acetate(step4, 1 eq), Ph₂CHBr(1.5 eq) and Cs₂CO₃(1.5 eq) were mixed in dryacetonitrile (0.1M). The mixture was refluxed with stirring for 2 hours.The reaction mixture was cooled to room temperature, added water andextracted with EtOAc. Organic phase was concentrated and the residue wascolumned with CH₂Cl₂ as eluent to give the desired product as orange gumin 45% yield. m/z(M+H)⁺701.3

[0474] Step 6: Ethyl[1-benzhydryl-2-({[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl](oxo)acetate(step 5, 1 eq) was dissolved in THF (0.1M), then BH₃.Me₂S(2M in THF)(2eq)was added to it. The resulting mixture was refluxed withstirring overnight under N₂. The reaction mixture was cooled to roomtemperature, then quenched slowly with 1N NaOH. Followed by EtOAcextraction, brine wash. Striping-off the solvent to give the describedproduct in 65% yield. m/z(M+H)⁺645.0

[0475] Step7:_(—)2-[1-Benzhydryl-2-({[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethanol(Step 6, 1 eq) was dissolved in CH₂Cl₂(0.08M), then1,3-bis(diphenylphosphino)-propane (DPPP, 0.75 eq) was added. Thesolution was cooled to 0° C. under N₂, then CBr₄ (1.25eq) was added withstirring. The stirring was continued for 2 hours while the reactiontemperature was allowed to return to room temperature. The solvent wasstripped off, and the residue was purified by passing through a shortcolumn with CH₂Cl₂ as eluent to give the desired product in quantitativeyield. m/z(M+H)⁺708.0

[0476] Step 8:1-Benzhydryl-3-(2-bromoethyl)-2-({[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indole(Step7, 1 eq) was mixed with methyl-3-(4-mercaptolphenyl)propionate (1.5 eq)and K₂CO₃ (1.5 eq) in DMF(0.1M). The resulting mixture was stirred atroom temperature under N₂ for 2hrs, then water was added, followed ethylacetate extraction, brine wash, and column purification (CH₂Cl₂ aseluent) to give 80% of the desired product as brownish gum.m/z(M+H)823.0

[0477] Step 9: Methyl3-[4-({2-[1-benzhydryl-2-({[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)phenyl]propanoate(Step 8, 1 eq) was dissolved in acetonitrile(0.1M), then molecular sieve(powder, 4 A,) and 4-methylmorphorline N-oxide(NMO)(4 eq) were addedunder N₂. After 5 min, n-Pr₄NRuO₄ (TPAP)(5% eq) was added to it. Theresulting mixture was heated to 40° C. with stirring and kept for 1.5hrs. Strip-off the solvent, residue was columned with CH₂Cl₂, then 1%EtOAc/CH₂Cl₂ as eluent to give the desired product as white foam in 44%yield. m/z(M+H)⁺855.1

[0478] Step 10: Methyl3-(4-{2-[1-benzhydryl-2-({[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethoxy}phenyl)propanoate(Step 9, 1 eq) was dissolved in THF(0.1M) and cooled to 0° C., followedby nBu₄NF (1M in THF) (1.2 eq). The resulting mixture was stirred at 0°C. for 5′, then warmed up to room temperature and stirred for 30′.Strip-off solvent. The residue was columned with EtOAc/CH₂Cl₂ (1:9 to1:4) as eluent to give the described intermediate as white foam in 90%yield. m/z(M+H)⁺616.20

[0479] Step 11: Methyl3-[4-{2-[1-benzhydryl-5-chloro-2-(hydroxyethyl)-1H-indol-3-yl]ethyl}-sulfonyl)phenyl]propanoate(step 10, 1 eq) in dichloromethane(0.02M) was treated at 0° C.with MeSO₂Cl (2.0 eq) and Et₃N(2.5eq) and stirred for 1 hour. Theice-bath was removed and the reaction mixture was stirred for another 1hour at room temperature before it was diluted with CH₂Cl₂, washed withNaH₂PO₄ ,brine and dried over Na₂SO₄. Evaporate solvent to give thedescribed product in quantitative yield. m/z(M+H)⁺695.0

[0480] Step 11: Methyl3-(4-{[2-(1-benzhydryl-5-chloro-2-{2-[(methylsulfonyl)oxy]ethyl}-1H-indol-3-yl)ethyl]sulfonyl}phenyl)propanoate(step11, 1.0 eq) was dissolved in DMF(0.03M) and treated with NaN₃ (3.0 eq).The resulting mixture was heated to 60° C. and stirred for 2 hours,then, was added water, extracted with ethyl acetate, washed with brineand dried with Na₂SO₄. Evaporation of solvent yields quantitatively thedescribed product. m/z (M+H)⁺641.1

[0481] Step 12:_Methyl3-[4-({2-[2-(2-azidoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate(step 12, 1 eq) was dissolved in THF(0.1M),and treated with triphenylphosphine(1.1 eq). The reaction mixture waskept stirred for 2 days before the addition of water, then stirredovernight. Strip off solvent, residue was columned with 4% MeOH:CH₂Cl₂as eluent to give the described product in 71% yield. m/z(M+H)⁺615.2

[0482] Step 13: Methyl3-[4-({2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate(step 12, 1 eq) and(3,4-dichlorobenzyl)sulfonyl chloride(1.1) were dissolved inCH₂Cl₂(0.1M) at room temperature, then aqueous Na₂CO₃ solution was addedwith stirring. The stirring was continued for 2 hours. Then, organicphase was separated, washed with brine, dried with Na₂SO₄. Evaporate thesolvent, the residue was columned with CH₂Cl₂ to 2% MeOH: CH₂Cl₂ aseluent to give 85% yield of the described product as white solid.m/z(M−H)⁻834.9

[0483] Step 14: Methyl3-[4-({2-[1-benzhydryl-5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate (step 13, 1.0 eq)was dissolved in THF:MeOH (1:1) (0.1M), then added 1N NaOH. The mixturewas kept stirred overnight at room temperature. The solvent was strippedoff and the residue was dissolved in water to form a basic solution,which was neutralized with diluted HCl solution to precipitate theproduct. The solid was collected by filtration, washed with water,rinsed with hexane, then dried to give the desired product in 86% yield.m/z(M−H)⁻820.9

EXAMPLE 1303-(4-{[2-(1-Benzhydryl-2-{2-[(benzylsulfonyl)amino]ethyl}-5-chloro-1H-indol-3-yl)ethyl]sulfonyl}phenyl)propanoicAcid

[0484] Step 1: The intermediate from example 129, step 12 was treatedwith □-toluenesulfonyl chloride according to the procedure in example129 step 13 to yield the desired compound in 94% yield.

[0485] Step 2: The intermediate from above was treated with NaOHaccording to the procedure described in example 129, step 13 to yieldthe desired acid in 92% %.

EXAMPLE 131 3-[4-({2-[1-benzhydryl-5-chloro-2-2{[(2,6-difluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl} sulfonyl)phenyl]propanoicAcid

[0486] Step 1: The intermediate from example 129, step 12 was treatedwith (2,6-Difluoro-phenyl)-methanesulfonyl chloride according to theprocedure in example 129 step 13 to yield the desired compound in 42%yield.

[0487] Step 2: The intermediate from above was treated with NaOHaccording to the procedure described in example 129, step 13 to yieldthe desired acid in 83% %.

EXAMPLE 132 3-[4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-fluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl] propanoicAcid

[0488] Step 1: The intermediate from example 129, step 12 was treatedwith (2-fluoro-phenyl)-methanesulfonyl chloride according to theprocedure in example 129 step 13 to yield the desired compound in 42%yield.

[0489] Step 2: The intermediate from above was treated with NaOHaccording to the procedure described in example 129, step 13 to yieldthe desired acid in 86% yield.

[0490] An intermediate from Method F could be alkylated at the C3position with aldehydes or the corresponding acetals in the presence ofa Lewis or Bronsted acid, such as boron triflouride etherate ortriflouroacetic acid. The indole nitrogen may then be alkylated bytreatment with a strong base such as sodium bis(trimethylsilyl)amide,n-BuLi, sodium hydride or potassium hydride in a solvent such as DMF,DMSO or THF followed by exposure to the appropriate halide. Theresulting thioether could be oxidized by a variety of oxidizing agentsincluding oxone and TPAP/NMO. The resulting sulfone can be deprotectedvia the action of a flouride source such as TBAF, CsF or HF. Theresulting alcohol could be converted to a halide or mesylate, forexample using methane sulfonyl chlroide and an organic base, which couldthen be displaced by sodium azide in DMF.The resulting alkyl azide couldbe reduced under the action of triphneyl phosphine and wet THF. Theamine could be sulfonylated by the action of a sulfonyl chloride undereither biphasic Shcott and Baumman conditions, Aq. Bicarbonate anddichloromethane, or under anhydrous conditions consisting ofdichloromethane and an organic base such as Hunigs base. The reultingintermediate was hydrolyzed using a base, NaOH, KOH, LiOH and a mixtureof solvents including an alcoholic solvent, water and tetrahydrofuran.

[0491] The following examples were synthesized with Method G: Examples133, 135-138, 140-141.

EXAMPLE 1333-[4-({2-[1-benzhydryl-5-chloro-2-(2{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoicAcid

[0492] The title compound was synthesized as depicted in Scheme G.

[0493] Step 1: Ethyl 4-[(2-oxoethyl)sulfanyl]propanoate (example 129step 3, 4.2 eq) was added to a solution containing2-({[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indole (1 eq), TFA(3 eq), and 1,2-dichloroethane (0.1 M) at 0° C. under N₂. Then Et₃SiH(12 eq) was added and the reaction was allowed to return to roomtemperature and stirred overnight. Quenched reaction with NaHCO₃(aq) andextracted with EtOAc and washed with brine and dried over sodiumsulfate. Purified with silica gel column and 1:5 EtOAc/Hexane as eluent.Obtained ethyl4-({2-[2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)propanoate(yellow oil) in 79% yield.

[0494] Step 2: Ethyl4-({2-[2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)propanoate(1 eq) was added to a suspension of NaH (1.1 eq) in DMF (0.38M) at 0° C.under N₂. After 30 minutes Ph₂CHBr was added and the reaction was warmedto room temperature. After 2.5 hours the reaction was quenched withNH₄Cl_((aq)) and extracted with EtOAc/Et₂O mix and washed with water andbrine and dried over sodium sulfate. Purified with silica gel column and1:6 EtOAc/Hexane. Obtained ethyl3-[4-({2-[1-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)phenyl]propanoate(yellow gum) in 42% yield.

[0495] Step 3: NMO (4eq) was added to a solution/suspension containingethyl3-[4-({2-[1-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)phenyl]propanoate(1 eq), ACN (0.1M), and molecular sieves (1 g/mmole of propanoate) underN₂. After 10 minutes TPAP (0.05 eq) was added and the mixture was heatedto 40° C. After 2 hours the reaction was cooled and filtered and thefiltrate was collected. Purified with silica gel column and 1:4EtOAc/Hexane. Obtained ethyl3-[4-({2-[1-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate(white solid) in 86% yield.

[0496] Step 4: Tetrabutylammonium fluoride (1M in THF) (1.2 eq) wasadded to a solution of ethyl3-[4-({2-[1-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate(1 eq) and THF (0.1M) at 0° C. under N₂. Warmed reaction to roomtemperature and after 30 minutes quenched with NH₄Cl_((aq)). Extractedwith EtOAc and washed with brine and dried over sodium sulfate. Purifiedwith silica gel column and 1:9 EtOAc/CH₂Cl₂. Obtained ethyl3-[4-({2-[1-benzhydryl-5-chloro-2-(2-hydroxyethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate(white solid) in 88% yield.

[0497] Step 5: CH₃SO₂Cl (2 eq) and Et₃N (2.5 eq) were added to asolution of ethyl3-[4-({2-[1-benzhydryl-5-chloro-2-(2-hydroxyethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate(1 eq) in CH₂Cl₂ (0.02M) at 0° C. under N₂. After 1 hour the reactionwas warmed to room temperature. After an additional hour water was addedand extracted with CH₂Cl₂ and washed with brine and dried over sodiumsulfate. Removed solvent to obtain ethyl3-(4-{[2-(1-benzhydryl-5-chloro-2-{2-[(methylsulfonyl)oxy]ethyl}-1H-indol-3-yl)ethyl]sulfonyl}phenyl)propanoate(white solid) in 98% yield.

[0498] Step 6: Ethyl3-(4-{[2-(1-benzhydryl-5-chloro-2-{2-[(methylsulfonyl)oxy]ethyl}-1H-indol-3-yl)ethyl]sulfonyl}phenyl)propanoate(1 eq), sodium azide (5 eq), and DMF (0.05M) were placed together underN₂ and heated to 60° C. After 1 hour the reaction was cooled and waterwas added. Extracted with EtOAc/Et₂O mix and washed with water and brineand dried over sodium sulfate. Removed solvent to obtain ethyl3-[4-({2-[2-(2-azidoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate(light-brown solid) in 96% yield.

[0499] Step 7: Ethyl3-[4-({2-[2-(2-azidoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]Aethyl}sulfonyl)phenyl]propanoate(1 eq), PPh₃ (polymer supported) (1.3 eq), and THF (0.1M) were placedtogether under N₂. After 3 days water (1 mL/1 mmole propanoate) wasadded and reaction was stirred overnight. Filtered and collectedfiltrate. Purified with silica gel column and 2% MeOH in CH₂Cl₂.Obtained ethyl3-[4-({2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate(light-brown solid) in 65% yield.

[0500] Step 8: (2-chlorobenzyl)sulfonyl chloride (2.2 eq) was added to amixture of ethyl3-[4-({2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate(1 eq), CH₂Cl₂ (0.08M), water (1 mL/1 mL CH₂Cl₂), and Na₂CO₃ (2.5 eq).After 2 hours more (2-chlorobenzyl)sulfonyl chloride (1.1 eq) was added.After an additional 1.5 hours the organic layer was recovered and washedwith brine and dried over sodium sulfate. Purified with silica gelpreparatory plate and 2% MeOH in CH₂Cl₂. Obtained ethyl3-[4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate(light-yellow gum) in 75% yield.

[0501] Step 9: Ethyl3-[4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoate(1 eq), THF (0.1 M), MeOH (1 mL/1 mL THF), and NaOH (1N) (11 eq) werestirred together overnight. Solvents were removed and the resultingresidue was taken up in water. The solution was acidified with 1N HCland collected resulting precipitate by filtration. Obtained3-[4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]propanoicacid (light-brown solid) in 83% yield.

[0502] The suitably substituted indole-2-carboxylate could be reducedvia a suitable reducing agent such as lithium aluminum hydride, dibaletc and then the resulting alcohol could be oxidized to the 2-formylindole using MnO₂, under Swern oxidation conditions or other oxidants.The indole nitrogen may then be alkylated by treatment with a strongbase such as sodium bis(trimethylsilyl)amide, n-BuLi, sodium hydride orpotassium hydride in a solvent such as DMF, DMSO or THF followed byexposure to the appropriate halide. The aldehyde was next treated withnitromethane and a base such as ammonium acetate to yield a vinyl nitrointermediate that could be reduced by a variety of agents such asLithium Aluminum Hydride or Zn(Hg) amalgam in HCl. The resulting aminewas sulfonylated using a sulfonyl chloride either under biphasic Schottand Baummen conditions or anhydrous conditions with an organic base.Treatment of the resulting sulfonamide with a strong base such as sodiumbis(trimethylsilyl)amide, n-BuLi, sodium hydride or potassium hydride ina solvent such as DMF, DMSO or THF followed by exposure to a silylchloride such as t-butyidimethyl silyl chloride to generate theprotected sulfonamide. This material could be formylated at C3 usingstandard Vilsmeier conditions conditions of POCl₃/DMF. The thus formed3-formyl indole was reductively aminated using a suitable amine, areducing agent such as sodium triacetoxyborohydride and acid such asglacial acetic acid. The reulting intermediate was hydrolyzed using abase, NaOH, KOH, LiOH and a mixture of solvents including an alcoholicsolvent, water and tetrahydrofuran.

[0503] The following examples were synthesized with Method H: Examples134.

EXAMPLE 1344-({[(1-benzhydryl-2-{2-[(benzylsulfonyl)amino]ethyl}-5-chloro-1H-indol-3-yl)methyl]amino}methyl)benzoicAcid

[0504] Step 1: 5-Chloro-1H-indole-2-carboxylic acid ethyl ester (1 eq.)was dissolved in THF (0.4M), flushed with a nitrogen atmosphere and thenthe mixture was cooled to 0° C. and LAH (3 eq of a 1M solution in THF)was slowly added. The reaction was allowed to warm slowly to roomtemperature and stirred until TLC analysis indicated completion. Aftercooling the flask to 0° C., NaOH (60 ml 3N solution) was slowly addedand the reaction stirred until two layers were obtained. The layers wereseparated, aqueous was extracted 2× ethyl acetate, the combine organicswere washed with brine and then dried over magnesium sulfate andconcentrated to yield the desired alcohol that was used crude for thenext step.

[0505] Step 2: The product (1 eq.) from above was dissolved in THF(0.5M) and treated with mangense dioxide (3 eq), and stirred for 1.5hours until TLC analysis indicated that reaction was complete. Thereaction was filtered through celite, dried over magnesium sulfate, andconcentrated to yield the desired crude aldehyde in 82% yield.

[0506] Step 3: To the indole from above (1.0 eq) in DMF (0.36 M) at 25°C. was added NaH (1.2 eq, 60% dispersion in oil), and the brown solutionwas stirred at 0 to −5° C. for 1 h and then bromodiphenylmethane wasadded (1.1 eq), and then the reaction mixture was stirred overnight. Itwas then quenched with water, diluted with ethyl acetate, washed withwater and brine, dried over sodium sulfate and purified by columnchromatography to yield 60% of the desired product.

[0507] Step 4: To the above aldehyde (1.0 equiv) in CH₃NO₂ (0.075 M) wasadded ammonium acetate (9 equiv) and the resulting mixture was heated toreflux overnight. The reaction mixture concentrated to a small volumeand then diluted with EtOAc and washed with brine. The aqueous phase wasextracted with EtOAc. The combined organic extracts were washed withbrine, dried over sodium sulfate and concentrated and purification bycolumn chromatography to the desired nitroolefin (51% yield).

[0508] Step 5: Zinc dust (20 equiv) was suspended in 5% aqueous HClsolution (8 M Zn/5% HCl). To this mixture was added HgCl₂ (0.28 equiv).The mixture was shaken for 10 min, the aqueous phase was decanted andreplaced with fresh 5% HCl, and again the mixture was shaken for 5 minand the aqueous phase was removed. The zinc-mercury amalgam thusgenerated was then added to a mixture of the nitroolefin (1.0 equiv) andconc. HCl (80 equiv) in THF (0.04M nitroolefin/THF). The mixture wasmaintained at a gentle reflux for 1 h. The formation of product wasfollowed by TLC analysis. The mixture was cooled to room temperature andthe solids were removed by filtration through Celite. Conc. NH₄OH wasadded to the solution phase and the mixture was concentrated on therotary evaporator. The residue was dissolved in CH₂Cl₂ and conc. NH₄OH.The aqueous phase was extracted with CH₂Cl₂, and the organic phase waswashed with brine, dried over sodium sulfate, and concentrated to yieldthe desired crude amine(100%) that was used in the next step withoutpurification.

[0509] Step 7: To the amine form above (1.0 equiv) and sat. NaHCO₃ (0.14M) in CH₂Cl₂ (0.07 M) was added □-toluenesulfonyl chloride (1.0 equiv).After 1 h the mixture was poured into saturated sodium bicarbonate andextracted with CH₂Cl₂. The combined organic phase was washed with brine,dried over sodium sulfate and purified by column chromatography(gradient elution using 10% EtOAc-hexanes→20% EtOAc-hexanes) to afford40% of the desired sulfonamide.

[0510] Step 8:The sulfonamide from above was dissolved in DMF (0.5M)under nitrogen atmosphere, cooled to 0° C., treated with sodium hydride(1.05 eq of a 60 oil dipersion), stirred for 15 minutes to ensure aniongeneration, treated with t-butyldimethsilyl chloride (1.2 eq) and thenstirred for twp hours at 0° C. at which time TLC analysis indicated thereaction was complete. The reaction was worked up by partitioningbetween ½ saturated ammonium chloride solution and ethyl acetate,extraction of the aqueous layers with ethyl acetate(2×), washingcombined organic layers with brine (1×), drying over magnesium sulfateand concentrating to yield quantitative crude yield of the desiredprotected sulfonamide.

[0511] Step 9: To DMF (˜1 ml) was added phosporous oxychloride (1.2 eq),these reagents were stirred for 10 minutes and then a solution of theindole (1 eq) from above in DMF (0.8 M) was added. The resulting redreaction mixture is stirred for 4 hours, diluted with water and then thepH was adjusted to 8 (total volume of aqueous added about ¾ of DMF addedinitially) and then the reaction was refluxed for 2 hours and finallycooled, extracted with dicloromethane, aqueous layer extracted withdichloromethane (2×), combined organic layers washed with brine (1×),dried over magnesium sulfate and concentrated to yield 75% of a crudealdehyde that was used without further purification.

[0512] Step 10: To the aldehyde from above (1 eq) in THF (1.2 M) wasadded 4-aminomethyl-benzoic acid methyl ester (1.2 eq), sodiumtriacetoxyborohydride (1.5 eq) and acetic acid (glacial, 1.5 eq). Thereaction was stirred overnight and then worked up by the addition ofsaturated sodium bicarbonate and ethyl acetate, the layers wereseparated, the aqueous layer extracted with dichloromethane (2×),combined organic layers washed with brine (1×), dried over magnesiumsulfate and concentrated and purified via chromatography to yield 37% ofthe desired product.

[0513] Step 11: The resulting ester was hydrolyzed by stirring with 1NNaOH (5 equiv) in THF (0.07 M) and enough MeOH to produce a clearsolution. The reaction was monitored by TLC (10% MeOH—CH₂Cl₂) for thedisappearance of starting material. The mixture was stirred at roomtemperature for 72 hours.. The mixture was concentrated, diluted withH₂O, and acidified to pH 5 using 1 M HCl. The aqueous phase wasextracted with EtOAc and the organic phase was washed with brine, driedover sodium sulfate, and concentrated to afford the desired product in83% yield. HRMS calc for [C₃₉H₃₆ClN₃O₄S—H] 676.20423 found 676.20397.

EXAMPLE 1354-{[2-(1-benzhydryl-2-{2-[(benzylsulfonyl)amino]ethyl}-5-chloro-1H-indol-3yl)ethyl]sulfonyl}benzoicAcid

[0514] Step 1: 2-(5-chloro-1H-indol-2-yl)ethanol (1 eq) was added to asolution (under N₂) containing tert-Butyldiphenylchlorosilane (1.2 eq),imidazole (2.5eq), and DMF (1.8M). The reaction was stirred overnight.Quenched with NaHCO_(3 (aq)) and extracted with a Et₂O/EtOAc mixture.The organic layer was washed with water and brine and dried over sodiumsulfate. Purified with silica gel column and 1:4 Hexane/CH₂Cl₂ aseluent. Obtained2-({[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indole (yellowoil) in 98% yield.

[0515] Step 2: Methyl 4-[(2-oxoethyl)sulfanyl]benzoate (3.7 eq) wasadded to a solution containing2-({[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indole (1 eq), TFA(3 eq), and 1,2-dichloroethane (0.1M) at 0° C. under N₂. Then Et₃SiH (12eq) was added and the reaction was allowed to return to room temperatureand stirred overnight. Quenched reaction with NaHCO_(3(aq)) andextracted with EtOAc and washed with brine and dried over sodiumsulfate. Purified with silica gel column and 1:5 EtOAc/Hexane as eluent.Obtained methyl4-({2-[2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)benzoate(yellow solid) in 79% yield.

[0516] Step 3: Methyl4-({2-[2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)benzoate(1 eq) was added to a suspension of NaH (1.1 eq) in DMF (0.37M) at 0° C.under N₂. After 30 minutes Ph₂CHBr (1.8 eq) was added and the reactionwas warmed to room temperature. After 3 hours the reaction was quenchedwith NH₄Cl_((aq)) and extracted with EtOAc/Et₂O mix and washed withwater and brine and dried over sodium sulfate. Purified with silica gelcolumn and 1:5 EtOAc/Hexane. Obtained methyl3-[4-({2-[1-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)phenyl]benzoate(yellow gum) in 65% yield.

[0517] Step 4: NMO (4 eq) was added to a solution/suspension containingmethyl3-[4-({2-[1-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfanyl)phenyl]benzoate(1 eq), ACN (0.1M), and molecular sieves (1 g/mmole of benzoate) underN₂. After 10 minutes TPAP (0.12 eq) was added and the mixture was heatedto 40° C. After 1.5 hours the reaction was cooled and filtered and thefiltrate was collected. Purified with silica gel column and 1:5EtOAc/Hexane. Obtained methyl3-[4-({2-[l-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(white solid) in 71% yield.

[0518] Step 5: Tetrabutylammonium fluoride (1 M in THF) (1.2 eq) wasadded to a solution of methyl3-[4-({2-[1-benzhydryl-2-(2-{[tert-butyl(diphenyl)silyl]oxy}ethyl)-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(1 eq) and THF (0.1M) at 0° C. under N₂. Warmed reaction to roomtemperature and after 1 hour quenched with NH₄Cl_((aq)). Extracted withEtOAc and washed with brine and dried over sodium sulfate. Purified withsilica gel column and 1:9 EtOAc/CH₂Cl₂. Obtained methyl3-[4-({2-[1-benzhydryl-5-chloro-2-(2-hydroxyethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(white solid) in 86% yield.

[0519] Step 6: CH₃SO₂Cl (2eq) and Et₃N (2.5 eq) were added to a solutionof methyl3-[4-({2-[1-benzhydryl-5-chloro-2-(2-hydroxyethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(1 eq) in CH₂Cl₂ (0.02M) at 0° C. under N₂. After 1 hour the reactionwas warmed to room temperature. After an additional hour water was addedand extracted with CH₂Cl₂ and washed with brine and dried over sodiumsulfate. Removed solvent to obtain methyl3-(4-{[2-(1-benzhydryl-5-chloro-2-{2-[(methylsulfonyl)oxy]ethyl}-1H-indol-3-yl)ethyl]sulfonyl}phenyl)benzoate(light-yellow solid) in 99% yield.

[0520] Step 7: Methyl3-(4-{[2-(1-benzhydryl-5-chloro-2-{2-[(methylsulfonyl)oxy]ethyl}-1H-indol-3-yl)ethyl]sulfonyl}phenyl)benzoate(1 eq), sodium azide (5 eq), and DMF (0.05 M) were placed together underN₂ and heated to 60° C. After 1 hour the reaction was cooled and waterwas added. Extracted with EtOAc/Et₂O mix and washed with water and brineand dried over sodium sulfate. Removed solvent to obtain methyl3-[4-({2-[2-(2-azidoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(light-yellow solid) in 99% yield.

[0521] Step 8: Methyl3-[4-({2-[2-(2-azidoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(1 eq), PPh₃ (2 eq), and THF (0.1 M) were placed together under N₂ andstirred overnight. Water (1 mL/1 mmole benzoate) was added and reactionwas again stirred overnight. The solution was concentrated and purifiedwith silica gel column and 3:1 EtOAc/Hexane followed by 5% MeOH inCH₂Cl₂. Obtained methyl3-[4-({2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(light-yellow solid) in 99% yield.

[0522] Step 9: alpha-Toluene sulfonyl chloride (2 eq) was added to amixture of methyl3-[4-({2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(1 eq), CH₂Cl₂ (0.08M), water (1 mL/1 mL CH₂Cl₂), and Na₂CO₃ (2.5eq).After 2 hours the organic layer was recovered and washed with brine anddried over sodium sulfate. Purified with silica gel preparatory plateand 3% MeOH in CH₂Cl₂. Obtained methyl4-{[2-(1-benzhydryl-2-{2-[(benzylsulfonyl)amino]ethyl}-5-chloro-1H-indol-3-yl)ethyl]sulfonyl}benzoate (off-whitesolid) in 94% yield.

[0523] Step 10: Methyl4-{[2-(1-benzhydryl-2-{2-[(benzylsulfonyl)amino]ethyl}-5-chloro-1H-indol-3-yl)ethyl]sulfonyl}benzoate(1 eq), THF (0.1 M), MeOH (1 mL/1 mL THF), and NaOH (1 N) (11 eq) werestirred together overnight. Solvents were removed and the resultingresidue was taken up in water. The solution was acidified with 1 N HCland collected resulting precipitate by filtration. Obtained4-{[2-(1-benzhydryl-2-{2-[(benzylsulfonyl)amino]ethyl}-5-chloro-1H-indol-3-yl)ethyl]sulfonyl}benzoicacid (off-white solid) in 92% yield.

EXAMPLE 1364-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino)ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoic Acid

[0524] Step 1: (2-chlorobenzyl)sulfonyl chloride (3.4eq) was added to amixture of methyl3-[4-({2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(Example 135, Step 8, 1 eq), CH₂Cl₂ (0.08M), water (1 mU/1 mL CH₂Cl₂),and Na₂CO₃ (2.5 eq). After 2 hours more (2-chlorobenzyl)sulfonylchloride (3.4 eq) was added. After an additional 1.5 hours the organiclayer was recovered and washed with brine and dried over sodium sulfate.Purified with silica gel preparatory plate and 3% MeOH in CH₂Cl₂.Obtained methyl3-[4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(orange gum) in 40% yield.

[0525] Step 2: Methyl3-[4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(1 eq), THF (0.1 M), MeOH (1 mL/1 mL THF), and NaOH (1 N) (11 eq) werestirred together overnight. Solvents were removed and the resultingresidue was taken up in water. The solution was acidified with 1 N HCland collected resulting precipitate by filtration. Obtained4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-chlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoicacid (red-orange solid) in 80% yield.

EXAMPLE 137 4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2,6-difluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoic Acid

[0526] Step 1: (2,6-difluorobenzyl)sulfonyl chloride (3.4 eq) was addedto a mixture of methyl3-[4-({2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(Example 135, Step 8, 1 eq), CH₂Cl₂ (0.08M), water (1 mL/1 mL CH₂Cl₂),and Na₂CO₃ (2.5 eq). After 2 hours the organic layer was recovered andwashed with brine and dried over sodium sulfate. Purified with silicagel preparatory plate and 3% MeOH in CH₂Cl₂. Obtained methyl4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2,6-difluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoate(off-white solid) in 87% yield.

[0527] Step 2: Methyl4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2,6-difluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoate(1 eq), THF (0.1M), MeOH (1 mL/1 mL THF), and NaOH (1N) (11 eq) werestirred together overnight. Solvents were removed and the resultingresidue was taken up in water. The solution was acidified with 1N HCland collected resulting precipitate by filtration. Obtained4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2,6-difluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoicacid (white-yellow solid) in 96% yield.

EXAMPLE 1384-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-fluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoic Acid

[0528] Step 1: (2-fluorobenzyl)sulfonyl chloride (3.4 eq) was added to amixture of methyl3-[4-({2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(Example 135, Step 8 , 1 eq), CH₂Cl₂ (0.08M), water (1 mL/1 mL CH₂Cl₂),and Na₂CO₃ (2.5 eq). After 2 hours the organic layer was recovered andwashed with brine and dried over sodium sulfate. Purified with silicagel preparatory plate and 3% MeOH in CH₂Cl₂. Obtained methyl4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-fluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoate(off-white solid) in 82% yield.

[0529] Step 2: Methyl4-({2-[1-benzhydryl-5-chloro-2-(2-{([(2-fluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoate(1 eq), TH F (0.1M), MeOH (1 mL/1 mL THF), and NaOH (1N) (11 eq) werestirred together overnight. Solvents were removed and the resultingresidue was taken up in water. The solution was acidified with 1N HCland collected resulting precipitate by filtration. Obtained4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-fluorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoicacid (off-white solid) in 99% yield.

EXAMPLE 139 4-(2-{1-Benzhydryl-5-chloro-2-[2-(2-pyrrolidin-1-yl-ethanesulfonylamino)-ethyl]-1H-indol-3-yl}-ethoxy)-benzoic Acid

[0530] Step 1: The compound was prepared from the intermediate fromExample 87 step 1 and pyrrolidine according to the procedure in Example87 step 2 in 92% yield without the column purification.

[0531] Step2: The ester intermediate was hydrolyzed according to Step 8Example 1, except that the pH was adjusted to 4-5, to afford the titleacid in 92% yield. HRMS calc for [C₃₈H₄₀ClN₃O₅S—H] 684.23044 found684.23009.

EXAMPLE 140 4-({2-[1-benzhydryl-5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)1H-indol-3-yl]ethyl}sulfonyl)benzoic Acid

[0532] Step 1: (3,4-dichlorobenzyl)sulfonyl chloride (2.1 eq) was addedto a mixture of methyl3-[4-({2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(Example 135, Step 8, 1 eq), CH₂Cl₂ (0.08M), water (1 mL/1 mL CH₂Cl₂),and Na₂CO₃ (2.5 eq). After 1 hours the organic layer was recovered andwashed with brine and dried over sodium sulfate. Purified with silicagel preparatory plate and 3% MeOH in CH₂Cl₂. Obtained methyl4-({2-[1-benzhydryl-5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoate(white solid) in 87% yield.

[0533] Step 2: Methyl4-({2-[1-benzhydryl-5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoate(1 eq), THF (0.1 M), MeOH (1 mL/1 mL THF), and NaOH (1N) (11 eq) werestirred together overnight. Solvents were removed and the resultingresidue was taken up in water. The solution was acidified with 1N HCland collected resulting precipitate by filtration. Obtained4-({2-[1-benzhydryl-5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoicacid (white-yellow solid) in 93% yield.

EXAMPLE 141 4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2,6-dimethylbenzyl)sulfonyl]amino}ethyl) 1H-indol-3-yl]ethyl}sulfonyl)benzoic Acid

[0534] Step 1: (2,6-methylbenzyl)sulfonyl chloride (3.0 eq, example 52,step 1) was added to a mixture of methyl3-[4-({2-[2-(2-aminoethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]ethyl}sulfonyl)phenyl]benzoate(Example 135, Step 8, 1 eq), CH₂Cl₂ (0.08M), water (1 mL/1 mL CH₂Cl₂),and Na₂CO₃ (2.5 eq). After 2 hours the organic layer was recovered andwashed with brine and dried over sodium sulfate. Purified with silicagel preparatory plate and 3% MeOH in CH₂Cl₂. Obtained methyl4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2,6-dimethylbenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoate(light-brown solid) in 81% yield.

[0535] Step 2: Methyl4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2,6-dimethylbenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoate(1 eq), THF (0.1 M), MeOH (1 mL/1 mL THF), and NaOH (1N) (11 eq) werestirred together overnight. Solvents were removed and the resultingresidue was taken up in water. The solution was acidified with 1N HCland collected resulting precipitate by filtration. Obtained4-({2-[1-benzhydryl-5-chloro-2-(2-{[(2,6-dimethylbenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}sulfonyl)benzoicacid (white solid) in 99% yield.

[0536] Method J provides an alternative reaction scheme to a subset ofthe compounds contained in this document. A suitably substituted anilineis halogenated using ICl, I₂, or Br₂ and then the amine is protected asa carbamate, using for example thriethylamine and a chloroformate. Thisaryl halide is coupled to a suitably functionalized alkyne under thereaction of Pd and copper catalysis in the presence of a base such astriethylamine. This resulting product could be cyclized using Pdcatalysis in the presence of allyl chloride and a substituted oxirane.The indole nitrogen may then be alkylated by treatment with a strongbase such as sodium bis(trimethylsilyl)amide, n-BuLi, sodium hydride orpotassium hydride in a solvent such as DMF, DMSO or THF followed byexposure to the appropriate halide. The allyl indole could then betreated with 9-BBN and then a palladium catalyst follwed by an aryl orvinyl iodide to efrfect a Suzuki coupling reaction. The resultingintermediate could be deprotected usiong a hydrazine or an alkyl amineto yiled the primary amine. This amine could then be treated with therequisite sulfonyl chloride under biphasic conditions, aqueous sodiumbicarbonate/dichloromethane, or in organic solvent with the addition ofa hindered organic amine base. The final hydrolysis was accomplishedunder basic conditions with sodium hydroxide in water and methanol andTHF at room temperature or at elevated temperature. Alternatively it maybe cleaved by treatment with sodium thiomethoxide in a solvent such asTHF or DMF at elevated temperatures (50° C.-100° C.).

[0537] Method K provides an alternative method to prepare the compoundsincluded in this document.

[0538] A suitably substituted aniline is halogenated using ICl, I₂, orBr₂ and then the amine is protected as a carbamate or amide ,using forexample triflouroacetic anhydride triethyamine and dimethylaminopyridine. This intermediate is then reacted with a suitablyfunctionalized alkyne under palladium and copper catalysis in thepresence of a base. The resulting aryl alkyne is cyclized to the indoleby heating with an amine such as piperidine. Standard Mitsunobu reactionconditions, a phosphine, an azodicarboxylate andphthalamide were used togenerated the protected amine. The indole may be alkylated at the C3position with aldehydes or the corresponding acetals in the presence ofa Lewis or Bronsted acid, such as boron triflouride etherate ortriflouroacetic acid. The indole nitrogen may then be alkylated bytreatment with a strong base such as sodium bis(trimethylsilyl)amide,n-BuLi, sodium hydride or potassium hydride in a solvent such as DMF,DMSO or THF followed by exposure to the appropriate halide. Theresulting intermediate could be deprotected usiong a hydrazine or analkyl amine to yiled the primary amine. This amine could then be treatedwith the requisite sulfonyl chloride under biphasic conditions, aqueoussodium bicarbonate/dichloromethane, or in organic solvent with theaddition of a hindered organic amine base. The final hydrolysis wasaccomplished under basic conditions with sodium hydroxide in water andmethanol and THF at room temperature or at elevated temperature.Alternatively it may be cleaved by treatment with sodium thiomethoxidein a solvent such as THF or DMF at elevated temperatures (50° C.-100°C.).

[0539] Method L provides an alternative method to prepare the compoundsincluded in this document. A suitably substituted halo aniline, seemethods J and K, and a symmetric alkynol or a monoprotected alkynol, forexample THP protection are reacted in the presence of a base, copper andpalladium catalysis, follwed by deprotection under acidic conditions ifa monoprotected substrate is used yielded the symmetrical indole diol.The diol is dysymmetrized by treatment with carbonyl diimidazole in asuitable solvent and then the primary alcohol was substituted understandard Mitsunobu conditions, a phosphine, an azodicarboxylate and analcohol were used to generated the desired ether. The carbamate could beopened up by reaction with sodium azide to yield the alkyl azide. Theindole nitrogen may then be alkylated by treatment with a strong basesuch as sodium bis(trimethylsilyl)amide, n-BuLi, sodium hydride orpotassium hydride in a solvent such as DMF, DMSO or THF followed byexposure to the appropriate halide. Treatment with triphenyl phosphinein wet THf delivered the desired alkyl amine. This amine could then betreated with the requisite sulfonyl chloride under biphasic conditions,aqueous sodium bicarbonate/dichloromethane, or in organic solvent withthe addition of a hindered organic amine base. The final hydrolysis wasaccomplished under basic conditions with sodium hydroxide in water andmethanol and THF at room temperature or at elevated temperature.Alternatively it may be cleaved by treatment with sodium thiomethoxidein a solvent such as THF or DMF at elevated temperatures (50° C.-100°C.).

[0540] Method M provides an alternative strategy to furnish thecompounds herein.

[0541] A suitably substituted aniline is halogenated using ICl, I₂, orBr₂ and then the amine can be alkylated using an organic base and ahalide. The thus formed alkyl amine is then reacted under palladiumcatalyzed conditions in the presence of a chloride souce a base and withor without a phsophine and the requisite alkyne to yield the indole.When the Z in the alkyne is NHSO₂X₁R₁ the synthesis is finished byhydrolysis under basic conditions with sodium hydroxide in water andmethanol and THF at room temperature or at elevated temperature.Alternatively it may be cleaved by treatment with sodium thiomethoxidein a solvent such as THF or DMF at elevated temperatures (50° C.-100°C.).

[0542] When Z═NH₂

[0543] The resulting indole could then be treated with the requisitesulfonyl chloride under biphasic conditions, aqueous sodiumbicarbonate/dichloromethane, or in organic solvent with the addition ofa hindered organic amine base. The final hydrolysis was accomplishedunder basic conditions with sodium hydroxide in water and methanol andTHF at room temperature or at elevated temperature. Alternatively it maybe cleaved by treatment with sodium thiomethoxide in a solvent such asTHF or DMF at elevated temperatures (50° C.-100° C.).

[0544] When Z═OH

[0545] The resulting alcohol could be converted to a halide or mesylate,for example using methane sulfonyl chiroide and an organic base, whichcould then be displaced by sodium azide in DMF.The resulting alkyl azidecould be reduced under the action of triphennyl phosphine and wet THF.The amine could be sulfonylated by the action of a sulfonyl chlorideunder either biphasic Shcott and Baumman conditions, Aq. Bicarbonate anddichloromethane, or under anhydrous conditions consisting ofdichloromethane and an organic base such as Hunigs base. The resultingintermediate was hydrolyzed using a base, NaOH, KOH, LiOH and a mixtureof solvents including an alcoholic solvent, water and tetrahydrofuran.

[0546] The appropriately substituted halo amine is reacted with asuitable halide and a tertiary amine base to yield an N-alkylatedsubstrate for a Shonigishiru coupling (with an alkynol in the presenceof Pd^(ii) and a suitable base). This arylalkynol is cyclized to theindole under the action of a copper halide and heat. The free alcoholwas protected with a silyl protecting group by reaction with a silylchloride in the presence of a base such as imidazole. This indole wasnext C₃ acylated by reaction with a suitable acid chloride and theresulting compound reduced with most reducing agents but preferablyborane or a borane complex. The primary alcohol was then oxidized to analdehyde by any number of oxiidizing agents, including oxalylchloride/DMSO (swern conditions) or TPAP/NMO. This aldehyde wassubjected to reductive amination conditions, which include a borohydridereducing agent and in some cases a protice acid, and a primary orsecondary amine. The silyl ether was then deprotected with a flouridesource including CsF, TBAF, HF etc. This free alcohol was converted intoa leaving group, halide with CBr₄ and a phosphine, or a sulfonate esterwith methane sulfonyl chloride and a tertiary amine. The activatedalcohol is reacted with sodium azide in either DMF or DMSO to yield thedesired azide which in turn was reduced under Staudinger conditions,phosphine and THF/H₂O, or via hydrogenation using hydrogen and asuitable catalyst. The amine could be sulfonylated by the action of asulfonyl chloride under either biphasic Shcott and Baumman conditions,Aq. Bicarbonate and dichloromethane, or under anhydrous conditionsconsisting of dichloromethane and an organic base such as Hunigs base.The resulting intermediate was hydrolyzed using a base, NaOH, KOH, LiOHand a mixture of solvents including an alcoholic solvent, water andtetrahydrofuran.

[0547] The following Examples 142-150 were synthesized with Method N.

EXAMPLE 1424-{[2-(1-benzhydryl-2-{2-[(benzylsulfonyl)amino]ethyl}-5-chloro-1H-indol-3-yl)ethyl]amino}benzoicAcid

[0548] Step 1: To a solution of 4-chloro-2-iodoaniline (16.5 g, 65.1mmol) in DMF (250 mL) at rt were added α-bromodiphenylmethane (21.5 g,84.6 mmol) and ^(i)Pr₂NEt (23 mL, 130 mmol) and the reaction mixture washeated at 45° C. overnight. After the volatile was removed under reducedpressure, the residue was dissolved in EtOAc, washed with water (3×) andbrine and dried over MgSO₄. Purification on SiO₂ column chromoatography(hexanes to 5% EtOAc/hexanes) gave the desiredBenzhydryl-(4-chloro-2-iodo-phenyl)-amine (26.1 g, 97% yield) as ayellowish solid.

[0549] Step 2: A mixture of benzhydryl-(4-chloro-2-iodo-phenyl)-amine(26.1 g, 62.2 mmol), PdCl₂(PPh₃)₂ (1.90 g, 2.67 mmol), Cul (1.2 g, 6.2mmol), 3-butyn-1-ol, and Et₃N (120 mL) was stirred at 45° C. for 20hours. The reaction mixture was filtered through celite and rinsed withEtOAc. The filtrate was concentrated, redissolved in EtOAc, washed withwater (3×) and brine, and dried over MgSO₄. The crude4-[2-(Benzhydryl-amino)-5-chloro-phenyl]-but-3-yn-1-ol (25.5 g) was usedin the next step directly without further purification.

[0550] Step 3: A solution of the crude4-[2-(benzhydryl-amino)-5-chloro-phenyl]-but-3-yn-1-ol (25.5 g) and Cul(2.7 g, 14.1 mmol) in DMF (200 mL) was heated at 125° C. for 24 hours.The reaction mixture was filtered through celite and rinsed with EtOAc.The filtrate was concentrated, redissolved in EtOAc, washed with water(3×) and brine, and dried over MgSO₄. Silica gel column chromatography(30% EtOAc/hexanes) yielded the desired2-(1-Benzhydryl-5-chloro-1H-indol-2-yl)-ethanol as a yellow solid (14.5g, 73% over 2 steps).

[0551] Step 4: To a solution of2-(1-benzhydryl-5-chloro-1H-indol-2-yl)-ethanol (15.3 g, 42.3 mmol) inCH₂Cl₂ (190 mL) at 0° C. were added imidazole (3.72 g, 55.0 mmol) andTBDPSCl (13.2 mL, 50.8 mmol). After stirring at the same temperature for1.5 hours, the reaction mixture was washed with cold water (3×) andbrine, and dried over MgSO₄. The crude silyl ether was used in the nextstep directly without further purification.

[0552] Step 5: To a solution of the crude silyl ether in Et₂O (200 mL)at 0° C. was added oxalyl chloride (4.84 mL, 55.5 mmol) dropwise. Thereaction mixture was allowed to warm to rt and stirring continued for 4hours before Et₃N (35 mL) and MeOH (10 mL) were added. The mixture waswashed with water, brine, and dried over MgSO₄. The crude keto ester wasused directly in the next step.

[0553] Step 6: To the keto ester in THF (300 mL) was added BH₃.Me₂S (10M, 36 mL) dropwise at rt and the reaction mixture was refluxedovernight. The mixture was cooled at 0° C. before NaOH (30%, 150 mL) wasadded and stirring continued for 30 min. THF was removed under reducedpressure and the reaction mixture was extracted with EtOAc, washed withwater, brine, and dried over MgSO₄. Purification on columnchromatography (15 to 20% EtOAc/hexanes) yielded the desired product asa white solid (15.9 g, 24.7 mmol, 58% over 3 steps).

[0554] Step 7: To a solution of oxalyl chloride (0.372 mL, 4.27 mmol) inCH₂Cl₂ (10 mL) at −78° C. was added DMSO (0.661 mL, 9.31 mmol) dropwise.The reaction mixture was stirred at the same temperature for 5 minbefore a solution of2-{1-benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl}-ethanol(2.50 g, 3.88 mmol) in CH₂Cl₂ (8 mL) was introduced. After additional 40min stirring, ^(i)Pr₂NEt (3.38 mL, 19.4 mmol) was added and the reactionwas quenched with cold water (5 mL) and extracted with CH₂Cl₂. Theorganic layer was dried over MgSO₄ and evaporated. The crude{1-Benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl}-acetaldehydewas used directly in the next step.

[0555] Step 8: To a solution of the crude aldehyde (3.88 mmol) in1,2-dichloroethane (39 mL) at 0° C were added methyl 4-aminobenzoate(645 mg, 4.27 mmol), acetic acid (1.33 mL), and NaBH(OAc)₃. The reactionmixture was allowed to warm to rt overnight and quenched with coldNaHCO₃. An extractive workup furnished the desired4-(2-{1-Benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl}-ethylamino)-benzoicacid methyl ester which was used directly in the next step withoutfurther purification.

[0556] Step 9: To4-(2-{1-benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl}-ethylamino)-benzoicacid methyl ester (3.88 mmol) in THF (25 mL) at 0° C. was added amixture of HOAc:1M TBAF (in THF) (2.3 mL:5.8 mL) and the reactionmixture was allowed to stir at rt for 18 h. Extractive workup followedby trituration with 5%EtOAc/hex gave the desired4-{2-[1-Benzhydryl-5-chloro-2-(2-hydroxy-ethyl)-1H-indol-3-yl]-ethylamino}-benzoicacid methyl ester with slight impurity as an off-white solid (92%, over3 steps).

[0557] Step 10: To a solution of4-{2-[1-benzhydryl-5-chloro-2-(2-hydroxy-ethyl)-1H-indol-3-yl]-ethylamino}-benzoicacid methyl ester (1.64 g, 3.04 mmol) in CH₂Cl₂ at 0° C. were added Et₃N(0.636 mL, 4.56 mmol) and MsCl (0.282 mL, 3.64 mmol). After stirring atthe same temperature for 35 min, the reaction mixture was quenched withcold water. An extractive workup revealed the crude mesylate as anoff-white solid (1.70 g, 90%).

[0558] Step 11: A solution of the crude mesylate (1.70 g, 2.75 mmol) andNaN₃ (89 mg, 13.8 mmol) in DMF (14 mL) was stirred at 80° C. for 6 h.The reaction mixture was diluted with EtOAc and subjected to an aqueousworkup followed by flash column chromatography to yield the desired4-{2-[2-(2-Azido-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethylamino}-benzoicacid methyl ester (813 mg, 52% yield).

[0559] Step 12: To4-{2-[2-(2-azido-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethylamino}-benzoicacid methyl ester (400 mg, 0.709 mmol) in THF (4 mL) at 0° C. was addedPh₃P (223 mg, 0.851 mmol) in portions. The reaction mixture was stirredat rt for 11 h and 35° C. for 4 h before water (50 uL) was added andstirring continued overnight. The reaction mixture was diluted withEtOAc, dried with MgSO₄ and purified by flash column chromatography(EtOAc to 20%MeOH/EtOAc with 1% Et₃N) to give the desired4-{2-[2-(2-Amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethylamino}-benzoicacid methyl ester (201 mg, 53%) as a solid.

[0560] Step 13: The intermediate from step 8 was treated withα-toluenesulfonyl chloride according to the procedure in Example 87 step2 to generate the desired product in 72% yield.

[0561] Step 14: The ester intermediate was hydrolyzed according to Step8 Example 1, to afford the title acid in 87% yield. HRMS calc for[C₃₉H₃₆ClN₃O₄S+H] 678.21879 found 678.2178.

Example 1434-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-chloro-6-methylphenyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}amino)benzoicAcid

[0562] Step 1: The intermediate from example 142 step 12 was treatedwith 2-chloro-6-methyl-benzenesulfonyl chloride according to theprocedure in Example 87 step 2 to generate the desired product in 85%yield.

[0563] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1, to afford the title acid in 96% yield. HRMS calc for[C₃₉H₃₅Cl₂N₃O₄S+H] 712.17981 found 712.17895.

Example 1444-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-methoxyphenyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}amino)benzoicAcid

[0564] Step 1: The intermediate from example 142 step 12 was treatedwith 2-methoxy-benzenesulfonyl chloride according to the procedure inExample 87 step 2 to generate the desired product in 85% yield.

[0565] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1, to afford the title acid in 92% yield. HRMS calc for[C₃₉H₃₆ClN₃O₅S+H] 694.2137 found 694.21311.

EXAMPLE 1454-({2-[1-benzhydryl-5-chloro-2-(2-{[(2-chlorophenyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}amino)benzoicAcid

[0566] Step 1: The intermediate from example 142 step 12 was treatedwith 2-chloro-benzenesulfonyl chloride according to the procedure inExample 87 step 2 to generate the desired product in 21% yield.

[0567] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1, to afford the title acid in 94% yield. HRMS calc for[C₃₈H₃₃Cl₂N₃0₄S+H] 698.16416 found 698.16365.

Example 1464-[[2-(1-benzhydryl-2-{2-[(benzylsulfonyl)amino]ethyl}-5-chloro-1H-indol-3-yl)ethyl](methyl)amino]benzoicAcid

[0568] Step 1: Crude{1-Benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl}-acetaldehydefrom step 7, example 142 was treated with 4-Methylamino-benzoic acidmethyl ester according to the procedure in Example 142 step 8 to yieldthe desired4-[(2-{1-Benzhydryl-2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-5-chloro-1H-indol-3-yl}-ethyl)-methyl-amino]-benzoicacid methyl ester in 73% yield.

[0569] Step 2: The title compound was prepared according to theprocedure described for Example 142 step 9. The crude4-({2-[1-Benzhydryl-5-chloro-2-(2-hydroxy-ethyl)-1H-indol-3-yl]-ethyl}-methyl-amino)-benzoicacid methyl ester was used in the next step directly without furtherpurification.

[0570] Step 3-6:4-({2-[2-(2-Azido-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethyl}-methyl-amino)-benzoicacid methyl ester was prepared according to the procedure described forexample 142 steps 10-12 in 61% (3 steps).

[0571] Step 7: A solution of4-({2-[2-(2-azido-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethyl}-methyl-amino)-benzoicacid methyl ester (410 mg, 0.709 mmol) and 10% Pd/C (155 mg) inMeOH:CH₂Cl₂ (=7 mL:1 mL) was stirred under H₂ atmosphere (1 atm) for 2h15 min. The reaction mixture was filtered through celite and rinsedwith MeOH and CH₂Cl₂. Flash column chromatography (CH₂Cl₂ to 8%MeOH/CH₂Cl₂) of the residue gave the desired4-({2-[2-(2-Amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethyl}-methyl-amino)-benzoicacid methyl ester in 78% yield (305 mg).

[0572] Step 8: The intermediate from step 7 was treated withα-toluenesulfonyl chloride according to the procedure in Example 87 step2 to generate the desired product in 83% yield.

[0573] Step 9: The ester intermediate was hydrolyzed according to Step 8Example 1, to afford the title acid in 91% yield. HRMS calc for[C₃₉H₃₈ClN₃0₄S+H] 692.23444 found 692.23374.

Example 1474-[{2-[1-benzhydryl-5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}(methyl)amino]benzoicAcid

[0574] Step 1: The intermediate from example 146 step 7 was treated with3,4-dichlorophenylmethanesulfonylchloride according to the procedure inExample 87 step 2 to generate the desired product in 87% yield.

[0575] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1, to afford the title acid in 68% yield. HRMS calc for[C₄₀H₃₆Cl₃N₃O₄S+H] 760.15649 found 760.1573.

EXAMPLE 148 4-[{2-[1-benzhydryl-5-chloro-2-(2-{[(2-chloro-6-methylphenyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}(methyl)amino]benzoicAcid

[0576] Step 1: The intermediate from example 146 step 7 was treated with2-chloro-6-methyl-benzenesulfonyl chloride according to the procedure inExample 87 step 2 to generate the desired product in 96% yield.

[0577] Step 2: The ester intermediate was hydrolyzed according to Step 8Example 1, to afford the title acid in 88% yield. HRMS calc for[C₄₀H₃₇Cl₂N₃0₄S+H] 726.19546 found 726.19461.

EXAMPLE 1494-[{2-[1-benzhydryl-5-chloro-2-(2-{[(2-chlorophenyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}(methyl)amino]benzoicAcid

[0578] Step 1: The intermediate from example 146 step 7 was treated with2-chlorobenzenesulfonyl chloride according to the procedure in Example87 step 2 to generate the desired product in 96% yield. Step 2: Theester intermediate was hydrolyzed according to Step 8 Example 1, toafford the title acid in 84% yield. HRMS calc for [C₃₉H₃₅Cl₂N₃O₄S+H]712.17981 found 712.17966.

EXAMPLE 1504-[{2-[1-benzhydryl-5-chloro-2-(2-{[(2-methoxyphenyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]ethyl}(methyl)amino]benzoicAcid

[0579] Step 1: The intermediate from example 146 step 7 was treated with2-methoxy-benzenesulfonyl chloride according to the procedure in Example87 step 2 to generate the desired product in 95% yield.

[0580] Step 10: The ester intermediate was hydrolyzed according to Step8 Example 1, to afford the title acid in 73% yield. HRMS calc for[C₄₀H₃₈ClN₃O₅S+H] 708.22935 found 708.2286.

[0581] Coumarine Assay

[0582] 7-hydroxycoumarinyl 6-heptenoate was used as a monomericsubstrate for cPLA₂ as reported previously (Huang, Z. et al., 1994,Nalytical Biochemistry 222, 110-115). Inhibitors were mixed with 200 μLassay buffer (80 mM Heped, pH 7.5, 1 mM EDTA) containing 60 μM7-hydroxycoumarinyl 6-heptenoate. The reaction was initiated by adding 4μg cPLA₂ in 50 μL assay buffer. Hydrolysis of the 7-hydroxycounarimyl6-heptenoate ester was monitored in a fluorometer by exciting at 360 nmand monitoring emission at 460 nm. Enzyme activity is proportional tothe increase in emission at 460 nm per minute. In the presence of acPLA₂ inhibitor, the rate of increase is less. Coumarin Example # IC₅₀(μM) Example 1 0.42 Example 2 2 Example 3 2.5 Example 4 56 Example 5 3Example 6 2.0 Example 7 0.55 Example 8 2 Example 9 0.7 Example 10 0.57Example 11 0.45 Example 12 150 Example 13 0.64 Example 14 0.8 Example 150.63 Example 16 0.98 Example 17 0.2 Example 18 0.4 Example 19 0.31Example 20 1.1 Example 21 1.1 Example 22 1.8 Example 23 1.5 Example 240.34 Example 25 3.4 Example 26 1.1 Example 27 0.8 Example 28 0.95Example 29 0.19 Example 30 0.15 Example 31 0.15 Example 32 0.085 Example33 2.9 Example 35 0.33 Example 36 0.5 Example 37 0.37 Example 38 0.5Example 39 0.32 Example 40 0.73 Example 41 0.2 Example 42 0.18 Example43 0.2 Example 44 0.25 Example 45 4.7 Example 46 4.8 Example 47 0.58Example 48 2.35 Example 49 1.1 Example 50 0.69 Example 51 2.2 Example 520.13 Example 53 0.37 Example 54 0.31 Example 55 0.26 Example 56 0.13Example 57 0.28 Example 58 0.36 Example 59 0.29 Example 60 0.15 Example61 0.34 Example 62 0.38 Example 63 0.30 Example 64 0.12 Example 65 0.13Example 66 0.15 Example 67 0.14 Example 68 0.16 Example 69 0.15 Example70 0.18 Example 71 0.45 Example 72 0.28 Example 73 0.30 Example 74 0.28Example 75 0.4 Example 76 0.4 Example 77 0.48 Example 78 0.34 Example 790.15 Example 80 3.7 Example 81: 0.47 Example 82: 0.5 Example 83 0.45Example 84 0.5 Example 85 0.4 Example 86 0.6 Example 87 1.2 Example 88<7.4 Example 89 0.38 Example 90 0.65 Example 91 0.5 Example 92 1.0Example 93 0.56 Example 94 0.8 Example 95 0.85 Example 96 0.95 Example97 0.95 Example 98 1.1 Example 99 1.0 Example 100 0.12 Example 101 0.1Example 102 0.19 Example 103 1.1 Example 104 1.1 Example 105 0.65Example 106 0.22 Example 107 0.33 Example 108 0.15 Example 109 0.4Example 110 0.5 Example 111 1.0 Example 112 1.2 Example 113 1.3 Example114 1.1 Example 115 0.9 Example 116 1.2 Example 117 1.6 Example 118 0.4Example 119 0.4 Example 120 0.4 Example 121 0.46 Example 122 2.5 Example123 1.7 Example 124 0.8 Example 125 1.4 Example 126 0.2 Example 127 0.2Example 128 0.32 Example 129 0.13 Example 130 0.17 Example 131 0.2Example 132 0.2 Example 133 0.09 Example 134 >1 Example 135 0.2 Example136 0.18 Example 137 NT Example 138 0.2 Example 139 1.7 Example 140 0.2Example 141 0.17

[0583] Many variations of the present invention not illustrated hereinwill occur to those skilled in the art. The present invention is notlimited to the embodiments illustrated and described herein, butencompasses all the subject matter within the scope of the appendedclaims

1. A compound of the formula

wherein R is —(CH₂)_(n)—A, —(CH₂)_(n)—S—A, or —(CH₂)_(n)—O—A, where Arepresents:

D represents C₁-C₆ alkyl, C₁-C₆ alkoxy, —CF₃ or —C₁₋₃alkyl-CF₃, B and Care each independently selected from the group consisting of phenyl,pyridinyl, pyrimidinyl, furanyl, thiophenyl or pyrrolyl groups, eachoptionally substituted by from 1 to 3, preferably 1 to 2, substituentsselected independently from the group consisting of H, halogen, —CN,—CHO, —CF₃, —OCF₃, —OH, —C₁-C₆ alkyl, C₁-C₆ alkoxy, —NH₂ , —N(C₁-C₆)₂,—NH(C₁-C₆), —N—C(O)—(C₁-C₆), —NO₂, or by a 5- or 6-membered heterocyclicor heteroaromatic ring containing 1 or 2 heteroatoms selected from O, Nor S; R′ is selected from the group consisting of —CH₂—OH,—CH₂—NH—S(O)₂—(CH₂)_(n2)-halo, —CH₂—NH-S(O)₂—CH═CH, —CH₂—NH₂, or aprotected form of —CH₂—NH₂; R₇ and R₈ are independently selected from H,halogen, —CN, —CHO, —CF₃, —OCF₃, —OH, —C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆thioalkyl, —NH₂, —N(C₁-C₆)₂, —NH(C₁-C₆), —N—C(O)—(C₁-C₆), or —NO₂; R₉represents —(CH₂)_(n4)—CO₂H, a C₁-C₈ alkyl ester of —(CH₂)_(n4)—CO₂H, ora pharmaceutically acceptable acid mimic or mimetic; R₁₀ is selectedfrom H, halogen, —CN, —CHO, —CF₃, —OCF₃, —OH, —C₁-C₆ alkyl, C₁-C₆alkoxy, C₁-C₆ thioalkyl, —NH₂, —N(C₁-C₆)₂, —NH(C₁-C₆), —N—C(O)—(C₁-C₆),or —NO₂; R₁₁ is selected from H, halogen, —CN, —CHO, —CF₃, —OCF₃, —OH,—C₁-C₆ alkyl, C₁-C₆ alkoxy, C₁-C₆ thioalkyl, —NH₂, —N(C₁-C₆)₂,—NH(C₁-C₆), —N—C(O)—(C₁-C₆), —NO₂, —N—C(O)—N(C₁-C₃ alkyl)₂ ,—N—C(O)—NH(C₁-C₃ alkyl), —N—C(O)—O—(C₁-C₃ alkyl), —SO₂—C₁-C₆ alkyl,—S—C₃-C₆ cycloalkyl, —S—CH₂—C₃-C₆ cycloalkyl, —SO₂—C₃-C₆ cycloalkyl,—SO₂—CH₂—C₃-C₆ cycloalkyl, C₃—C₆ cycloalkyl, —CH₂—C₃-C₆ cycloalkyl,—O—C₃-C₆ cycloalkyl, , —O—CH₂—C₃-C₆ cycloalkyl, phenyl, benzyl,benzyloxy, morpholino or other heterocycles such as pyrrolidino,piperidine, piperizine, furan, thiophene, imidazole, tetrazole,pyrazine, pyrazolone, pyrazole, imidazole, oxazole or isoxazole, therings of each of these groups each being optionally substituted by from1 to 3 substituents selected from the group of H, halogen, —CN, —CHO,—CF₃, —OH, —C₁-C₆ alkyl, C₁-C₆ alkoxy, —NH₂, —N(C₁-C₆)₂, —NH(C₁-C₆),—N—C(O)—(C₁-C₆), —NO₂, —SO₂(C₁-C₃ alkyl), —SO₂NH(C₁-C₃ alkyl),—SO₂N(C₁-C₃ alkyl)₂, or OCF₃; n is an integer from 0 to 3; n₁ is aninteger from 0 to 3; n₂ is an integer from 0 to 3 n₃ is an integer from0 to 3; n₄ is an integer from 0 to 2; and, X is a linking group selectedfrom the group consisting of of —O—, —CH₂—, —SO₂—, —NH—, and—N(C₁-C₆-alkyl)—.
 2. A compound according to claim 1 having the formula

wherein: R′, R₇₋₁₁, X, n₁, n₂ and n₄ are as defined in claim 1 and R₁,R₂, R₃, R₄, R₅ and R₆ are each independently selected from the groupconsisting of H, halogen, —CN, —CHO, —CF₃, —OCF₃, —OH, —C₁-C₆ alkyl,C₁-C₆ alkoxy, —NH₂ , —N(C₁-C₆)₂, —NH(C₁-C₆), —N13 C(O)13 (C₁-C₆), —NO₂,or a 5- or 6-membered heterocyclic or heteroaromatic ring containing 1or 2 heteroatoms selected from O, N or S.
 3. A compound according toclaim 2 wherein the halogen atom in the R′ group—CH₂—NH—S(O)₂—(CH₂)_(n2)-halo is bromine or chlorine.
 4. A compoundaccording to claim 2 having the formula


5. A compound according to claim 4 wherein R₁, R₂, R₃, R₄, R₅ and R₆ areeach H.
 6. A compound according to claim 1 having the formula

wherein R₁, R₂, R₃, R₄, R₅ and R₆ are each independently selected fromH, halogen, —CN, —CHO, —CF₃, —OCF₃, —OH, —C₁-C₆ alkyl, C₁-C₆ alkoxy,—NH₂, —N(C₁-C₆)₂, —NH(C₁-C₆), —N—C(O)—(C₁-C₆), —NO₂, or a 5- or6-membered heterocyclic or heteroaromatic ring containing 1 or 2heteroatoms selected from O, N or S.
 7. A compound according to claim 6wherein R₁, R₂, R₃, R₄, R₅ and R₆ are each H.
 8. A compound selectedform the group consisting of:4-{2-[2-(2-Amino-ethyl)-1-benzyhydryl-5-chloro-1H-indol-3-yl]-ethanesulfonyl}-benzoicacid methyl ester;4-{2-[2-(2-Amino-ethyl)-1-benzyhydryl-5-chloro-1H-indol-3-yl]-ethoxy}-benzoic acid methyl ester; and4-{3-[2-(2-Amino-ethyl)-1-benzyhydryl-5-chloro-1H-indol-3-yl]-propyl}-benzoic acid methyl ester.4-{2-[2-(2-Amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethylamino}-benzoic acid methyl ester4-({2-[2-(2-Amino-ethyl)-1-benzhydryl-5-chloro-1H-indol-3-yl]-ethyl}-methyl-amino)-benzoicacid methyl ester